data_1mot_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mot _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 N--CA 1.461 0.101 0 CA-C-O 120.635 0.255 . . . . 1.28 110.708 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.84 -48.0 85.01 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.116 -0.564 . . . . 0.51000000000000001 111.797 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.3 mt -61.45 -45.27 94.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.109 0.481 . . . . 1.4099999999999999 110.785 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 260' ' ' VAL . . . -61.43 -52.27 52.44 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.643 -0.708 . . . . 0.34999999999999998 113.116 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.66 -38.59 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 117.415 0.608 . . . . 1.25 110.896 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.5 m -63.25 -42.85 99.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.079 0.466 . . . . 1.1599999999999999 109.987 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.401 ' O ' ' HG2' ' A' ' 263' ' ' MET . 57.5 m -62.69 -48.92 77.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.906 -0.588 . . . . 1.24 110.156 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 256' ' ' GLY . 98.9 t -59.2 -49.14 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.122 -0.49 . . . . 1.2 110.452 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 23.5 tp -57.52 -40.19 78.18 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.305 -0.407 . . . . 1.3600000000000001 110.321 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 93.2 m -64.25 -48.54 75.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.888 -0.596 . . . . 1.28 110.525 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 259' ' ' THR . 96.3 mmm . . . . . 0 CA--C 1.534 0.339 0 CA-C-N 115.837 -0.62 . . . . 1.4199999999999999 112.38 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.751 0.31 . . . . 1.76 111.505 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.08 -46.21 94.1 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.922 -0.581 . . . . 0.89000000000000001 112.17 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 6.2 mt -62.47 -45.06 94.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.896 0.379 . . . . 1.6200000000000001 110.779 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.13 -50.85 61.25 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.034 -0.603 . . . . 0.68999999999999995 112.821 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.5 pp -64.07 -36.53 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 117.31 0.555 . . . . 1.45 110.69 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 88.4 m -66.06 -42.06 89.96 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.718 -0.475 . . . . 1.5 109.718 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.7 m -63.96 -49.19 73.5 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.915 -0.584 . . . . 1.51 110.012 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 82.6 t -59.9 -48.97 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.126 -0.488 . . . . 1.3500000000000001 110.391 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.2 OUTLIER -56.7 -42.82 79.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.039 0.447 . . . . 1.75 109.826 178.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 85.5 m -61.61 -47.46 85.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.761 -0.654 . . . . 1.72 110.666 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 89.4 mtp . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 115.993 -0.548 . . . . 1.9399999999999999 111.689 179.587 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.673 0.273 . . . . 1.4099999999999999 110.712 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.99 91.42 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.913 -0.585 . . . . 0.48999999999999999 111.992 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.66 -46.02 91.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.268 0.556 . . . . 1.3600000000000001 111.297 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 260' ' ' VAL . . . -62.51 -51.73 54.08 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.705 -0.76 . . . . 0.60999999999999999 113.092 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 258' ' ' THR . 2.2 pp -63.45 -40.99 91.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 117.384 0.592 . . . . 1.3600000000000001 111.928 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.426 HG23 HD13 ' A' ' 257' ' ' ILE . 25.7 p -65.88 -43.9 86.93 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.79 0.293 . . . . 1.3200000000000001 111.79 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.0 p -65.77 -47.09 76.34 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.902 -0.319 . . . . 1.2 110.623 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 256' ' ' GLY . 71.9 t -59.65 -45.94 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.487 -0.324 . . . . 1.3999999999999999 110.438 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.77 -46.71 89.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.893 0.377 . . . . 1.54 110.522 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 91.1 m -59.92 -49.85 76.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.332 0.587 . . . . 1.2 110.66 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.613 -0.721 . . . . 1.77 111.926 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 112.978 0.733 . . . . 1.1899999999999999 112.978 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.96 26.55 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 116.087 -0.506 . . . . 0.47999999999999998 113.485 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.45 -41.24 93.67 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.538 -0.389 . . . . 1.4199999999999999 110.415 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 260' ' ' VAL . . . -60.52 -52.38 52.94 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.694 -0.765 . . . . 0.46999999999999997 112.689 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.82 -41.58 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.96 0.38 . . . . 1.1899999999999999 111.831 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 20.5 p -64.68 -38.75 92.07 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.648 -0.421 . . . . 1.21 110.688 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 87.4 m -65.32 -49.23 70.25 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.016 -0.364 . . . . 1.24 110.016 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 256' ' ' GLY . 78.4 t -59.6 -45.57 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 1.21 110.578 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.72 -45.41 89.65 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.046 0.45 . . . . 1.95 110.132 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 91.7 m -60.83 -49.96 75.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.927 -0.579 . . . . 1.22 110.67 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.769 -0.651 . . . . 1.6499999999999999 111.864 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.685 0.279 . . . . 2.3500000000000001 110.3 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.98 -47.19 91.94 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.965 -0.562 . . . . 1.5600000000000001 111.806 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.36 -46.13 91.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.105 0.479 . . . . 1.9099999999999999 110.885 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.01 -51.97 53.3 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.59 -0.732 . . . . 1.25 113.193 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.72 -38.48 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 117.452 0.626 . . . . 1.8799999999999999 111.031 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 88.7 m -64.42 -42.18 96.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.778 0.323 . . . . 1.3500000000000001 110.223 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 57.1 m -63.52 -47.4 81.82 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.216 -0.447 . . . . 1.25 110.177 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.3 t -61.4 -48.61 88.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.094 -0.503 . . . . 1.6699999999999999 110.864 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -58.68 -42.67 89.05 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.133 0.492 . . . . 1.98 110.36 179.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.6 m -63.29 -49.2 74.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.792 -0.64 . . . . 1.3 111.008 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 CA--C 1.535 0.385 0 CA-C-N 115.964 -0.562 . . . . 1.9299999999999999 111.51 -179.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 254' ' ' GLY . 13.2 p . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.085 0.469 . . . . 1.45 110.914 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.421 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -59.59 -46.21 94.36 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.537 -0.756 . . . . 0.62 112.202 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.14 -45.7 92.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.101 0.477 . . . . 1.51 110.929 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -59.98 -50.63 65.62 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.948 -0.644 . . . . 0.59999999999999998 112.953 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.55 -37.93 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.26 0.53 . . . . 1.3100000000000001 111.159 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.4 m -62.36 -46.52 88.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.768 0.318 . . . . 1.23 110.941 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 41.1 p -65.51 -46.94 77.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.264 -0.425 . . . . 1.3300000000000001 110.773 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 256' ' ' GLY . 76.4 t -60.18 -50.45 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.562 -0.29 . . . . 1.3200000000000001 110.639 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 261' ' ' LEU . 25.3 tp -57.45 -47.12 82.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.638 -0.256 . . . . 1.3600000000000001 110.865 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.9 m -57.58 -48.02 80.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.171 0.51 . . . . 1.1699999999999999 110.946 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 CA--C 1.54 0.567 0 CA-C-N 115.685 -0.689 . . . . 1.7 112.431 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 121.093 0.473 . . . . 1.24 111.346 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -60.77 -45.6 96.13 Favored Glycine 0 C--N 1.323 -0.171 0 CA-C-N 115.498 -0.774 . . . . 0.39000000000000001 112.259 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.17 -46.66 87.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.116 0.484 . . . . 1.3400000000000001 111.069 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.35 54.66 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.736 -0.665 . . . . 0.37 113.313 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.2 pp -62.58 -41.32 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 117.429 0.614 . . . . 1.1899999999999999 111.644 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.407 HG23 HD12 ' A' ' 257' ' ' ILE . 24.3 p -66.28 -40.88 90.37 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 122.23 -0.294 . . . . 1.21 110.988 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 85.6 m -64.16 -48.73 74.86 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.094 -0.336 . . . . 1.1899999999999999 110.094 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 75.3 t -60.54 -48.54 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.163 -0.471 . . . . 1.21 110.884 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.2 OUTLIER -56.52 -43.69 80.06 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.011 0.434 . . . . 1.74 110.357 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 92.6 m -60.73 -49.2 78.47 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.688 -0.687 . . . . 1.28 110.745 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' MET . . . . . 0.436 ' HE2' ' HB3' ' A' ' 263' ' ' MET . 88.8 mtp . . . . . 0 CA--C 1.538 0.486 0 CA-C-N 116.041 -0.527 . . . . 1.3799999999999999 112.412 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 121.02 0.438 . . . . 1.74 110.311 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -61.61 -46.44 94.26 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.709 -0.678 . . . . 0.68000000000000005 112.066 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.59 -41.24 98.84 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.105 0.479 . . . . 1.5800000000000001 110.314 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.25 -53.36 42.83 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.879 -0.601 . . . . 0.71999999999999997 112.639 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.46 -35.8 75.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.292 0.546 . . . . 1.3500000000000001 111.396 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.4 m -64.69 -47.8 77.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.835 0.35 . . . . 1.4399999999999999 110.8 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.3 p -64.75 -45.88 84.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.421 -0.354 . . . . 1.45 110.989 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 73.5 t -59.29 -48.26 87.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.758 -0.201 . . . . 1.3200000000000001 110.85 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.406 ' HA ' HD11 ' A' ' 261' ' ' LEU . 20.3 tp -62.48 -38.32 89.4 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.997 0.427 . . . . 1.6499999999999999 110.773 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 99.4 m -64.31 -49.19 72.72 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.012 -0.54 . . . . 1.8400000000000001 110.91 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 CA--C 1.537 0.449 0 CA-C-N 116.171 -0.468 . . . . 1.6799999999999999 112.063 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 CA--C 1.53 0.2 0 CA-C-O 120.636 0.255 . . . . 2.6400000000000001 110.905 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -61.34 -49.22 79.88 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.967 -0.635 . . . . 1.3400000000000001 111.854 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.26 -39.56 90.84 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.223 0.535 . . . . 2.6699999999999999 110.425 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.435 ' O ' HG21 ' A' ' 260' ' ' VAL . . . -63.13 -54.35 33.49 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.798 -0.637 . . . . 1.45 112.824 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.29 -35.63 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 117.471 0.636 . . . . 2.3999999999999999 111.064 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 90.8 m -64.29 -47.72 78.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.796 0.331 . . . . 2.2000000000000002 111.128 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.9 p -66.0 -46.13 79.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.37 -0.377 . . . . 2.3599999999999999 110.869 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 256' ' ' GLY . 79.2 t -59.82 -47.63 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.449 -0.341 . . . . 2.25 110.641 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.8 -45.51 92.12 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.779 0.323 . . . . 2.5699999999999998 110.283 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.8 m -60.39 -46.15 91.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.303 0.573 . . . . 2.54 111.32 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' MET . . . . . 0.457 ' HE1' ' HB3' ' A' ' 263' ' ' MET . 52.7 ttp . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.747 -0.66 . . . . 2.75 112.26 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 254' ' ' GLY . 6.3 p . . . . . 0 N--CA 1.464 0.243 0 CA-C-O 120.966 0.412 . . . . 1.3700000000000001 111.144 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.445 ' N ' HG11 ' A' ' 253' ' ' VAL . . . -57.38 -48.51 80.04 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.352 -0.84 . . . . 0.68000000000000005 112.435 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.02 -44.39 94.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.327 0.584 . . . . 1.5800000000000001 111.013 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.26 -52.29 48.27 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.687 -0.768 . . . . 0.53000000000000003 112.989 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.27 -39.96 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 117.482 0.641 . . . . 1.3100000000000001 111.973 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 22.2 p -65.73 -45.74 81.54 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.62 0.23 . . . . 1.29 111.62 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.6 p -65.2 -45.82 83.23 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 121.009 -0.276 . . . . 1.25 110.597 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.2 t -60.57 -46.86 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.594 -0.275 . . . . 1.3500000000000001 110.591 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 261' ' ' LEU . 0.4 OUTLIER -59.55 -45.94 90.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.125 0.488 . . . . 1.8100000000000001 109.753 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 90.7 m -60.24 -49.95 75.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.714 -0.675 . . . . 1.26 110.936 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 CA--C 1.537 0.467 0 CA-C-N 115.863 -0.608 . . . . 1.8600000000000001 111.963 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.271 0.558 . . . . 1.4099999999999999 110.354 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.426 ' O ' HG13 ' A' ' 257' ' ' ILE . . . -61.27 -49.35 78.72 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.027 -0.988 . . . . 0.48999999999999999 112.109 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.24 -43.6 92.38 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.013 0.435 . . . . 1.3899999999999999 111.152 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.443 ' O ' HG22 ' A' ' 260' ' ' VAL . . . -61.98 -53.54 42.08 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.816 -0.629 . . . . 0.45000000000000001 112.941 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 254' ' ' GLY . 2.4 pp -62.34 -38.43 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 117.36 0.58 . . . . 1.25 110.93 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 41.9 m -62.62 -43.35 99.04 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.987 0.422 . . . . 1.25 109.984 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 46.5 m -63.2 -46.55 86.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.069 -0.514 . . . . 1.1699999999999999 110.096 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 256' ' ' GLY . 99.1 t -61.41 -49.88 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.128 -0.487 . . . . 1.21 110.841 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.52 -43.55 79.92 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.029 0.442 . . . . 1.77 110.485 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 68.0 m -62.55 -50.99 69.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 1.21 110.618 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' MET . . . . . 0.45 ' HE1' ' HB3' ' A' ' 263' ' ' MET . 54.2 ttp . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 115.798 -0.637 . . . . 1.0700000000000001 111.934 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.376 0.131 . . . . 1.25 110.893 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.501 ' O ' HG13 ' A' ' 257' ' ' ILE . . . -61.19 -48.39 85.97 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.665 -0.779 . . . . 0.46000000000000002 111.46 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.64 -49.48 77.33 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 122.832 -0.217 . . . . 1.3600000000000001 110.948 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.91 -50.74 61.71 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 116.101 -0.499 . . . . 0.40999999999999998 113.117 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 254' ' ' GLY . 2.5 pp -63.07 -33.65 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 117.21 0.505 . . . . 1.21 110.016 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 91.4 m -63.82 -47.6 80.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.708 -0.224 . . . . 1.1599999999999999 110.546 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -43.43 96.23 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.682 0.277 . . . . 1.72 110.745 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.1 -48.32 89.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.327 -0.397 . . . . 1.23 110.77 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -41.69 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.502 . . . . 1.8700000000000001 110.481 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 86.2 m -63.45 -51.73 64.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.571 -0.741 . . . . 1.23 112.118 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' MET . . . . . 0.416 ' HE1' ' HB3' ' A' ' 263' ' ' MET . 20.5 ptp . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 113.896 1.073 . . . . 1.52 113.896 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.746 0.307 . . . . 2.8399999999999999 110.531 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.84 -47.67 89.29 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.991 -0.55 . . . . 2.1499999999999999 111.968 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.87 -44.31 97.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.378 0.609 . . . . 2.0699999999999998 110.892 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.76 -52.1 50.92 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.544 -0.753 . . . . 1.3600000000000001 113.031 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.71 -37.88 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 117.622 0.711 . . . . 2.4700000000000002 111.225 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 91.1 m -64.31 -47.56 78.98 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.83 0.347 . . . . 1.6699999999999999 111.16 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.2 p -64.71 -45.0 88.41 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.485 -0.325 . . . . 1.3200000000000001 110.731 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.81 -49.46 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.521 -0.309 . . . . 2.2000000000000002 110.416 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.65 -42.58 83.76 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.912 0.386 . . . . 2.5 110.626 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 93.1 m -62.17 -48.98 77.64 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.3 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 115.51 -0.768 . . . . 2.0600000000000001 111.616 179.351 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.499 0.19 . . . . 1.54 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.3 -48.68 84.81 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.906 -0.664 . . . . 0.75 111.622 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.448 HD21 ' HA ' ' A' ' 255' ' ' LEU . 8.0 mt -61.14 -43.7 98.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.158 0.504 . . . . 1.45 110.824 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 260' ' ' VAL . . . -62.09 -53.01 45.93 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.37 -0.919 . . . . 0.52000000000000002 112.983 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.85 -40.13 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 117.471 0.636 . . . . 1.3899999999999999 111.948 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 19.3 p -64.65 -45.72 85.55 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.718 0.266 . . . . 1.3200000000000001 111.718 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.3 p -65.95 -46.12 79.28 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.187 -0.205 . . . . 1.3 110.923 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 256' ' ' GLY . 65.0 t -59.42 -48.43 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.824 -0.171 . . . . 1.28 110.662 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 42.3 mt -61.33 -40.51 94.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.791 0.329 . . . . 1.3600000000000001 111.182 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.2 m -67.12 -46.7 73.36 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.203 0.525 . . . . 1.4399999999999999 111.32 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 CA--C 1.536 0.421 0 CA-C-N 115.657 -0.701 . . . . 1.9399999999999999 112.313 -179.195 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.675 0.274 . . . . 1.72 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -61.43 -48.21 86.33 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 121.023 -0.608 . . . . 0.81999999999999995 112.006 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.71 -42.65 99.23 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.953 0.406 . . . . 1.77 110.448 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 260' ' ' VAL . . . -61.07 -54.22 38.5 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.076 -0.583 . . . . 0.81000000000000005 112.804 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.46 -35.85 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 117.345 0.573 . . . . 1.6599999999999999 111.352 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.2 m -65.16 -47.0 78.55 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.758 0.313 . . . . 1.48 111.028 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 27.6 p -66.56 -46.66 75.32 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.521 -0.309 . . . . 1.55 110.734 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 256' ' ' GLY . 73.0 t -58.88 -46.82 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.674 -0.239 . . . . 1.72 110.517 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 261' ' ' LEU . 26.5 tp -61.3 -44.6 96.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.869 0.366 . . . . 1.71 110.329 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 96.7 m -60.41 -48.12 83.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.149 0.499 . . . . 1.5600000000000001 111.213 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' MET . . . . . 0.413 ' HB3' ' HE3' ' A' ' 263' ' ' MET . 95.9 mmm . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 112.531 0.567 . . . . 2.6800000000000002 112.531 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.742 HG13 ' H ' ' A' ' 254' ' ' GLY . 2.5 p . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 120.872 0.368 . . . . 1.3999999999999999 111.865 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.742 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -56.52 -46.31 88.28 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.666 -0.697 . . . . 0.73999999999999999 112.822 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 6.7 mt -62.45 -45.4 93.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.981 0.42 . . . . 1.4399999999999999 111.048 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.8 -51.39 56.06 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.841 -0.618 . . . . 0.34000000000000002 112.756 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.78 -37.68 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 117.175 0.487 . . . . 1.3799999999999999 111.063 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.6 m -64.84 -41.96 95.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.933 0.397 . . . . 1.3 110.017 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 54.1 m -63.17 -46.44 87.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.121 -0.49 . . . . 1.1799999999999999 110.051 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.6 t -59.75 -48.18 88.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 116.212 -0.449 . . . . 1.26 110.201 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.34 -44.66 92.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.919 0.39 . . . . 1.71 110.512 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 92.7 m -58.51 -49.39 77.54 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.803 -0.635 . . . . 1.23 111.482 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 21.4 ptp . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.785 0.661 . . . . 1.4399999999999999 112.785 -179.748 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.0 t . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.351 0.119 . . . . 2.04 110.99 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.32 -49.4 72.99 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.006 -0.616 . . . . 0.67000000000000004 111.888 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.8 mt -60.0 -45.81 91.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.277 0.561 . . . . 1.8400000000000001 111.025 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.92 -52.64 48.91 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.798 -0.715 . . . . 0.75 113.354 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.32 -40.33 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 117.628 0.714 . . . . 1.3100000000000001 111.687 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.1 p -65.3 -45.33 84.82 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.947 -0.301 . . . . 1.3100000000000001 111.697 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.3 p -64.72 -44.45 90.15 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 121.046 -0.262 . . . . 1.55 110.703 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 256' ' ' GLY . 59.5 t -61.49 -51.58 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.753 -0.203 . . . . 1.45 110.615 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 261' ' ' LEU . 46.2 mt -57.66 -38.49 75.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.655 0.264 . . . . 1.4299999999999999 111.068 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 96.1 m -65.66 -49.05 70.06 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.204 0.526 . . . . 1.53 110.575 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 CA--C 1.537 0.471 0 CA-C-N 115.858 -0.61 . . . . 1.8700000000000001 111.552 179.622 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.778 HG12 ' H ' ' A' ' 254' ' ' GLY . 2.5 p . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 112.391 0.515 . . . . 1.99 112.391 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.778 ' H ' HG12 ' A' ' 253' ' ' VAL . . . -55.26 -48.28 69.88 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.869 -0.605 . . . . 1.1000000000000001 112.671 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.0 mt -60.18 -45.88 91.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.199 0.523 . . . . 1.6599999999999999 111.156 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.68 -50.85 58.58 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.7 -0.762 . . . . 0.5 113.238 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.2 pp -63.24 -40.23 88.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 117.394 0.597 . . . . 1.75 111.955 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 26.7 p -68.04 -43.92 77.59 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 121.028 -0.269 . . . . 1.8 111.723 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 p -64.81 -45.26 86.99 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.065 -0.254 . . . . 1.6399999999999999 110.568 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 56.6 t -62.16 -49.71 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.56 -0.291 . . . . 1.25 110.626 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.4 OUTLIER -56.31 -45.1 80.43 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.959 0.409 . . . . 1.8700000000000001 110.674 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 97.8 m -60.96 -47.22 87.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.745 -0.661 . . . . 2.0 110.629 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.535 0.397 0 CA-C-N 115.832 -0.622 . . . . 2.1000000000000001 111.507 179.633 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 50.0 t . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.77 0.319 . . . . 1.5800000000000001 110.57 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.03 -47.51 90.4 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.949 -0.569 . . . . 0.79000000000000004 112.148 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 17.2 tp -61.75 -42.99 99.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.998 0.428 . . . . 2.3300000000000001 110.198 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.03 -53.24 44.33 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.9 -0.667 . . . . 1.1699999999999999 112.907 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.63 -40.13 87.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 117.286 0.543 . . . . 1.48 111.646 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 21.0 p -65.69 -39.17 90.99 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.95 -0.3 . . . . 1.5 110.982 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 90.2 m -65.32 -47.75 75.46 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.947 -0.39 . . . . 1.74 109.947 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 78.0 t -59.66 -48.05 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.031 -0.531 . . . . 1.7 110.422 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.446 ' HA ' HD21 ' A' ' 261' ' ' LEU . 50.6 mt -59.62 -47.41 85.71 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.532 -0.304 . . . . 1.5 110.859 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.8 m -58.44 -44.16 89.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.338 0.59 . . . . 1.6599999999999999 111.172 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 CA--C 1.538 0.482 0 CA-C-N 115.549 -0.75 . . . . 2.7400000000000002 111.904 -179.745 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 120.884 0.374 . . . . 1.48 111.934 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -55.67 -49.29 66.35 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.609 -0.723 . . . . 0.63 112.768 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.2 mt -63.61 -41.9 98.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.848 0.356 . . . . 1.6599999999999999 110.764 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.39 -52.49 51.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.804 -0.712 . . . . 0.60999999999999999 112.601 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.43 -37.83 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 117.086 0.443 . . . . 1.3300000000000001 111.172 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.7 m -64.98 -41.25 95.6 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.745 0.307 . . . . 1.3100000000000001 110.328 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 58.8 m -64.8 -48.71 73.46 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 110.002 -0.37 . . . . 1.25 110.002 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.51 -46.57 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.121 -0.49 . . . . 1.29 110.626 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.455 ' HA ' HD11 ' A' ' 261' ' ' LEU . 21.7 tp -60.45 -42.8 96.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.861 0.363 . . . . 1.49 110.842 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 97.2 m -63.82 -46.87 83.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.223 0.535 . . . . 0.96999999999999997 110.839 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' MET . . . . . 0.411 ' HE2' ' HB2' ' A' ' 263' ' ' MET . 49.0 tpp . . . . . 0 CA--C 1.537 0.478 0 CA-C-N 115.603 -0.726 . . . . 1.1799999999999999 112.037 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.776 0.322 . . . . 3.5600000000000001 111.311 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.514 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 22.5 Cg_exo -68.12 106.51 1.37 Allowed 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.158 2.572 . . . . 1.8999999999999999 112.496 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.41 98.51 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.197 -0.456 . . . . 1.54 111.743 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -44.77 95.95 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.267 -0.424 . . . . 2.0699999999999998 110.749 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 93.9 t -64.93 -47.98 86.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 1.28 110.708 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.84 -48.0 85.01 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.116 -0.564 . . . . 0.51000000000000001 111.797 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.3 mt -61.45 -45.27 94.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.109 0.481 . . . . 1.4099999999999999 110.785 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 260' ' ' VAL . . . -61.43 -52.27 52.44 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.643 -0.708 . . . . 0.34999999999999998 113.116 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.66 -38.59 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 117.415 0.608 . . . . 1.25 110.896 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.5 m -63.25 -42.85 99.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.079 0.466 . . . . 1.1599999999999999 109.987 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.401 ' O ' ' HG2' ' A' ' 263' ' ' MET . 57.5 m -62.69 -48.92 77.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.906 -0.588 . . . . 1.24 110.156 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.595 ' O ' HG21 ' A' ' 264' ' ' THR . 98.9 t -59.2 -49.14 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.122 -0.49 . . . . 1.2 110.452 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 23.5 tp -57.52 -40.19 78.18 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.305 -0.407 . . . . 1.3600000000000001 110.321 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 93.2 m -64.25 -48.54 75.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.888 -0.596 . . . . 1.28 110.525 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 259' ' ' THR . 96.3 mmm -62.2 -46.09 90.44 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.837 -0.62 . . . . 1.4199999999999999 112.38 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.595 HG21 ' O ' ' A' ' 260' ' ' VAL . 9.8 t -78.16 53.56 1.23 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.372 0.508 . . . . 1.03 112.372 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.911 ' HA ' ' HA ' ' A' ' 272' ' ' ALA . 1.2 t -60.3 -46.96 88.05 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.279 0.474 . . . . 1.1499999999999999 112.279 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 68.67 -47.37 0.56 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.271 0.628 . . . . 1.48 112.249 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 45.3 t -69.91 -22.19 63.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.521 -0.308 . . . . 0.76000000000000001 111.591 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.5 t 65.66 47.5 2.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.256 0.551 . . . . 1.1499999999999999 111.828 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -147.58 49.55 0.61 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.825 -0.702 . . . . 0.85999999999999999 112.731 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 60.4 m 69.65 -52.89 0.61 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.651 0.78 . . . . 1.0900000000000001 112.32 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -86.2 152.39 22.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.438 -0.346 . . . . 0.93999999999999995 110.76 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.911 ' HA ' ' HA ' ' A' ' 265' ' ' THR . . . -75.45 -122.41 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.466 -0.334 . . . . 1.25 110.17 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.574 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 20.8 p -80.49 51.85 1.53 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.642 0.734 . . . . 1.02 111.291 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.661 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 27.2 tp -129.11 48.32 3.57 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.991 -1.004 . . . . 1.45 109.827 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 51.1 Cg_exo -61.29 56.82 0.1 Allowed 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 123.194 2.596 . . . . 0.68000000000000005 114.758 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.393 0 CA-C-O 118.32 -0.848 . . . . 1.52 110.973 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 111.291 0.108 . . . . 4.2400000000000002 111.291 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.33 -147.02 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.265 2.644 . . . . 3.54 113.362 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -150.92 -70.33 0.18 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.126 0.489 . . . . 2.5499999999999998 111.452 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.782 ' HB3' ' HB2' ' A' ' 255' ' ' LEU . 14.3 mmt180 -94.73 67.77 3.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.437 0.637 . . . . 1.8600000000000001 111.916 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.3 t -55.39 -50.86 62.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.739 -1.119 . . . . 1.76 111.505 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.08 -46.21 94.1 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.922 -0.581 . . . . 0.89000000000000001 112.17 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.782 ' HB2' ' HB3' ' A' ' 252' ' ' ARG . 6.2 mt -62.47 -45.06 94.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.896 0.379 . . . . 1.6200000000000001 110.779 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.13 -50.85 61.25 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.034 -0.603 . . . . 0.68999999999999995 112.821 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.5 pp -64.07 -36.53 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 117.31 0.555 . . . . 1.45 110.69 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 88.4 m -66.06 -42.06 89.96 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.718 -0.475 . . . . 1.5 109.718 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.7 m -63.96 -49.19 73.5 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.915 -0.584 . . . . 1.51 110.012 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 82.6 t -59.9 -48.97 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.126 -0.488 . . . . 1.3500000000000001 110.391 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.2 OUTLIER -56.7 -42.82 79.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.039 0.447 . . . . 1.75 109.826 178.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 85.5 m -61.61 -47.46 85.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.761 -0.654 . . . . 1.72 110.666 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 89.4 mtp -62.57 -54.4 40.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.993 -0.548 . . . . 1.9399999999999999 111.689 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.0 t -86.49 46.05 1.31 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.493 0.663 . . . . 1.45 111.248 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.805 HG23 ' HG2' ' A' ' 275' ' ' PRO . 8.9 t -74.09 43.76 0.17 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.879 -0.601 . . . . 1.78 112.582 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -96.91 64.43 2.02 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.158 -0.338 . . . . 1.4099999999999999 111.23 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 34.5 t -158.03 130.6 7.22 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.065 0.46 . . . . 2.1400000000000001 111.716 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 73.6 m -91.94 120.49 32.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.114 -0.494 . . . . 2.3100000000000001 110.6 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 176.9 -133.69 2.34 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.698 -0.763 . . . . 2.4500000000000002 112.865 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.8 m -61.9 -40.61 96.03 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.793 0.296 . . . . 3.1699999999999999 111.409 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -78.15 127.67 32.64 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.836 0.35 . . . . 1.9199999999999999 110.736 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -73.17 85.98 1.39 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.358 -0.383 . . . . 1.54 111.309 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.551 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 70.3 m -73.89 60.84 0.75 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.169 0.509 . . . . 1.52 112.131 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.673 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 22.2 tp -124.51 41.91 0.66 Allowed Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 115.648 -0.705 . . . . 2.6099999999999999 110.998 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.805 ' HG2' HG23 ' A' ' 265' ' ' THR . 51.1 Cg_exo -60.74 -31.05 91.48 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.448 2.099 . . . . 2.8900000000000001 112.63 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.911 ' HA ' ' HE2' ' A' ' 276' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.325 -0.845 . . . . 4.75 111.145 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.678 0.275 . . . . 2.27 110.977 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.493 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 85.6 Cg_endo -74.97 59.88 5.28 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.47 2.78 . . . . 1.6799999999999999 113.327 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.82 91.3 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.915 0.339 . . . . 1.3999999999999999 111.915 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -44.38 95.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.189 0.518 . . . . 2.3599999999999999 110.075 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 61.7 t -62.43 -49.0 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.618 -0.719 . . . . 1.4099999999999999 110.712 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.99 91.42 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.913 -0.585 . . . . 0.48999999999999999 111.992 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.66 -46.02 91.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.268 0.556 . . . . 1.3600000000000001 111.297 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 260' ' ' VAL . . . -62.51 -51.73 54.08 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.705 -0.76 . . . . 0.60999999999999999 113.092 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 258' ' ' THR . 2.2 pp -63.45 -40.99 91.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 117.384 0.592 . . . . 1.3600000000000001 111.928 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.426 HG23 HD13 ' A' ' 257' ' ' ILE . 25.7 p -65.88 -43.9 86.93 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.79 0.293 . . . . 1.3200000000000001 111.79 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.0 p -65.77 -47.09 76.34 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.902 -0.319 . . . . 1.2 110.623 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 256' ' ' GLY . 71.9 t -59.65 -45.94 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.487 -0.324 . . . . 1.3999999999999999 110.438 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.446 ' O ' HG21 ' A' ' 265' ' ' THR . 25.1 tp -60.77 -46.71 89.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.893 0.377 . . . . 1.54 110.522 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 91.1 m -59.92 -49.85 76.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.332 0.587 . . . . 1.2 110.66 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 47.4 ttm -60.62 -47.62 85.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.613 -0.721 . . . . 1.77 111.926 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.434 HG23 ' N ' ' A' ' 265' ' ' THR . 13.2 t -65.89 -38.2 88.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.748 0.648 . . . . 1.3200000000000001 112.748 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 261' ' ' LEU . 12.0 t -73.06 -33.44 65.66 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.514 -0.474 . . . . 1.29 110.959 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -68.81 -42.15 77.69 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.218 0.532 . . . . 1.1299999999999999 109.909 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 35.3 t -91.09 -152.73 0.29 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.506 -0.77 . . . . 1.03 110.18 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 54.3 p -73.88 124.96 27.13 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.203 -0.311 . . . . 1.1499999999999999 110.56 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -71.66 62.45 1.2 Allowed Glycine 0 CA--C 1.522 0.531 0 C-N-CA 121.277 -0.487 . . . . 0.93999999999999995 112.823 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.9 t -166.12 143.61 5.39 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 122.419 0.287 . . . . 1.0900000000000001 110.862 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 71.43 43.86 0.58 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.004 -0.544 . . . . 1.2 111.804 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -89.81 130.8 36.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 1.6000000000000001 111.178 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.48 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 77.4 p -88.39 -175.87 5.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.52 0.676 . . . . 1.3700000000000001 112.134 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.622 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 22.7 tp 56.16 40.42 0.65 Allowed Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 114.588 -1.187 . . . . 1.72 111.959 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.622 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 81.8 Cg_exo -52.95 132.56 47.88 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.342 2.028 . . . . 1.0600000000000001 114.063 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.187 -0.911 . . . . 2.48 111.091 179.277 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.454 0.168 . . . . 2.7000000000000002 110.611 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.45 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 17.8 Cg_exo -70.1 76.72 1.25 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.357 2.705 . . . . 1.8200000000000001 112.859 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.12 118.42 4.67 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.808 0.337 . . . . 1.5 111.233 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.618 ' HG3' ' HB2' ' A' ' 255' ' ' LEU . 5.7 tpt180 50.39 44.51 26.75 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.81 0.814 . . . . 1.6899999999999999 111.817 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 6.3 p -47.81 -51.87 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 114.692 -1.14 . . . . 1.1899999999999999 112.978 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.96 26.55 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 116.087 -0.506 . . . . 0.47999999999999998 113.485 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.618 ' HB2' ' HG3' ' A' ' 252' ' ' ARG . 1.1 mt -65.45 -41.24 93.67 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.538 -0.389 . . . . 1.4199999999999999 110.415 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 260' ' ' VAL . . . -60.52 -52.38 52.94 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.694 -0.765 . . . . 0.46999999999999997 112.689 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.82 -41.58 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.96 0.38 . . . . 1.1899999999999999 111.831 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 20.5 p -64.68 -38.75 92.07 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.648 -0.421 . . . . 1.21 110.688 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 87.4 m -65.32 -49.23 70.25 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.016 -0.364 . . . . 1.24 110.016 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 256' ' ' GLY . 78.4 t -59.6 -45.57 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 1.21 110.578 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.486 ' O ' HG21 ' A' ' 264' ' ' THR . 0.2 OUTLIER -58.72 -45.41 89.65 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.046 0.45 . . . . 1.95 110.132 178.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.465 ' O ' HG21 ' A' ' 265' ' ' THR . 91.7 m -60.83 -49.96 75.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.927 -0.579 . . . . 1.22 110.67 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.32 -46.91 88.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.769 -0.651 . . . . 1.6499999999999999 111.864 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.486 HG21 ' O ' ' A' ' 261' ' ' LEU . 11.8 t -68.86 -40.24 79.42 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.842 0.682 . . . . 1.2 112.842 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 262' ' ' THR . 14.9 t -68.1 -36.23 79.43 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.784 -0.367 . . . . 1.1899999999999999 111.649 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . 0.583 ' HG2' ' HA3' ' A' ' 269' ' ' GLY . 54.7 tt0 -81.25 -35.8 30.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.519 0.199 . . . . 0.95999999999999996 111.026 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 70.5 m 61.66 -126.08 0.81 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.356 -0.384 . . . . 0.83999999999999997 111.127 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.3 p -77.24 43.66 0.38 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.998 0.427 . . . . 1.27 112.078 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.583 ' HA3' ' HG2' ' A' ' 266' ' ' GLN . . . -76.62 56.43 3.39 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.439 -0.41 . . . . 0.77000000000000002 113.581 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.4 t -56.91 136.42 55.89 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.196 0.443 . . . . 1.2 112.196 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 58.6 48.82 11.24 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.091 -0.504 . . . . 1.1799999999999999 112.15 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 60.85 49.42 6.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.04 0.448 . . . . 1.72 111.315 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.613 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 25.3 m 64.02 50.88 2.39 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.514 -0.766 . . . . 1.23 111.97 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.651 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 27.0 tp -126.85 49.3 3.9 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.252 -0.885 . . . . 1.6799999999999999 109.714 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 62.7 Cg_exo -60.18 60.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.451 2.767 . . . . 0.90000000000000002 115.499 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.257 1.458 0 CA-C-O 118.262 -0.875 . . . . 2.1499999999999999 111.363 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.369 0.128 . . . . 3.0299999999999998 110.783 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -76.57 58.58 5.92 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.823 2.349 . . . . 2.6499999999999999 112.787 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.48 82.76 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.017 0.377 . . . . 2.29 112.017 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -41.36 98.57 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.88 0.371 . . . . 2.79 110.306 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.32 -49.26 81.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 2.3500000000000001 110.3 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.98 -47.19 91.94 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.965 -0.562 . . . . 1.5600000000000001 111.806 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.36 -46.13 91.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.105 0.479 . . . . 1.9099999999999999 110.885 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.01 -51.97 53.3 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.59 -0.732 . . . . 1.25 113.193 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.72 -38.48 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 117.452 0.626 . . . . 1.8799999999999999 111.031 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 88.7 m -64.42 -42.18 96.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.778 0.323 . . . . 1.3500000000000001 110.223 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 57.1 m -63.52 -47.4 81.82 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.216 -0.447 . . . . 1.25 110.177 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.3 t -61.4 -48.61 88.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.094 -0.503 . . . . 1.6699999999999999 110.864 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -58.68 -42.67 89.05 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.133 0.492 . . . . 1.98 110.36 179.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.6 m -63.29 -49.2 74.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.792 -0.64 . . . . 1.3 111.008 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.3 tpt -63.4 -53.14 57.12 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.964 -0.562 . . . . 1.9299999999999999 111.51 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.9 t -132.21 134.21 45.08 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.366 0.603 . . . . 1.54 111.877 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.3 t -73.72 -32.19 63.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 1.5800000000000001 111.53 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -162.57 127.36 3.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.494 . . . . 1.2 110.64 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 74.9 m -163.68 -52.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.059 -0.519 . . . . 1.1100000000000001 110.588 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.6 p -68.6 135.56 51.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.378 . . . . 2.0099999999999998 111.0 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -148.94 152.44 24.47 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.639 -0.791 . . . . 2.0299999999999998 113.441 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.2 t -63.3 133.64 54.5 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.241 0.46 . . . . 3.46 112.241 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? 69.28 -53.44 0.59 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.507 0.723 . . . . 4.1200000000000001 112.152 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -139.82 123.69 17.55 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.725 -0.472 . . . . 2.6699999999999999 109.725 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.514 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 54.7 m -90.75 -179.01 5.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.214 0.53 . . . . 2.2400000000000002 111.805 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.694 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 19.6 tp 58.93 36.68 0.28 Allowed Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.869 -1.06 . . . . 2.02 111.524 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.694 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 53.1 Cg_exo -59.85 -39.53 71.25 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.056 1.837 . . . . 1.7 112.473 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? . . . . . 0 C--O 1.253 1.251 0 CA-C-O 117.766 -1.111 . . . . 2.0 109.441 179.818 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.426 0.155 . . . . 2.27 111.077 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.765 ' HD2' ' HA3' ' A' ' 254' ' ' GLY . 30.1 Cg_exo -66.06 60.84 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.02 3.147 . . . . 1.3 113.938 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 56.47 -142.61 0.75 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.507 0.929 . . . . 1.4099999999999999 113.507 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -50.86 71.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.815 -0.63 . . . . 1.8300000000000001 112.306 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 254' ' ' GLY . 13.2 p -59.19 -47.63 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.085 0.469 . . . . 1.45 110.914 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.765 ' HA3' ' HD2' ' A' ' 250' ' ' PRO . . . -59.59 -46.21 94.36 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.537 -0.756 . . . . 0.62 112.202 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.14 -45.7 92.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.101 0.477 . . . . 1.51 110.929 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -59.98 -50.63 65.62 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.948 -0.644 . . . . 0.59999999999999998 112.953 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.55 -37.93 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.26 0.53 . . . . 1.3100000000000001 111.159 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.4 m -62.36 -46.52 88.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.768 0.318 . . . . 1.23 110.941 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.773 HG23 ' HB3' ' A' ' 275' ' ' PRO . 41.1 p -65.51 -46.94 77.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.264 -0.425 . . . . 1.3300000000000001 110.773 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 256' ' ' GLY . 76.4 t -60.18 -50.45 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.562 -0.29 . . . . 1.3200000000000001 110.639 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.454 ' O ' HG21 ' A' ' 264' ' ' THR . 25.3 tp -57.45 -47.12 82.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.638 -0.256 . . . . 1.3600000000000001 110.865 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.431 HG23 ' HB3' ' A' ' 267' ' ' SER . 98.9 m -57.58 -48.02 80.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.171 0.51 . . . . 1.1699999999999999 110.946 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 28.3 ttt -66.43 -46.11 77.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.685 -0.689 . . . . 1.7 112.431 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.454 HG21 ' O ' ' A' ' 261' ' ' LEU . 13.0 t -67.81 -35.27 78.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.313 0.857 . . . . 1.24 113.313 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 12.7 t -76.62 -1.65 28.69 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.195 -0.316 . . . . 1.1899999999999999 111.691 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 62.23 47.38 5.52 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.225 0.536 . . . . 1.24 110.831 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.431 ' HB3' HG23 ' A' ' 262' ' ' THR . 44.5 t -69.4 151.99 45.46 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.448 -0.796 . . . . 1.0600000000000001 110.979 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.0 m -69.78 56.48 0.13 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.473 0.546 . . . . 1.55 112.473 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 179.8 -140.82 4.41 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 112.149 -0.38 . . . . 1.3400000000000001 112.149 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 274' ' ' LEU . 13.8 t 58.25 -142.23 0.69 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.822 0.311 . . . . 1.74 111.66 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 270' ' ' SER . 57.6 mtp85 72.12 121.08 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.391 0.676 . . . . 2.0499999999999998 111.995 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 57.27 -140.2 0.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.08 -0.509 . . . . 2.23 111.217 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.608 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 58.1 p -86.41 49.46 1.8 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.335 0.588 . . . . 2.1600000000000001 111.996 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.646 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 2.7 mm? -126.79 51.22 6.0 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.393 -0.821 . . . . 1.6299999999999999 110.217 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.773 ' HB3' HG23 ' A' ' 259' ' ' THR . 85.3 Cg_exo -56.31 50.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 124.292 3.328 . . . . 2.2400000000000002 115.945 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 276' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.897 -0.573 . . . . 4.3499999999999996 110.377 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.257 0.075 . . . . 3.5 110.924 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.673 ' HG2' ' HA3' ' A' ' 254' ' ' GLY . 97.2 Cg_endo -73.23 -137.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.212 2.608 . . . . 1.5800000000000001 113.768 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.517 ' HB2' ' H ' ' A' ' 252' ' ' ARG . . . -76.39 -148.41 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.033 0.753 . . . . 1.3799999999999999 113.033 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.517 ' H ' ' HB2' ' A' ' 251' ' ' ALA . 0.7 OUTLIER -59.06 -41.88 88.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.699 -0.682 . . . . 1.48 111.864 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.08 -53.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.093 0.473 . . . . 1.24 111.346 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.673 ' HA3' ' HG2' ' A' ' 250' ' ' PRO . . . -60.77 -45.6 96.13 Favored Glycine 0 C--N 1.323 -0.171 0 CA-C-N 115.498 -0.774 . . . . 0.39000000000000001 112.259 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.17 -46.66 87.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.116 0.484 . . . . 1.3400000000000001 111.069 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.35 54.66 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.736 -0.665 . . . . 0.37 113.313 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.2 pp -62.58 -41.32 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 117.429 0.614 . . . . 1.1899999999999999 111.644 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.407 HG23 HD12 ' A' ' 257' ' ' ILE . 24.3 p -66.28 -40.88 90.37 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 122.23 -0.294 . . . . 1.21 110.988 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 85.6 m -64.16 -48.73 74.86 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.094 -0.336 . . . . 1.1899999999999999 110.094 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 75.3 t -60.54 -48.54 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.163 -0.471 . . . . 1.21 110.884 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.2 OUTLIER -56.52 -43.69 80.06 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.011 0.434 . . . . 1.74 110.357 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 92.6 m -60.73 -49.2 78.47 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.688 -0.687 . . . . 1.28 110.745 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' MET . . . . . 0.672 ' HA ' ' HG2' ' A' ' 275' ' ' PRO . 88.8 mtp -63.83 -54.58 32.81 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.041 -0.527 . . . . 1.3799999999999999 112.412 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 264' ' ' THR . 14.6 t -126.2 134.96 51.1 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.206 0.527 . . . . 1.1599999999999999 111.937 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.8 t -64.56 119.1 9.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.165 0.507 . . . . 1.3 112.031 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 67.5 -61.99 0.34 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.315 -0.857 . . . . 1.4099999999999999 112.322 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 32.4 t -172.33 -141.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.418 . . . . 1.22 110.274 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 32.7 t 61.06 -140.81 0.52 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.758 0.423 . . . . 0.95999999999999996 111.317 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -146.58 79.08 0.23 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.902 -0.666 . . . . 0.76000000000000001 112.927 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 50.1 m -60.43 135.94 57.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.913 0.387 . . . . 0.62 111.556 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -62.08 -39.01 90.97 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.277 -0.419 . . . . 2.46 111.683 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -81.23 33.81 0.35 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.126 0.788 . . . . 1.97 113.126 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.57 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 54.0 m -80.18 56.79 2.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.362 0.601 . . . . 0.62 111.435 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.702 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 21.2 tp -127.82 42.67 0.9 Allowed Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.582 -0.736 . . . . 1.5900000000000001 110.536 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.702 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 45.5 Cg_exo -64.52 100.38 0.33 Allowed 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 122.53 2.153 . . . . 2.2000000000000002 113.186 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.443 ' HE3' ' HG ' ' A' ' 274' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.448 0 CA-C-O 117.919 -1.039 . . . . 1.8799999999999999 110.561 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.461 0.172 . . . . 1.6599999999999999 111.052 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.487 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 20.1 Cg_exo -70.13 49.5 0.8 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.921 3.081 . . . . 1.3600000000000001 114.107 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.517 ' HB1' ' H ' ' A' ' 252' ' ' ARG . . . 47.34 -123.62 1.49 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.315 0.857 . . . . 1.7 113.315 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.517 ' H ' ' HB1' ' A' ' 251' ' ' ALA . 0.1 OUTLIER -57.05 -40.74 77.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.951 -0.568 . . . . 2.2200000000000002 111.618 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 46.9 t -62.66 -45.18 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.02 0.438 . . . . 1.74 110.311 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.449 ' HA3' ' HD2' ' A' ' 250' ' ' PRO . . . -61.61 -46.44 94.26 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.709 -0.678 . . . . 0.68000000000000005 112.066 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.59 -41.24 98.84 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.105 0.479 . . . . 1.5800000000000001 110.314 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.25 -53.36 42.83 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.879 -0.601 . . . . 0.71999999999999997 112.639 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.46 -35.8 75.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.292 0.546 . . . . 1.3500000000000001 111.396 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.4 m -64.69 -47.8 77.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.835 0.35 . . . . 1.4399999999999999 110.8 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.3 p -64.75 -45.88 84.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.421 -0.354 . . . . 1.45 110.989 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 73.5 t -59.29 -48.26 87.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.758 -0.201 . . . . 1.3200000000000001 110.85 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.406 ' HA ' HD11 ' A' ' 261' ' ' LEU . 20.3 tp -62.48 -38.32 89.4 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.997 0.427 . . . . 1.6499999999999999 110.773 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 99.4 m -64.31 -49.19 72.72 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.012 -0.54 . . . . 1.8400000000000001 110.91 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 70.2 mtm -67.03 -50.2 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.171 -0.468 . . . . 1.6799999999999999 112.063 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.1 t -127.97 134.87 49.32 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.32 0.581 . . . . 1.3 112.289 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 273' ' ' SER . 2.8 t -77.15 61.28 2.04 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.524 0.678 . . . . 1.6699999999999999 111.729 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -64.98 92.04 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.634 -0.712 . . . . 1.6599999999999999 111.381 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 270' ' ' SER . 88.3 p -78.88 46.89 0.71 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.863 0.32 . . . . 1.4399999999999999 111.863 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 47.4 t 67.11 -54.71 0.46 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.579 0.752 . . . . 2.0499999999999998 112.455 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.41 32.26 6.19 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.957 -0.639 . . . . 2.3399999999999999 113.005 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.431 ' HB3' ' OG ' ' A' ' 267' ' ' SER . 88.8 p -95.63 -43.24 8.02 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.896 0.332 . . . . 1.3799999999999999 111.896 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.6 mtm-85 68.07 -74.93 0.07 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.237 0.615 . . . . 2.46 111.644 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -77.58 -38.73 47.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.43 -0.35 . . . . 1.71 111.096 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.566 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 19.2 m 65.68 57.89 0.83 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.779 -0.646 . . . . 1.72 112.057 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.658 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 2.4 mm? -122.7 44.84 0.95 Allowed Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.875 -0.602 . . . . 2.8500000000000001 112.099 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.658 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 77.7 Cg_exo -56.87 -43.15 57.06 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.655 2.237 . . . . 2.2599999999999998 112.763 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm . . . . . 0 C--O 1.254 1.291 0 CA-C-O 117.943 -1.027 . . . . 3.5499999999999998 109.831 179.481 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.439 0.161 . . . . 2.48 110.794 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -71.0 56.38 1.92 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.914 3.076 . . . . 2.77 113.605 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.71 85.42 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.77 0.319 . . . . 1.5900000000000001 111.363 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 252' ' ' ARG . 20.8 tpt180 -64.83 -44.97 88.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.498 -0.319 . . . . 3.6000000000000001 110.728 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 29.4 t -60.24 -47.75 90.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.612 -0.267 . . . . 2.6400000000000001 110.905 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -61.34 -49.22 79.88 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.967 -0.635 . . . . 1.3400000000000001 111.854 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.26 -39.56 90.84 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.223 0.535 . . . . 2.6699999999999999 110.425 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.435 ' O ' HG21 ' A' ' 260' ' ' VAL . . . -63.13 -54.35 33.49 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.798 -0.637 . . . . 1.45 112.824 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.29 -35.63 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 117.471 0.636 . . . . 2.3999999999999999 111.064 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 90.8 m -64.29 -47.72 78.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.796 0.331 . . . . 2.2000000000000002 111.128 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.9 p -66.0 -46.13 79.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.37 -0.377 . . . . 2.3599999999999999 110.869 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 256' ' ' GLY . 79.2 t -59.82 -47.63 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.449 -0.341 . . . . 2.25 110.641 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.514 ' O ' HG22 ' A' ' 265' ' ' THR . 26.8 tp -59.8 -45.51 92.12 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.779 0.323 . . . . 2.5699999999999998 110.283 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.8 m -60.39 -46.15 91.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.303 0.573 . . . . 2.54 111.32 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' MET . . . . . 0.457 ' HE1' ' HB3' ' A' ' 263' ' ' MET . 52.7 ttp -67.51 -42.83 82.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.747 -0.66 . . . . 2.75 112.26 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.469 HG21 ' HA ' ' A' ' 261' ' ' LEU . 13.2 t -70.29 -28.03 64.87 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.917 0.71 . . . . 1.6399999999999999 112.917 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 261' ' ' LEU . 10.8 t -82.56 -142.48 0.06 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 120.761 -0.376 . . . . 2.21 111.005 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 62.52 32.27 16.63 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.316 0.579 . . . . 2.7599999999999998 110.812 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 48.2 t -111.82 134.76 53.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.861 -0.609 . . . . 2.52 111.228 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.4 t -61.98 -40.08 94.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.853 -0.612 . . . . 1.8600000000000001 111.89 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 78.33 -53.17 3.85 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.962 -0.637 . . . . 2.5099999999999998 113.878 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.632 ' O ' ' HG ' ' A' ' 274' ' ' LEU . 46.1 m -58.43 120.32 8.56 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.927 0.363 . . . . 3.3700000000000001 110.795 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.426 ' HD2' HD11 ' A' ' 274' ' ' LEU . 36.7 tpt85 -54.43 -43.22 71.38 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.759 0.651 . . . . 2.6800000000000002 112.759 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.93 -42.92 99.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.174 0.511 . . . . 3.0699999999999998 110.823 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.575 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 5.9 m -96.33 51.96 1.23 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.536 . . . . 3.1600000000000001 111.136 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 270' ' ' SER . 12.1 mt -114.12 38.74 0.21 Allowed Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 112.716 0.636 . . . . 2.2799999999999998 112.716 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 68.9 Cg_exo -58.36 -35.34 98.8 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.523 1.482 . . . . 3.8500000000000001 112.309 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.521 ' NZ ' ' HB3' ' A' ' 276' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.421 0 CA-C-N 115.591 -0.731 . . . . 6.0099999999999998 111.852 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.373 0.13 . . . . 3.6499999999999999 111.166 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 22.4 Cg_exo -68.9 68.67 1.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.761 2.974 . . . . 2.1000000000000001 113.128 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.26 -73.26 0.14 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.661 0.615 . . . . 1.3999999999999999 112.661 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.01 -51.63 56.57 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.643 0.259 . . . . 1.8999999999999999 111.594 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 254' ' ' GLY . 6.3 p -58.13 -50.57 77.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 1.3700000000000001 111.144 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.445 ' N ' HG11 ' A' ' 253' ' ' VAL . . . -57.38 -48.51 80.04 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.352 -0.84 . . . . 0.68000000000000005 112.435 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.02 -44.39 94.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.327 0.584 . . . . 1.5800000000000001 111.013 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.26 -52.29 48.27 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.687 -0.768 . . . . 0.53000000000000003 112.989 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.27 -39.96 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 117.482 0.641 . . . . 1.3100000000000001 111.973 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 22.2 p -65.73 -45.74 81.54 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.62 0.23 . . . . 1.29 111.62 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.6 p -65.2 -45.82 83.23 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 121.009 -0.276 . . . . 1.25 110.597 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.2 t -60.57 -46.86 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.594 -0.275 . . . . 1.3500000000000001 110.591 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 261' ' ' LEU . 0.4 OUTLIER -59.55 -45.94 90.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.125 0.488 . . . . 1.8100000000000001 109.753 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 90.7 m -60.24 -49.95 75.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.714 -0.675 . . . . 1.26 110.936 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.6 ttt -62.89 -47.35 83.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.863 -0.608 . . . . 1.8600000000000001 111.963 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.423 HG21 ' HA ' ' A' ' 261' ' ' LEU . 15.0 t -65.75 -36.51 83.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.866 0.691 . . . . 1.3700000000000001 112.866 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 266' ' ' GLN . 15.1 t -73.14 -37.98 66.44 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.425 -0.51 . . . . 1.1799999999999999 111.363 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . 0.465 ' N ' HG22 ' A' ' 265' ' ' THR . 62.6 tp60 -74.99 -39.95 60.95 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.564 0.221 . . . . 1.1699999999999999 111.127 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 30.6 t 62.94 -141.55 0.38 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.156 -0.474 . . . . 1.1399999999999999 110.753 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 64.7 p -74.75 -45.66 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 1.1000000000000001 111.384 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 165.12 -142.72 7.93 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.714 -0.755 . . . . 1.0700000000000001 112.824 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.2 t 55.97 -130.66 1.84 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.604 0.362 . . . . 1.6399999999999999 111.08 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 271' ' ' ARG . 7.8 tpt180 -84.05 9.01 13.56 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 111.792 0.293 . . . . 1.1599999999999999 111.792 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.423 ' HB2' ' H ' ' A' ' 273' ' ' SER . . . 52.28 -140.07 0.94 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.568 0.347 . . . . 1.3899999999999999 111.568 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.679 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 34.1 p -102.08 31.68 3.83 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.61 0.596 . . . . 1.3200000000000001 112.61 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.672 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 0.3 OUTLIER -123.22 45.8 1.21 Allowed Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 116.03 -0.532 . . . . 1.5700000000000001 110.456 175.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.679 ' HD3' ' C ' ' A' ' 273' ' ' SER . 47.0 Cg_exo -64.55 61.35 0.27 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.943 2.429 . . . . 2.0299999999999998 114.235 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.455 -0.783 . . . . 3.1499999999999999 111.835 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.8 0.333 . . . . 1.78 110.918 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.573 ' HG2' ' HA3' ' A' ' 254' ' ' GLY . 68.8 Cg_endo -71.06 73.24 2.01 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.293 2.662 . . . . 1.1399999999999999 113.587 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.443 ' HB1' ' H ' ' A' ' 252' ' ' ARG . . . 61.15 -150.55 0.4 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.536 0.939 . . . . 1.3400000000000001 113.536 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.443 ' H ' ' HB1' ' A' ' 251' ' ' ALA . 0.0 OUTLIER -64.37 -46.52 83.01 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.972 -0.558 . . . . 2.1600000000000001 112.197 -178.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.7 p -55.59 -47.54 78.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.271 0.558 . . . . 1.4099999999999999 110.354 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.573 ' HA3' ' HG2' ' A' ' 250' ' ' PRO . . . -61.27 -49.35 78.72 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.027 -0.988 . . . . 0.48999999999999999 112.109 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.24 -43.6 92.38 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.013 0.435 . . . . 1.3899999999999999 111.152 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.443 ' O ' HG22 ' A' ' 260' ' ' VAL . . . -61.98 -53.54 42.08 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.816 -0.629 . . . . 0.45000000000000001 112.941 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 254' ' ' GLY . 2.4 pp -62.34 -38.43 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 117.36 0.58 . . . . 1.25 110.93 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 41.9 m -62.62 -43.35 99.04 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.987 0.422 . . . . 1.25 109.984 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 46.5 m -63.2 -46.55 86.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.069 -0.514 . . . . 1.1699999999999999 110.096 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.52 ' O ' HG21 ' A' ' 264' ' ' THR . 99.1 t -61.41 -49.88 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.128 -0.487 . . . . 1.21 110.841 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.52 -43.55 79.92 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.029 0.442 . . . . 1.77 110.485 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 68.0 m -62.55 -50.99 69.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 1.21 110.618 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' MET . . . . . 0.45 ' HE1' ' HB3' ' A' ' 263' ' ' MET . 54.2 ttp -60.47 -46.53 89.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.798 -0.637 . . . . 1.0700000000000001 111.934 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.52 HG21 ' O ' ' A' ' 260' ' ' VAL . 11.6 t -75.23 -10.14 59.19 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.576 0.584 . . . . 1.0800000000000001 112.576 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.4 t 33.47 58.18 0.52 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.557 1.143 . . . . 1.0600000000000001 113.546 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -70.19 -26.08 63.72 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.487 -0.779 . . . . 1.04 112.521 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 37.4 m 64.04 48.43 3.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.908 0.385 . . . . 1.2 111.614 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 42.2 t 62.42 34.65 15.38 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.89 -0.595 . . . . 0.98999999999999999 112.204 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -176.88 -89.05 0.07 OUTLIER Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.994 -0.622 . . . . 0.85999999999999999 112.881 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 60.2 p -173.88 137.32 0.58 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 110.321 -0.252 . . . . 1.25 110.321 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.523 ' HD3' ' O ' ' A' ' 274' ' ' LEU . 17.0 ttm180 -131.92 132.2 43.36 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.585 -0.446 . . . . 0.85999999999999999 111.743 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.432 ' HB2' ' H ' ' A' ' 273' ' ' SER . . . -87.31 -137.1 0.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.257 -0.429 . . . . 1.6599999999999999 110.839 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.432 ' H ' ' HB2' ' A' ' 272' ' ' ALA . 58.0 p -76.46 59.93 1.52 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.495 0.664 . . . . 1.0800000000000001 112.056 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.561 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 25.6 tp -129.1 47.38 2.81 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.04 -0.982 . . . . 1.5600000000000001 110.174 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 91.9 Cg_exo -50.49 139.28 38.02 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.531 2.154 . . . . 1.02 113.688 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.712 -0.661 . . . . 2.3599999999999999 111.776 -179.811 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.592 0.234 . . . . 2.3100000000000001 111.119 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 32.6 Cg_exo -64.72 132.87 34.27 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.224 2.616 . . . . 1.5900000000000001 112.954 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.66 76.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.112 -0.495 . . . . 1.3500000000000001 112.289 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -59.42 -48.44 81.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.649 0.262 . . . . 1.3300000000000001 111.567 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.57 -45.73 98.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.409 -0.359 . . . . 1.25 110.893 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.501 ' O ' HG13 ' A' ' 257' ' ' ILE . . . -61.19 -48.39 85.97 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.665 -0.779 . . . . 0.46000000000000002 111.46 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.64 -49.48 77.33 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 122.832 -0.217 . . . . 1.3600000000000001 110.948 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.91 -50.74 61.71 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 116.101 -0.499 . . . . 0.40999999999999998 113.117 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 254' ' ' GLY . 2.5 pp -63.07 -33.65 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 117.21 0.505 . . . . 1.21 110.016 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 91.4 m -63.82 -47.6 80.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.708 -0.224 . . . . 1.1599999999999999 110.546 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -43.43 96.23 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.682 0.277 . . . . 1.72 110.745 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.1 -48.32 89.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.327 -0.397 . . . . 1.23 110.77 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -41.69 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.502 . . . . 1.8700000000000001 110.481 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 86.2 m -63.45 -51.73 64.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.571 -0.741 . . . . 1.23 112.118 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' MET . . . . . 0.416 ' HE1' ' HB3' ' A' ' 263' ' ' MET . 20.5 ptp -159.67 56.7 0.38 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.896 1.073 . . . . 1.52 113.896 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.8 t -55.23 -34.36 63.92 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.958 -0.464 . . . . 1.1699999999999999 112.133 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 9.3 t -71.31 -5.41 32.16 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.216 0.821 . . . . 1.3200000000000001 113.216 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -63.57 124.54 21.63 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.843 0.354 . . . . 1.6200000000000001 111.096 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 75.5 p -82.2 141.81 32.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.194 0.521 . . . . 1.3300000000000001 111.8 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.4 m -160.91 142.37 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.986 -0.552 . . . . 1.3500000000000001 110.469 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 70.78 -132.16 21.87 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.686 -0.768 . . . . 0.93000000000000005 112.098 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 58.1 m -163.51 131.82 3.73 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 122.774 -0.25 . . . . 0.93000000000000005 110.82 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 69.78 -46.4 0.59 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.583 0.586 . . . . 1.5900000000000001 112.583 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.429 ' HB2' ' H ' ' A' ' 273' ' ' SER . . . -145.55 -135.66 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.839 -0.164 . . . . 1.5800000000000001 111.296 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.457 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 65.5 p 54.19 59.15 4.39 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.797 0.666 . . . . 1.1799999999999999 112.797 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.56 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 92.5 mt -121.88 43.02 0.64 Allowed Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 115.611 -0.722 . . . . 1.6799999999999999 111.697 177.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 80.8 Cg_exo -54.25 -49.49 16.82 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 122.113 1.875 . . . . 1.55 113.113 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 96.1 mttt . . . . . 0 C--O 1.253 1.278 0 CA-C-N 115.612 -0.722 . . . . 1.8500000000000001 112.816 178.87 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.635 0.255 . . . . 4.3200000000000003 111.147 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 17.4 Cg_exo -70.51 58.18 1.89 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.93 3.087 . . . . 3.6200000000000001 113.429 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -59.17 -47.69 84.39 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 111.887 0.328 . . . . 2.8100000000000001 111.887 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.01 -42.27 99.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.997 0.427 . . . . 2.2799999999999998 110.225 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 49.8 t -64.11 -49.02 83.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.031 -0.531 . . . . 2.8399999999999999 110.531 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.84 -47.67 89.29 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.991 -0.55 . . . . 2.1499999999999999 111.968 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.87 -44.31 97.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.378 0.609 . . . . 2.0699999999999998 110.892 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.76 -52.1 50.92 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.544 -0.753 . . . . 1.3600000000000001 113.031 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.71 -37.88 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 117.622 0.711 . . . . 2.4700000000000002 111.225 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 91.1 m -64.31 -47.56 78.98 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.83 0.347 . . . . 1.6699999999999999 111.16 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.2 p -64.71 -45.0 88.41 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.485 -0.325 . . . . 1.3200000000000001 110.731 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.589 ' O ' HG21 ' A' ' 264' ' ' THR . 57.8 t -61.81 -49.46 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.521 -0.309 . . . . 2.2000000000000002 110.416 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.65 -42.58 83.76 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.912 0.386 . . . . 2.5 110.626 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 93.1 m -62.17 -48.98 77.64 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.3 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 57.0 ttp -60.02 -47.75 84.55 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.51 -0.768 . . . . 2.0600000000000001 111.616 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.589 HG21 ' O ' ' A' ' 260' ' ' VAL . 8.8 t -79.25 46.33 0.71 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.252 0.464 . . . . 2.2200000000000002 112.252 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.7 t -58.61 -39.43 80.42 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.892 0.377 . . . . 2.0800000000000001 111.201 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -89.89 129.88 36.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.235 -0.438 . . . . 2.3999999999999999 110.201 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.8 t -165.59 159.1 16.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.775 0.322 . . . . 1.5800000000000001 111.0 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 30.8 t -61.83 -36.66 81.84 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.358 -0.383 . . . . 1.6699999999999999 111.878 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 75.54 -60.28 2.86 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.627 -0.589 . . . . 1.6899999999999999 111.627 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.4 t -104.86 -152.43 0.46 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 110.053 -0.351 . . . . 2.4300000000000002 110.053 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? 69.93 -50.92 0.64 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.511 0.724 . . . . 2.52 112.414 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 59.04 42.12 19.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.036 0.446 . . . . 2.8999999999999999 110.887 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.511 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 14.1 m -74.18 59.39 0.75 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.345 0.593 . . . . 2.4199999999999999 112.283 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.645 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 0.8 OUTLIER -123.36 40.95 0.51 Allowed Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.608 -0.724 . . . . 4.3099999999999996 111.641 177.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.645 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 63.4 Cg_exo -57.58 -40.41 80.57 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.101 1.867 . . . . 4.5599999999999996 112.681 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.468 ' NZ ' ' HB3' ' A' ' 276' ' ' LYS . 1.6 ttpm? . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.978 -1.011 . . . . 6.0499999999999998 112.675 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.432 0.158 . . . . 2.1600000000000001 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -64.59 124.7 13.65 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.06 2.506 . . . . 1.3600000000000001 112.849 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.74 85.69 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.168 -0.469 . . . . 1.3700000000000001 112.264 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -56.9 -47.83 79.61 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.135 0.493 . . . . 1.1799999999999999 111.694 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 32.8 t -68.53 -45.0 82.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 1.54 110.867 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.3 -48.68 84.81 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.906 -0.664 . . . . 0.75 111.622 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.448 HD21 ' HA ' ' A' ' 255' ' ' LEU . 8.0 mt -61.14 -43.7 98.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.158 0.504 . . . . 1.45 110.824 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 260' ' ' VAL . . . -62.09 -53.01 45.93 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.37 -0.919 . . . . 0.52000000000000002 112.983 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.85 -40.13 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 117.471 0.636 . . . . 1.3899999999999999 111.948 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 19.3 p -64.65 -45.72 85.55 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.718 0.266 . . . . 1.3200000000000001 111.718 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.3 p -65.95 -46.12 79.28 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.187 -0.205 . . . . 1.3 110.923 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 256' ' ' GLY . 65.0 t -59.42 -48.43 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.824 -0.171 . . . . 1.28 110.662 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 42.3 mt -61.33 -40.51 94.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.791 0.329 . . . . 1.3600000000000001 111.182 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.2 m -67.12 -46.7 73.36 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.203 0.525 . . . . 1.4399999999999999 111.32 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.5 tpt -64.53 -43.61 93.47 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.657 -0.701 . . . . 1.9399999999999999 112.313 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.417 HG21 ' O ' ' A' ' 260' ' ' VAL . 14.6 t -70.99 136.06 48.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.372 0.606 . . . . 1.1599999999999999 111.624 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.2 t -73.89 141.05 46.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.921 -0.582 . . . . 1.27 111.824 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 69.76 -51.77 0.62 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.22 0.822 . . . . 1.3500000000000001 113.22 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 268' ' ' SER . 85.9 p 55.35 60.11 3.56 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.131 0.573 . . . . 0.73999999999999999 111.503 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 267' ' ' SER . 72.8 m 73.56 52.46 0.12 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.574 -0.739 . . . . 1.48 111.459 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 81.87 -52.39 4.59 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 116.028 -0.533 . . . . 1.1499999999999999 113.873 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 90.6 p -159.36 152.26 21.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.303 . . . . 1.4299999999999999 110.871 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.681 ' CZ ' ' HA ' ' A' ' 271' ' ' ARG . 2.7 tpm_? -79.18 49.32 0.95 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.334 0.588 . . . . 1.1499999999999999 112.195 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -96.68 99.23 10.85 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.118 -0.364 . . . . 1.77 110.973 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.585 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 69.1 m 58.5 -151.53 0.42 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.268 0.556 . . . . 2.1299999999999999 112.004 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.552 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 91.9 mt 60.42 31.06 0.11 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 114.048 1.129 . . . . 2.5800000000000001 114.048 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.585 ' HD3' ' C ' ' A' ' 273' ' ' SER . 89.1 Cg_exo -53.82 -33.56 71.55 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.818 1.679 . . . . 2.0 112.966 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.112 -0.947 . . . . 2.9100000000000001 110.591 179.072 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.318 0.104 . . . . 2.4300000000000002 111.07 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.458 ' HG2' ' N ' ' A' ' 254' ' ' GLY . 71.9 Cg_endo -72.64 47.85 1.23 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.221 2.614 . . . . 1.7 114.141 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 48.88 -115.84 0.79 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.403 0.89 . . . . 1.3999999999999999 113.403 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -49.88 -48.72 51.2 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.437 0.695 . . . . 2.9199999999999999 112.45 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.41 -44.1 97.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.336 -0.393 . . . . 1.72 111.113 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.458 ' N ' ' HG2' ' A' ' 250' ' ' PRO . . . -61.43 -48.21 86.33 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 121.023 -0.608 . . . . 0.81999999999999995 112.006 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.71 -42.65 99.23 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.953 0.406 . . . . 1.77 110.448 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 260' ' ' VAL . . . -61.07 -54.22 38.5 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.076 -0.583 . . . . 0.81000000000000005 112.804 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.46 -35.85 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 117.345 0.573 . . . . 1.6599999999999999 111.352 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.2 m -65.16 -47.0 78.55 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.758 0.313 . . . . 1.48 111.028 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 27.6 p -66.56 -46.66 75.32 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.521 -0.309 . . . . 1.55 110.734 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 256' ' ' GLY . 73.0 t -58.88 -46.82 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.674 -0.239 . . . . 1.72 110.517 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.458 ' HA ' HG23 ' A' ' 264' ' ' THR . 26.5 tp -61.3 -44.6 96.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.869 0.366 . . . . 1.71 110.329 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 96.7 m -60.41 -48.12 83.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.149 0.499 . . . . 1.5600000000000001 111.213 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' MET . . . . . 0.413 ' HB3' ' HE3' ' A' ' 263' ' ' MET . 95.9 mmm -65.15 -42.49 93.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.531 0.567 . . . . 2.6800000000000002 112.531 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.458 HG23 ' HA ' ' A' ' 261' ' ' LEU . 11.6 t -68.25 -32.87 73.36 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.91 0.708 . . . . 1.6599999999999999 112.91 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 10.4 t -84.91 32.47 0.53 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.18 0.514 . . . . 1.28 111.884 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -79.14 56.64 2.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.176 0.512 . . . . 1.5700000000000001 111.196 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 50.8 m -74.6 56.59 0.7 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.232 -0.44 . . . . 1.2 111.874 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 92.5 p -160.6 141.29 11.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.593 -0.276 . . . . 1.0800000000000001 111.133 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -72.44 72.2 1.0 Allowed Glycine 0 CA--C 1.524 0.614 0 CA-C-N 116.146 -0.479 . . . . 0.96999999999999997 113.37 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 77.8 p -65.73 -54.38 28.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.863 0.364 . . . . 1.22 111.972 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.401 ' NH1' ' H ' ' A' ' 276' ' ' LYS . 49.9 ttp180 -76.79 70.78 3.3 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.964 0.412 . . . . 1.8100000000000001 111.677 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.57 -29.91 68.27 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.608 0.596 . . . . 1.78 112.608 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.482 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 55.4 m -144.1 -174.76 4.37 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.973 0.416 . . . . 1.72 111.676 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.631 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 98.3 mt 59.03 38.14 0.36 Allowed Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 115.205 -0.907 . . . . 2.2799999999999998 111.759 -176.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.631 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 91.8 Cg_exo -51.36 133.83 43.57 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.808 2.339 . . . . 1.3 114.45 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.401 ' H ' ' NH1' ' A' ' 271' ' ' ARG . 55.2 mttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.455 -0.783 . . . . 2.4100000000000001 110.686 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.625 0.25 . . . . 2.3199999999999998 111.066 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 15.9 Cg_exo -71.91 50.91 1.52 Allowed 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 124.08 3.187 . . . . 2.23 113.458 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 63.42 -66.59 0.1 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.52 0.728 . . . . 1.6200000000000001 112.778 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.622 ' HB3' ' HB2' ' A' ' 255' ' ' LEU . 25.5 mmt180 -88.74 60.8 5.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.132 0.491 . . . . 1.53 111.849 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.742 HG13 ' H ' ' A' ' 254' ' ' GLY . 2.5 p -52.96 -56.45 7.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 1.3999999999999999 111.865 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.742 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -56.52 -46.31 88.28 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.666 -0.697 . . . . 0.73999999999999999 112.822 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 252' ' ' ARG . 6.7 mt -62.45 -45.4 93.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.981 0.42 . . . . 1.4399999999999999 111.048 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.8 -51.39 56.06 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.841 -0.618 . . . . 0.34000000000000002 112.756 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.78 -37.68 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 117.175 0.487 . . . . 1.3799999999999999 111.063 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.6 m -64.84 -41.96 95.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.933 0.397 . . . . 1.3 110.017 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 54.1 m -63.17 -46.44 87.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.121 -0.49 . . . . 1.1799999999999999 110.051 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 264' ' ' THR . 93.6 t -59.75 -48.18 88.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 116.212 -0.449 . . . . 1.26 110.201 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 264' ' ' THR . 0.9 OUTLIER -59.34 -44.66 92.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.919 0.39 . . . . 1.71 110.512 178.406 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 92.7 m -58.51 -49.39 77.54 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.803 -0.635 . . . . 1.23 111.482 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 21.4 ptp -72.69 -34.42 67.16 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.785 0.661 . . . . 1.4399999999999999 112.785 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 261' ' ' LEU . 14.3 t -80.64 -16.57 53.72 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.024 1.12 . . . . 1.23 114.024 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 9.2 t -75.17 49.84 0.47 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.075 0.941 . . . . 1.3899999999999999 111.741 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -75.35 68.53 2.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.142 -0.935 . . . . 0.85999999999999999 110.862 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 52.3 m 63.29 42.52 6.88 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.098 -0.501 . . . . 1.4199999999999999 110.8 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.837 ' HA ' ' HB2' ' A' ' 273' ' ' SER . 47.3 m -60.87 -40.99 95.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.737 -0.665 . . . . 0.76000000000000001 111.722 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -73.82 59.72 2.14 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.215 -0.448 . . . . 1.45 113.221 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 78.1 p -147.3 -49.33 0.18 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.83 0.347 . . . . 1.1200000000000001 110.71 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -159.41 46.67 0.28 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.218 -0.446 . . . . 1.8500000000000001 110.382 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 61.17 47.15 7.38 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.709 -0.678 . . . . 1.47 112.365 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.837 ' HB2' ' HA ' ' A' ' 268' ' ' SER . 10.0 m -78.33 65.21 3.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.329 0.585 . . . . 0.78000000000000003 111.717 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.602 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 17.7 tp -126.9 43.64 1.07 Allowed Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 115.689 -0.687 . . . . 1.6000000000000001 110.93 177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 85.8 Cg_exo -53.05 141.95 55.71 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.517 2.145 . . . . 1.0600000000000001 113.715 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.093 -0.956 . . . . 1.4299999999999999 110.898 179.791 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.665 0.269 . . . . 2.7599999999999998 111.342 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -70.16 66.36 2.01 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.703 2.935 . . . . 2.1600000000000001 113.208 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -55.42 -46.28 76.67 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.826 0.306 . . . . 1.76 111.826 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -59.48 -45.86 90.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.046 0.45 . . . . 2.3999999999999999 110.842 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.0 t -65.06 -48.34 84.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.885 -0.598 . . . . 2.04 110.99 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.32 -49.4 72.99 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.006 -0.616 . . . . 0.67000000000000004 111.888 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.8 mt -60.0 -45.81 91.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.277 0.561 . . . . 1.8400000000000001 111.025 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.92 -52.64 48.91 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.798 -0.715 . . . . 0.75 113.354 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.32 -40.33 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 117.628 0.714 . . . . 1.3100000000000001 111.687 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.1 p -65.3 -45.33 84.82 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.947 -0.301 . . . . 1.3100000000000001 111.697 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.3 p -64.72 -44.45 90.15 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 121.046 -0.262 . . . . 1.55 110.703 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.63 ' O ' HG22 ' A' ' 264' ' ' THR . 59.5 t -61.49 -51.58 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.753 -0.203 . . . . 1.45 110.615 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 261' ' ' LEU . 46.2 mt -57.66 -38.49 75.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.655 0.264 . . . . 1.4299999999999999 111.068 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 96.1 m -65.66 -49.05 70.06 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.204 0.526 . . . . 1.53 110.575 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 27.6 ttt -61.49 -50.9 70.86 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.858 -0.61 . . . . 1.8700000000000001 111.552 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 260' ' ' VAL . 9.4 t -94.24 41.39 1.09 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.226 0.536 . . . . 1.3300000000000001 111.689 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.5 t -61.36 -31.17 71.05 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.534 0.568 . . . . 1.3400000000000001 112.534 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . 0.483 ' HB2' HD11 ' A' ' 274' ' ' LEU . 15.2 mm100 -79.99 56.85 2.47 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.139 0.422 . . . . 1.1200000000000001 112.139 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.7 t 62.61 -125.16 0.67 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.608 -0.269 . . . . 1.1000000000000001 111.363 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.7 m -159.12 149.78 19.68 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.86 0.362 . . . . 1.21 111.47 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -170.97 -135.01 1.85 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.87 -0.681 . . . . 1.21 112.935 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 40.3 t -71.39 -11.62 60.99 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.688 0.625 . . . . 1.5 112.688 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.464 ' HB3' ' H ' ' A' ' 272' ' ' ALA . 0.6 OUTLIER 64.23 -143.71 0.28 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.588 0.355 . . . . 1.22 111.242 -178.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.464 ' H ' ' HB3' ' A' ' 271' ' ' ARG . . . 54.12 38.83 29.9 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.602 0.594 . . . . 2.1400000000000001 112.602 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.47 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 42.0 m -167.05 -166.79 0.84 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.982 0.42 . . . . 1.5 111.082 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.6 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 87.6 mt 62.57 35.36 0.21 Allowed Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 115.01 -0.996 . . . . 1.79 112.487 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 81.1 Cg_exo -52.32 129.56 32.05 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.968 1.779 . . . . 1.3700000000000001 113.123 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 276' ' ' LYS . 13.5 tptp . . . . . 0 C--O 1.257 1.477 0 CA-C-O 118.127 -0.94 . . . . 2.3900000000000001 111.351 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.563 0.221 . . . . 3.5800000000000001 111.028 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -65.27 131.79 29.49 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.077 2.518 . . . . 2.5499999999999998 112.695 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.23 -48.98 75.41 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.197 0.522 . . . . 1.79 111.039 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.532 ' HB3' ' HB2' ' A' ' 255' ' ' LEU . 21.8 mmt180 -93.96 55.21 2.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.157 0.503 . . . . 1.51 111.376 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.778 HG12 ' H ' ' A' ' 254' ' ' GLY . 2.5 p -49.76 -57.23 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.22 -0.9 . . . . 1.99 112.391 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.778 ' H ' HG12 ' A' ' 253' ' ' VAL . . . -55.26 -48.28 69.88 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.869 -0.605 . . . . 1.1000000000000001 112.671 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 252' ' ' ARG . 8.0 mt -60.18 -45.88 91.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.199 0.523 . . . . 1.6599999999999999 111.156 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.68 -50.85 58.58 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.7 -0.762 . . . . 0.5 113.238 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.2 pp -63.24 -40.23 88.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 117.394 0.597 . . . . 1.75 111.955 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 26.7 p -68.04 -43.92 77.59 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 121.028 -0.269 . . . . 1.8 111.723 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 p -64.81 -45.26 86.99 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.065 -0.254 . . . . 1.6399999999999999 110.568 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 56.6 t -62.16 -49.71 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.56 -0.291 . . . . 1.25 110.626 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.4 OUTLIER -56.31 -45.1 80.43 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.959 0.409 . . . . 1.8700000000000001 110.674 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 97.8 m -60.96 -47.22 87.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.745 -0.661 . . . . 2.0 110.629 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.1 ttt -62.55 -54.37 40.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.832 -0.622 . . . . 2.1000000000000001 111.507 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.8 t -86.72 38.53 0.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.212 0.53 . . . . 1.6299999999999999 111.59 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 7.2 t -64.39 -28.22 69.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.147 -0.479 . . . . 1.49 111.556 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 55.27 -108.21 0.42 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.085 -0.507 . . . . 1.77 112.319 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 58.2 m -162.04 137.36 7.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.749 0.309 . . . . 0.93999999999999995 111.178 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.4 p -76.89 46.37 0.46 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.353 0.501 . . . . 1.6499999999999999 112.353 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 159.94 -150.96 21.54 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.343 -0.932 . . . . 1.48 113.239 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 45.2 t -91.88 -23.05 19.76 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.734 0.272 . . . . 1.71 111.734 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.566 ' HB3' HD22 ' A' ' 274' ' ' LEU . 51.8 ttm-85 -66.02 131.09 45.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.994 0.426 . . . . 2.0099999999999998 111.968 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -69.43 135.24 49.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.8899999999999999 110.95 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.516 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 27.3 m 64.58 52.46 1.75 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.461 0.648 . . . . 1.96 111.418 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 271' ' ' ARG . 32.4 tp -122.74 49.86 2.52 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.252 -0.885 . . . . 1.77 110.04 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.516 ' HD3' ' C ' ' A' ' 273' ' ' SER . 76.0 Cg_exo -48.64 -44.31 31.22 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 122.494 2.13 . . . . 1.27 113.369 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.447 -0.787 . . . . 2.3700000000000001 111.064 179.16 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.539 0.209 . . . . 2.0600000000000001 111.01 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.563 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 94.5 Cg_endo -73.25 58.13 3.55 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.47 2.78 . . . . 1.4199999999999999 113.442 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -55.94 -45.58 78.77 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.946 0.35 . . . . 1.8400000000000001 111.946 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -42.24 99.2 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.993 0.425 . . . . 3.02 110.225 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 50.0 t -65.09 -49.01 81.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.071 -0.513 . . . . 1.5800000000000001 110.57 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.03 -47.51 90.4 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.949 -0.569 . . . . 0.79000000000000004 112.148 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 17.2 tp -61.75 -42.99 99.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.998 0.428 . . . . 2.3300000000000001 110.198 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.03 -53.24 44.33 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.9 -0.667 . . . . 1.1699999999999999 112.907 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.63 -40.13 87.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 117.286 0.543 . . . . 1.48 111.646 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 21.0 p -65.69 -39.17 90.99 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.95 -0.3 . . . . 1.5 110.982 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 90.2 m -65.32 -47.75 75.46 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.947 -0.39 . . . . 1.74 109.947 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 78.0 t -59.66 -48.05 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.031 -0.531 . . . . 1.7 110.422 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.446 ' HA ' HD21 ' A' ' 261' ' ' LEU . 50.6 mt -59.62 -47.41 85.71 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.532 -0.304 . . . . 1.5 110.859 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.8 m -58.44 -44.16 89.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.338 0.59 . . . . 1.6599999999999999 111.172 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.2 tpt -68.0 -46.99 69.73 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.549 -0.75 . . . . 2.7400000000000002 111.904 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 265' ' ' THR . 10.7 t -69.62 -39.3 77.26 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.279 0.474 . . . . 1.3400000000000001 112.279 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.487 ' N ' HG22 ' A' ' 264' ' ' THR . 8.5 t -139.84 138.65 35.93 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.351 0.596 . . . . 1.3999999999999999 111.35 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -163.43 -48.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.35 -0.386 . . . . 1.3899999999999999 111.209 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 78.4 p 52.11 50.55 18.24 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.102 -0.499 . . . . 1.46 111.84 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 68.5 m -159.22 -154.78 0.43 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.372 -0.376 . . . . 1.5800000000000001 110.983 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 171.49 -134.11 2.96 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.589 -0.815 . . . . 1.5900000000000001 112.821 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 50.4 m 67.59 -58.05 0.44 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.489 0.716 . . . . 2.75 112.4 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -94.26 -50.16 5.39 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.768 -0.196 . . . . 2.3799999999999999 111.247 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 68.31 -51.19 0.55 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.364 0.876 . . . . 2.7599999999999998 113.364 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 68.7 p -74.96 109.14 8.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.385 0.612 . . . . 2.3900000000000001 111.926 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.747 ' H ' HD21 ' A' ' 274' ' ' LEU . 2.1 pt? -84.52 -16.12 0.22 Allowed Pre-proline 0 CA--C 1.557 1.232 0 N-CA-C 114.315 1.228 . . . . 3.3300000000000001 114.315 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 274' ' ' LEU . 54.5 Cg_exo -58.97 -41.2 64.07 Favored 'Trans proline' 0 C--N 1.374 1.92 0 CA-C-N 121.905 1.716 . . . . 2.73 114.137 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.642 -0.694 . . . . 4.0099999999999998 111.338 -179.685 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.492 0.187 . . . . 3.04 111.012 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.35 50.66 2.69 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.315 2.677 . . . . 2.27 113.324 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 56.68 -101.17 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.053 -0.522 . . . . 2.0899999999999999 111.924 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 252' ' ' ARG . 15.2 mmt85 -81.17 61.52 4.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.555 0.576 . . . . 1.5700000000000001 112.555 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.0 p -51.09 -54.36 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 1.48 111.934 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -55.67 -49.29 66.35 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.609 -0.723 . . . . 0.63 112.768 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 252' ' ' ARG . 3.2 mt -63.61 -41.9 98.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.848 0.356 . . . . 1.6599999999999999 110.764 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.39 -52.49 51.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.804 -0.712 . . . . 0.60999999999999999 112.601 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.43 -37.83 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 117.086 0.443 . . . . 1.3300000000000001 111.172 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.7 m -64.98 -41.25 95.6 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.745 0.307 . . . . 1.3100000000000001 110.328 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 58.8 m -64.8 -48.71 73.46 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 110.002 -0.37 . . . . 1.25 110.002 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.51 -46.57 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.121 -0.49 . . . . 1.29 110.626 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.634 ' HG ' ' HB2' ' A' ' 267' ' ' SER . 21.7 tp -60.45 -42.8 96.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.861 0.363 . . . . 1.49 110.842 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 97.2 m -63.82 -46.87 83.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.223 0.535 . . . . 0.96999999999999997 110.839 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' MET . . . . . 0.411 ' HE2' ' HB2' ' A' ' 263' ' ' MET . 49.0 tpp -63.06 -45.0 94.23 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.603 -0.726 . . . . 1.1799999999999999 112.037 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 9.0 t -68.4 145.05 54.48 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.301 0.572 . . . . 1.26 111.698 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.633 ' HA ' ' HA3' ' A' ' 269' ' ' GLY . 9.0 t -64.19 -14.43 55.24 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.65 0.611 . . . . 1.48 112.65 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -57.38 -44.55 84.54 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.996 0.369 . . . . 1.49 111.996 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.634 ' HB2' ' HG ' ' A' ' 261' ' ' LEU . 38.2 t -83.75 48.68 1.47 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.77 0.319 . . . . 1.1200000000000001 110.884 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.4 m 60.3 41.06 16.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.998 -0.546 . . . . 1.6299999999999999 111.255 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 265' ' ' THR . . . -67.78 -44.12 81.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.067 -0.587 . . . . 1.02 112.811 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 47.2 m -79.0 48.75 0.87 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.745 0.307 . . . . 1.24 111.466 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 69.83 132.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.979 0.912 . . . . 1.76 111.642 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -75.44 51.06 0.55 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.617 0.599 . . . . 2.2200000000000002 112.617 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.581 ' HB2' ' HD2' ' A' ' 275' ' ' PRO . 69.6 p -170.91 114.65 0.43 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.762 0.791 . . . . 1.3300000000000001 111.922 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.488 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 51.0 tp -68.03 -28.58 1.91 Allowed Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 114.07 -1.423 . . . . 3.77 113.154 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 273' ' ' SER . 52.9 Cg_exo -61.54 -168.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 121.672 1.581 . . . . 2.6800000000000002 113.569 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 7.9 ttpp . . . . . 0 C--O 1.256 1.429 0 CA-C-O 118.406 -0.807 . . . . 4.0999999999999996 111.8 179.714 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 N--CA 1.461 0.101 0 CA-C-O 120.635 0.255 . . . . 0.68000000000000005 110.708 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.84 -48.0 85.01 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.116 -0.564 . . . . 0.42999999999999999 111.797 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 255' ' ' LEU . 7.3 mt -61.45 -45.27 94.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.109 0.481 . . . . 0.83999999999999997 110.785 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.43 -52.27 52.44 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.643 -0.708 . . . . 0.33000000000000002 113.116 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.66 -38.59 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 117.415 0.608 . . . . 0.57999999999999996 110.896 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.5 m -63.25 -42.85 99.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.079 0.466 . . . . 0.66000000000000003 109.987 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 263' ' ' MET . 57.5 m -62.69 -48.92 77.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.906 -0.588 . . . . 0.58999999999999997 110.156 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 256' ' ' GLY . 98.9 t -59.2 -49.14 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.122 -0.49 . . . . 0.51000000000000001 110.452 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 23.5 tp -57.52 -40.19 78.18 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.305 -0.407 . . . . 0.77000000000000002 110.321 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 93.2 m -64.25 -48.54 75.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.888 -0.596 . . . . 0.68999999999999995 110.525 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 259' ' ' THR . 96.3 mmm . . . . . 0 CA--C 1.534 0.339 0 CA-C-N 115.837 -0.62 . . . . 0.85999999999999999 112.38 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.751 0.31 . . . . 1.3400000000000001 111.505 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.08 -46.21 94.1 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.922 -0.581 . . . . 0.81000000000000005 112.17 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 255' ' ' LEU . 6.2 mt -62.47 -45.06 94.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.896 0.379 . . . . 1.1499999999999999 110.779 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.13 -50.85 61.25 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.034 -0.603 . . . . 0.57999999999999996 112.821 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.5 pp -64.07 -36.53 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 117.31 0.555 . . . . 0.95999999999999996 110.69 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 88.4 m -66.06 -42.06 89.96 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.718 -0.475 . . . . 1.01 109.718 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.7 m -63.96 -49.19 73.5 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.915 -0.584 . . . . 0.98999999999999999 110.012 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 256' ' ' GLY . 82.6 t -59.9 -48.97 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.126 -0.488 . . . . 0.81000000000000005 110.391 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.2 OUTLIER -56.7 -42.82 79.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.039 0.447 . . . . 1.3 109.826 178.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 85.5 m -61.61 -47.46 85.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.761 -0.654 . . . . 1.3300000000000001 110.666 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 89.4 mtp . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 115.993 -0.548 . . . . 1.51 111.689 179.587 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.673 0.273 . . . . 0.85999999999999999 110.712 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.99 91.42 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.913 -0.585 . . . . 0.40000000000000002 111.992 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 255' ' ' LEU . 11.1 mt -60.66 -46.02 91.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.268 0.556 . . . . 0.80000000000000004 111.297 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.51 -51.73 54.08 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.705 -0.76 . . . . 0.51000000000000001 113.092 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.45 -40.99 91.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 117.384 0.592 . . . . 0.81999999999999995 111.928 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 25.7 p -65.88 -43.9 86.93 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.79 0.293 . . . . 0.52000000000000002 111.79 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.0 p -65.77 -47.09 76.34 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.902 -0.319 . . . . 0.54000000000000004 110.623 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.65 -45.94 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.487 -0.324 . . . . 0.83999999999999997 110.438 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.77 -46.71 89.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.893 0.377 . . . . 1.02 110.522 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 91.1 m -59.92 -49.85 76.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.332 0.587 . . . . 0.58999999999999997 110.66 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.613 -0.721 . . . . 1.21 111.926 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 254' ' ' GLY . 6.3 p . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 112.978 0.733 . . . . 0.59999999999999998 112.978 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.483 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -50.46 -52.96 26.55 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 116.087 -0.506 . . . . 0.41999999999999998 113.485 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 255' ' ' LEU . 1.1 mt -65.45 -41.24 93.67 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.538 -0.389 . . . . 0.92000000000000004 110.415 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -60.52 -52.38 52.94 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.694 -0.765 . . . . 0.39000000000000001 112.689 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.82 -41.58 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.96 0.38 . . . . 0.53000000000000003 111.831 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 20.5 p -64.68 -38.75 92.07 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.648 -0.421 . . . . 0.57999999999999996 110.688 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 87.4 m -65.32 -49.23 70.25 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.016 -0.364 . . . . 0.64000000000000001 110.016 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 256' ' ' GLY . 78.4 t -59.6 -45.57 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.60999999999999999 110.578 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -58.72 -45.41 89.65 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.046 0.45 . . . . 1.3500000000000001 110.132 178.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 91.7 m -60.83 -49.96 75.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.927 -0.579 . . . . 0.60999999999999999 110.67 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.769 -0.651 . . . . 1.0900000000000001 111.864 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.685 0.279 . . . . 2.0600000000000001 110.3 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.98 -47.19 91.94 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.965 -0.562 . . . . 1.45 111.806 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 255' ' ' LEU . 8.4 mt -60.36 -46.13 91.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.105 0.479 . . . . 1.5600000000000001 110.885 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.01 -51.97 53.3 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.59 -0.732 . . . . 1.0900000000000001 113.193 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.72 -38.48 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 117.452 0.626 . . . . 1.5 111.031 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 88.7 m -64.42 -42.18 96.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.778 0.323 . . . . 0.95999999999999996 110.223 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 57.1 m -63.52 -47.4 81.82 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.216 -0.447 . . . . 0.70999999999999996 110.177 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 256' ' ' GLY . 87.3 t -61.4 -48.61 88.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.094 -0.503 . . . . 1.25 110.864 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -58.68 -42.67 89.05 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.133 0.492 . . . . 1.54 110.36 179.066 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.6 m -63.29 -49.2 74.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.792 -0.64 . . . . 0.81999999999999995 111.008 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 CA--C 1.535 0.385 0 CA-C-N 115.964 -0.562 . . . . 1.54 111.51 -179.913 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 254' ' ' GLY . 13.2 p . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.085 0.469 . . . . 0.96999999999999997 110.914 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.415 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -59.59 -46.21 94.36 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.537 -0.756 . . . . 0.56000000000000005 112.202 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 255' ' ' LEU . 7.0 mt -62.14 -45.7 92.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.101 0.477 . . . . 1.0 110.929 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -59.98 -50.63 65.62 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.948 -0.644 . . . . 0.52000000000000002 112.953 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.55 -37.93 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.26 0.53 . . . . 0.62 111.159 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.4 m -62.36 -46.52 88.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.768 0.318 . . . . 0.57999999999999996 110.941 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 41.1 p -65.51 -46.94 77.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.264 -0.425 . . . . 0.67000000000000004 110.773 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 256' ' ' GLY . 76.4 t -60.18 -50.45 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.562 -0.29 . . . . 0.66000000000000003 110.639 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 25.3 tp -57.45 -47.12 82.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.638 -0.256 . . . . 0.68000000000000005 110.865 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.9 m -57.58 -48.02 80.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.171 0.51 . . . . 0.54000000000000004 110.946 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 CA--C 1.54 0.567 0 CA-C-N 115.685 -0.689 . . . . 1.1399999999999999 112.431 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 254' ' ' GLY . 6.4 p . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 121.093 0.473 . . . . 0.58999999999999997 111.346 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.487 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -60.77 -45.6 96.13 Favored Glycine 0 C--N 1.323 -0.171 0 CA-C-N 115.498 -0.774 . . . . 0.34999999999999998 112.259 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 255' ' ' LEU . 11.0 mt -59.17 -46.66 87.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.116 0.484 . . . . 0.72999999999999998 111.069 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -63.68 -51.35 54.66 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.736 -0.665 . . . . 0.29999999999999999 113.313 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.2 pp -62.58 -41.32 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 117.429 0.614 . . . . 0.54000000000000004 111.644 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.3 p -66.28 -40.88 90.37 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 122.23 -0.294 . . . . 0.56999999999999995 110.988 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 85.6 m -64.16 -48.73 74.86 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.094 -0.336 . . . . 0.56999999999999995 110.094 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 256' ' ' GLY . 75.3 t -60.54 -48.54 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.163 -0.471 . . . . 0.5 110.884 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.2 OUTLIER -56.52 -43.69 80.06 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.011 0.434 . . . . 1.1499999999999999 110.357 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 92.6 m -60.73 -49.2 78.47 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.688 -0.687 . . . . 0.71999999999999997 110.745 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 CA--C 1.538 0.486 0 CA-C-N 116.041 -0.527 . . . . 0.78000000000000003 112.412 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 121.02 0.438 . . . . 1.26 110.311 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -61.61 -46.44 94.26 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.709 -0.678 . . . . 0.59999999999999998 112.066 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 255' ' ' LEU . 15.2 tp -62.59 -41.24 98.84 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.105 0.479 . . . . 1.05 110.314 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.25 -53.36 42.83 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.879 -0.601 . . . . 0.60999999999999999 112.639 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.46 -35.8 75.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.292 0.546 . . . . 0.81000000000000005 111.396 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.4 m -64.69 -47.8 77.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.835 0.35 . . . . 0.85999999999999999 110.8 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.3 p -64.75 -45.88 84.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.421 -0.354 . . . . 0.96999999999999997 110.989 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 256' ' ' GLY . 73.5 t -59.29 -48.26 87.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.758 -0.201 . . . . 0.71999999999999997 110.85 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 20.3 tp -62.48 -38.32 89.4 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.997 0.427 . . . . 1.0900000000000001 110.773 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 99.4 m -64.31 -49.19 72.72 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.012 -0.54 . . . . 1.3899999999999999 110.91 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 CA--C 1.537 0.449 0 CA-C-N 116.171 -0.468 . . . . 1.3200000000000001 112.063 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 CA--C 1.53 0.2 0 CA-C-O 120.636 0.255 . . . . 2.3300000000000001 110.905 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -61.34 -49.22 79.88 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.967 -0.635 . . . . 1.0 111.854 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.26 -39.56 90.84 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.223 0.535 . . . . 2.3399999999999999 110.425 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.13 -54.35 33.49 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.798 -0.637 . . . . 1.1299999999999999 112.824 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.29 -35.63 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 117.471 0.636 . . . . 2.0299999999999998 111.064 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 90.8 m -64.29 -47.72 78.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.796 0.331 . . . . 1.79 111.128 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.9 p -66.0 -46.13 79.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.37 -0.377 . . . . 1.9399999999999999 110.869 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.82 -47.63 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.449 -0.341 . . . . 1.8500000000000001 110.641 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.8 -45.51 92.12 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.779 0.323 . . . . 2.23 110.283 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.8 m -60.39 -46.15 91.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.303 0.573 . . . . 2.1699999999999999 111.32 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.747 -0.66 . . . . 2.7200000000000002 112.26 -179.859 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 254' ' ' GLY . 6.3 p . . . . . 0 N--CA 1.464 0.243 0 CA-C-O 120.966 0.412 . . . . 0.77000000000000002 111.144 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.436 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -57.38 -48.51 80.04 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.352 -0.84 . . . . 0.56000000000000005 112.435 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 255' ' ' LEU . 7.5 mt -60.02 -44.39 94.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.327 0.584 . . . . 1.0 111.013 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.26 -52.29 48.27 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.687 -0.768 . . . . 0.44 112.989 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.27 -39.96 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 117.482 0.641 . . . . 0.68000000000000005 111.973 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 22.2 p -65.73 -45.74 81.54 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.62 0.23 . . . . 0.64000000000000001 111.62 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.6 p -65.2 -45.82 83.23 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 121.009 -0.276 . . . . 0.65000000000000002 110.597 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.2 t -60.57 -46.86 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.594 -0.275 . . . . 0.75 110.591 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.55 -45.94 90.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.125 0.488 . . . . 1.3899999999999999 109.753 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 90.7 m -60.24 -49.95 75.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.714 -0.675 . . . . 0.58999999999999997 110.936 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 CA--C 1.537 0.467 0 CA-C-N 115.863 -0.608 . . . . 1.45 111.963 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 254' ' ' GLY . 10.7 p . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.271 0.558 . . . . 0.81999999999999995 110.354 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.425 ' O ' HG13 ' A' ' 257' ' ' ILE . . . -61.27 -49.35 78.72 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.027 -0.988 . . . . 0.42999999999999999 112.109 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.2 mt -59.24 -43.6 92.38 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.013 0.435 . . . . 0.87 111.152 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.98 -53.54 42.08 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.816 -0.629 . . . . 0.35999999999999999 112.941 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 254' ' ' GLY . 2.4 pp -62.34 -38.43 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 117.36 0.58 . . . . 0.64000000000000001 110.93 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 41.9 m -62.62 -43.35 99.04 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.987 0.422 . . . . 0.54000000000000004 109.984 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 46.5 m -63.2 -46.55 86.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.48999999999999999 110.096 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 256' ' ' GLY . 99.1 t -61.41 -49.88 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.128 -0.487 . . . . 0.55000000000000004 110.841 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.52 -43.55 79.92 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.029 0.442 . . . . 1.24 110.485 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 68.0 m -62.55 -50.99 69.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.54000000000000004 110.618 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 54.2 ttp . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 115.798 -0.637 . . . . 0.82999999999999996 111.934 179.649 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.376 0.131 . . . . 0.69999999999999996 110.893 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.501 ' O ' HG13 ' A' ' 257' ' ' ILE . . . -61.19 -48.39 85.97 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.665 -0.779 . . . . 0.40000000000000002 111.46 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.4 mt -60.64 -49.48 77.33 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 122.832 -0.217 . . . . 0.81000000000000005 110.948 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.91 -50.74 61.71 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 116.101 -0.499 . . . . 0.34999999999999998 113.117 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 254' ' ' GLY . 2.5 pp -63.07 -33.65 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 117.21 0.505 . . . . 0.53000000000000003 110.016 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 91.4 m -63.82 -47.6 80.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.708 -0.224 . . . . 0.54000000000000004 110.546 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -43.43 96.23 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.682 0.277 . . . . 1.1299999999999999 110.745 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.1 -48.32 89.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.327 -0.397 . . . . 0.55000000000000004 110.77 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -41.69 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.502 . . . . 1.3600000000000001 110.481 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 86.2 m -63.45 -51.73 64.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.571 -0.741 . . . . 0.60999999999999999 112.118 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 20.5 ptp . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 113.896 1.073 . . . . 0.94999999999999996 113.896 -178.599 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.746 0.307 . . . . 2.54 110.531 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.84 -47.67 89.29 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.991 -0.55 . . . . 2.0299999999999998 111.968 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 255' ' ' LEU . 8.9 mt -60.87 -44.31 97.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.378 0.609 . . . . 1.74 110.892 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.76 -52.1 50.92 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.544 -0.753 . . . . 1.25 113.031 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.71 -37.88 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 117.622 0.711 . . . . 2.1499999999999999 111.225 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 91.1 m -64.31 -47.56 78.98 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.83 0.347 . . . . 1.5900000000000001 111.16 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.2 p -64.71 -45.0 88.41 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.485 -0.325 . . . . 0.81999999999999995 110.731 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.81 -49.46 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.521 -0.309 . . . . 1.77 110.416 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.65 -42.58 83.76 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.912 0.386 . . . . 2.1800000000000002 110.626 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 93.1 m -62.17 -48.98 77.64 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.942 -0.572 . . . . 1.1100000000000001 110.3 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 115.51 -0.768 . . . . 1.6699999999999999 111.616 179.351 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.499 0.19 . . . . 0.94999999999999996 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.3 -48.68 84.81 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.906 -0.664 . . . . 0.67000000000000004 111.622 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 255' ' ' LEU . 8.0 mt -61.14 -43.7 98.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.158 0.504 . . . . 0.89000000000000001 110.824 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.09 -53.01 45.93 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.37 -0.919 . . . . 0.44 112.983 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.85 -40.13 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 117.471 0.636 . . . . 0.80000000000000004 111.948 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 19.3 p -64.65 -45.72 85.55 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.718 0.266 . . . . 0.77000000000000002 111.718 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.3 p -65.95 -46.12 79.28 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.187 -0.205 . . . . 0.62 110.923 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.42 -48.43 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.824 -0.171 . . . . 0.68999999999999995 110.662 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 42.3 mt -61.33 -40.51 94.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.791 0.329 . . . . 0.79000000000000004 111.182 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.2 m -67.12 -46.7 73.36 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.203 0.525 . . . . 0.82999999999999996 111.32 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 CA--C 1.536 0.421 0 CA-C-N 115.657 -0.701 . . . . 1.49 112.313 -179.195 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.675 0.274 . . . . 1.3 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -61.43 -48.21 86.33 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 121.023 -0.608 . . . . 0.66000000000000003 112.006 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 255' ' ' LEU . 15.7 tp -61.71 -42.65 99.23 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.953 0.406 . . . . 1.3300000000000001 110.448 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.07 -54.22 38.5 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.076 -0.583 . . . . 0.68000000000000005 112.804 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.46 -35.85 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 117.345 0.573 . . . . 1.1799999999999999 111.352 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.2 m -65.16 -47.0 78.55 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.758 0.313 . . . . 0.96999999999999997 111.028 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 27.6 p -66.56 -46.66 75.32 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.521 -0.309 . . . . 1.0900000000000001 110.734 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 73.0 t -58.88 -46.82 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.674 -0.239 . . . . 1.29 110.517 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 26.5 tp -61.3 -44.6 96.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.869 0.366 . . . . 1.26 110.329 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 96.7 m -60.41 -48.12 83.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.149 0.499 . . . . 1.0700000000000001 111.213 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 112.531 0.567 . . . . 2.1899999999999999 112.531 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 254' ' ' GLY . 2.5 p . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 120.872 0.368 . . . . 0.79000000000000004 111.865 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.556 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -56.52 -46.31 88.28 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.666 -0.697 . . . . 0.63 112.822 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 255' ' ' LEU . 6.7 mt -62.45 -45.4 93.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.981 0.42 . . . . 0.89000000000000001 111.048 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.447 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.8 -51.39 56.06 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.841 -0.618 . . . . 0.29999999999999999 112.756 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.78 -37.68 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 117.175 0.487 . . . . 0.81999999999999995 111.063 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.6 m -64.84 -41.96 95.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.933 0.397 . . . . 0.69999999999999996 110.017 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 54.1 m -63.17 -46.44 87.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.121 -0.49 . . . . 0.52000000000000002 110.051 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 256' ' ' GLY . 93.6 t -59.75 -48.18 88.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 116.212 -0.449 . . . . 0.67000000000000004 110.201 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.34 -44.66 92.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.919 0.39 . . . . 1.2 110.512 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 92.7 m -58.51 -49.39 77.54 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.803 -0.635 . . . . 0.55000000000000004 111.482 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 21.4 ptp . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.785 0.661 . . . . 0.85999999999999999 112.785 -179.748 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.0 t . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.351 0.119 . . . . 1.48 110.99 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.32 -49.4 72.99 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.006 -0.616 . . . . 0.52000000000000002 111.888 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 255' ' ' LEU . 8.8 mt -60.0 -45.81 91.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.277 0.561 . . . . 1.29 111.025 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.92 -52.64 48.91 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.798 -0.715 . . . . 0.59999999999999998 113.354 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.32 -40.33 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 117.628 0.714 . . . . 0.72999999999999998 111.687 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.1 p -65.3 -45.33 84.82 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.947 -0.301 . . . . 0.78000000000000003 111.697 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.3 p -64.72 -44.45 90.15 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 121.046 -0.262 . . . . 1.04 110.703 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.5 t -61.49 -51.58 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.753 -0.203 . . . . 0.95999999999999996 110.615 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.2 mt -57.66 -38.49 75.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.655 0.264 . . . . 0.85999999999999999 111.068 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 96.1 m -65.66 -49.05 70.06 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.204 0.526 . . . . 1.03 110.575 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 CA--C 1.537 0.471 0 CA-C-N 115.858 -0.61 . . . . 1.4199999999999999 111.552 179.622 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.586 HG13 ' H ' ' A' ' 254' ' ' GLY . 2.5 p . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 112.391 0.515 . . . . 1.3799999999999999 112.391 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.586 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -55.26 -48.28 69.88 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.869 -0.605 . . . . 0.94999999999999996 112.671 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' A' ' 255' ' ' LEU . 8.0 mt -60.18 -45.88 91.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.199 0.523 . . . . 1.21 111.156 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.68 -50.85 58.58 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.7 -0.762 . . . . 0.40000000000000002 113.238 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.2 pp -63.24 -40.23 88.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 117.394 0.597 . . . . 1.3100000000000001 111.955 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 26.7 p -68.04 -43.92 77.59 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 121.028 -0.269 . . . . 1.3999999999999999 111.723 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 p -64.81 -45.26 86.99 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.065 -0.254 . . . . 1.1000000000000001 110.568 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 56.6 t -62.16 -49.71 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.56 -0.291 . . . . 0.71999999999999997 110.626 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.4 OUTLIER -56.31 -45.1 80.43 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.959 0.409 . . . . 1.3500000000000001 110.674 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 97.8 m -60.96 -47.22 87.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.745 -0.661 . . . . 1.6499999999999999 110.629 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.535 0.397 0 CA-C-N 115.832 -0.622 . . . . 1.6000000000000001 111.507 179.633 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 50.0 t . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.77 0.319 . . . . 1.1000000000000001 110.57 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.03 -47.51 90.4 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.949 -0.569 . . . . 0.62 112.148 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 255' ' ' LEU . 17.2 tp -61.75 -42.99 99.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.998 0.428 . . . . 1.9099999999999999 110.198 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.03 -53.24 44.33 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.9 -0.667 . . . . 0.96999999999999997 112.907 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.63 -40.13 87.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 117.286 0.543 . . . . 0.96999999999999997 111.646 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 21.0 p -65.69 -39.17 90.99 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.95 -0.3 . . . . 0.98999999999999999 110.982 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 90.2 m -65.32 -47.75 75.46 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.947 -0.39 . . . . 1.49 109.947 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 256' ' ' GLY . 78.0 t -59.66 -48.05 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.031 -0.531 . . . . 1.25 110.422 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 261' ' ' LEU . 50.6 mt -59.62 -47.41 85.71 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.532 -0.304 . . . . 1.03 110.859 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.8 m -58.44 -44.16 89.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.338 0.59 . . . . 1.23 111.172 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 CA--C 1.538 0.482 0 CA-C-N 115.549 -0.75 . . . . 2.1200000000000001 111.904 -179.745 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 254' ' ' GLY . 3.0 p . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 120.884 0.374 . . . . 1.0 111.934 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.503 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -55.67 -49.29 66.35 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.609 -0.723 . . . . 0.56999999999999995 112.768 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.2 mt -63.61 -41.9 98.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.848 0.356 . . . . 1.01 110.764 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.39 -52.49 51.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.804 -0.712 . . . . 0.5 112.601 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.43 -37.83 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 117.086 0.443 . . . . 0.75 111.172 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.7 m -64.98 -41.25 95.6 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.745 0.307 . . . . 0.70999999999999996 110.328 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 58.8 m -64.8 -48.71 73.46 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 110.002 -0.37 . . . . 0.63 110.002 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 256' ' ' GLY . 97.4 t -60.51 -46.57 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.121 -0.49 . . . . 0.63 110.626 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 21.7 tp -60.45 -42.8 96.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.861 0.363 . . . . 0.98999999999999999 110.842 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 97.2 m -63.82 -46.87 83.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.223 0.535 . . . . 0.81000000000000005 110.839 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 49.0 tpp . . . . . 0 CA--C 1.537 0.478 0 CA-C-N 115.603 -0.726 . . . . 1.05 112.037 -179.755 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.776 0.322 . . . . 3.1499999999999999 111.311 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.53 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 22.5 Cg_exo -68.12 106.51 1.37 Allowed 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.158 2.572 . . . . 1.3500000000000001 112.496 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.41 98.51 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.197 -0.456 . . . . 0.89000000000000001 111.743 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -44.77 95.95 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.267 -0.424 . . . . 1.8100000000000001 110.749 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 93.9 t -64.93 -47.98 86.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 0.68000000000000005 110.708 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.84 -48.0 85.01 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.116 -0.564 . . . . 0.42999999999999999 111.797 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 255' ' ' LEU . 7.3 mt -61.45 -45.27 94.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.109 0.481 . . . . 0.83999999999999997 110.785 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.43 -52.27 52.44 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.643 -0.708 . . . . 0.33000000000000002 113.116 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.66 -38.59 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 117.415 0.608 . . . . 0.57999999999999996 110.896 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.5 m -63.25 -42.85 99.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.079 0.466 . . . . 0.66000000000000003 109.987 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 263' ' ' MET . 57.5 m -62.69 -48.92 77.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.906 -0.588 . . . . 0.58999999999999997 110.156 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.607 ' O ' HG22 ' A' ' 264' ' ' THR . 98.9 t -59.2 -49.14 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.122 -0.49 . . . . 0.51000000000000001 110.452 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 23.5 tp -57.52 -40.19 78.18 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.305 -0.407 . . . . 0.77000000000000002 110.321 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 93.2 m -64.25 -48.54 75.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.888 -0.596 . . . . 0.68999999999999995 110.525 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 259' ' ' THR . 96.3 mmm -62.2 -46.09 90.44 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.837 -0.62 . . . . 0.85999999999999999 112.38 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 260' ' ' VAL . 9.8 t -78.16 53.56 1.23 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.372 0.508 . . . . 0.53000000000000003 112.372 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.914 ' HA ' ' HA ' ' A' ' 272' ' ' ALA . 1.2 t -60.3 -46.96 88.05 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.279 0.474 . . . . 0.47999999999999998 112.279 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 68.67 -47.37 0.56 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.271 0.628 . . . . 1.3300000000000001 112.249 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 45.3 t -69.91 -22.19 63.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.521 -0.308 . . . . 0.75 111.591 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.5 t 65.66 47.5 2.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.256 0.551 . . . . 1.1499999999999999 111.828 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -147.58 49.55 0.61 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.825 -0.702 . . . . 0.69999999999999996 112.731 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 60.4 m 69.65 -52.89 0.61 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.651 0.78 . . . . 0.91000000000000003 112.32 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -86.2 152.39 22.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.438 -0.346 . . . . 0.80000000000000004 110.76 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.914 ' HA ' ' HA ' ' A' ' 265' ' ' THR . . . -75.45 -122.41 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.466 -0.334 . . . . 0.60999999999999999 110.17 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.59 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 20.8 p -80.49 51.85 1.53 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.642 0.734 . . . . 0.71999999999999997 111.291 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.663 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 27.2 tp -129.11 48.32 3.57 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.991 -1.004 . . . . 0.83999999999999997 109.827 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.663 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 51.1 Cg_exo -61.29 56.82 0.1 Allowed 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 123.194 2.596 . . . . 0.59999999999999998 114.758 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.393 0 CA-C-O 118.32 -0.848 . . . . 1.0700000000000001 110.973 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 111.291 0.108 . . . . 3.9300000000000002 111.291 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.421 ' HB2' ' H ' ' A' ' 251' ' ' ALA . 61.5 Cg_endo -76.33 -147.02 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.265 2.644 . . . . 3.1299999999999999 113.362 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.421 ' H ' ' HB2' ' A' ' 250' ' ' PRO . . . -150.92 -70.33 0.18 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.126 0.489 . . . . 2.0600000000000001 111.452 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.801 ' HB3' ' HB2' ' A' ' 255' ' ' LEU . 14.3 mmt180 -94.73 67.77 3.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.437 0.637 . . . . 1.74 111.916 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.3 t -55.39 -50.86 62.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.739 -1.119 . . . . 1.3400000000000001 111.505 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.08 -46.21 94.1 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.922 -0.581 . . . . 0.81000000000000005 112.17 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.801 ' HB2' ' HB3' ' A' ' 252' ' ' ARG . 6.2 mt -62.47 -45.06 94.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.896 0.379 . . . . 1.1499999999999999 110.779 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.13 -50.85 61.25 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.034 -0.603 . . . . 0.57999999999999996 112.821 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.5 pp -64.07 -36.53 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 117.31 0.555 . . . . 0.95999999999999996 110.69 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 88.4 m -66.06 -42.06 89.96 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.718 -0.475 . . . . 1.01 109.718 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.7 m -63.96 -49.19 73.5 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.915 -0.584 . . . . 0.98999999999999999 110.012 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.621 ' O ' HG22 ' A' ' 264' ' ' THR . 82.6 t -59.9 -48.97 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.126 -0.488 . . . . 0.81000000000000005 110.391 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.2 OUTLIER -56.7 -42.82 79.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.039 0.447 . . . . 1.3 109.826 178.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 85.5 m -61.61 -47.46 85.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.761 -0.654 . . . . 1.3300000000000001 110.666 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 89.4 mtp -62.57 -54.4 40.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.993 -0.548 . . . . 1.51 111.689 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 260' ' ' VAL . 10.0 t -86.49 46.05 1.31 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.493 0.663 . . . . 1.1499999999999999 111.248 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.763 HG21 ' HG2' ' A' ' 275' ' ' PRO . 8.9 t -74.09 43.76 0.17 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.879 -0.601 . . . . 1.55 112.582 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -96.91 64.43 2.02 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.158 -0.338 . . . . 1.24 111.23 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 34.5 t -158.03 130.6 7.22 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.065 0.46 . . . . 1.9299999999999999 111.716 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 73.6 m -91.94 120.49 32.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.114 -0.494 . . . . 2.3100000000000001 110.6 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 176.9 -133.69 2.34 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.698 -0.763 . . . . 2.23 112.865 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.8 m -61.9 -40.61 96.03 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.793 0.296 . . . . 2.9300000000000002 111.409 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -78.15 127.67 32.64 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.836 0.35 . . . . 1.8100000000000001 110.736 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -73.17 85.98 1.39 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.358 -0.383 . . . . 1.0900000000000001 111.309 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.57 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 70.3 m -73.89 60.84 0.75 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.169 0.509 . . . . 1.4099999999999999 112.131 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.675 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 22.2 tp -124.51 41.91 0.66 Allowed Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 115.648 -0.705 . . . . 2.3100000000000001 110.998 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.763 ' HG2' HG21 ' A' ' 265' ' ' THR . 51.1 Cg_exo -60.74 -31.05 91.48 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.448 2.099 . . . . 2.8900000000000001 112.63 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.909 ' HA ' ' HE2' ' A' ' 276' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.325 -0.845 . . . . 4.4199999999999999 111.145 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.678 0.275 . . . . 1.98 110.977 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.512 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 85.6 Cg_endo -74.97 59.88 5.28 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.47 2.78 . . . . 1.24 113.327 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.82 91.3 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.915 0.339 . . . . 0.72999999999999998 111.915 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -44.38 95.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.189 0.518 . . . . 1.8400000000000001 110.075 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 61.7 t -62.43 -49.0 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.618 -0.719 . . . . 0.85999999999999999 110.712 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.99 91.42 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.913 -0.585 . . . . 0.40000000000000002 111.992 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 255' ' ' LEU . 11.1 mt -60.66 -46.02 91.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.268 0.556 . . . . 0.80000000000000004 111.297 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.51 -51.73 54.08 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.705 -0.76 . . . . 0.51000000000000001 113.092 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.45 -40.99 91.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 117.384 0.592 . . . . 0.81999999999999995 111.928 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 25.7 p -65.88 -43.9 86.93 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.79 0.293 . . . . 0.52000000000000002 111.79 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.0 p -65.77 -47.09 76.34 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.902 -0.319 . . . . 0.54000000000000004 110.623 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.65 -45.94 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.487 -0.324 . . . . 0.83999999999999997 110.438 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.406 ' HA ' HG22 ' A' ' 264' ' ' THR . 25.1 tp -60.77 -46.71 89.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.893 0.377 . . . . 1.02 110.522 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 91.1 m -59.92 -49.85 76.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.332 0.587 . . . . 0.58999999999999997 110.66 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 47.4 ttm -60.62 -47.62 85.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.613 -0.721 . . . . 1.21 111.926 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 261' ' ' LEU . 13.2 t -65.89 -38.2 88.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.748 0.648 . . . . 0.88 112.748 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 12.0 t -73.06 -33.44 65.66 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.514 -0.474 . . . . 0.84999999999999998 110.959 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -68.81 -42.15 77.69 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.218 0.532 . . . . 1.0 109.909 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 35.3 t -91.09 -152.73 0.29 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.18 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 54.3 p -73.88 124.96 27.13 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.203 -0.311 . . . . 0.71999999999999997 110.56 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -71.66 62.45 1.2 Allowed Glycine 0 CA--C 1.522 0.531 0 C-N-CA 121.277 -0.487 . . . . 0.81000000000000005 112.823 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.9 t -166.12 143.61 5.39 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 122.419 0.287 . . . . 0.85999999999999999 110.862 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 71.43 43.86 0.58 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.004 -0.544 . . . . 1.0900000000000001 111.804 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -89.81 130.8 36.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 1.3200000000000001 111.178 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.466 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 77.4 p -88.39 -175.87 5.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.52 0.676 . . . . 1.0600000000000001 112.134 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.627 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 22.7 tp 56.16 40.42 0.65 Allowed Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 114.588 -1.187 . . . . 1.23 111.959 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 81.8 Cg_exo -52.95 132.56 47.88 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.342 2.028 . . . . 1.02 114.063 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.187 -0.911 . . . . 2.4300000000000002 111.091 179.277 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.454 0.168 . . . . 2.29 110.611 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.493 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 17.8 Cg_exo -70.1 76.72 1.25 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.357 2.705 . . . . 1.3999999999999999 112.859 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.12 118.42 4.67 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.808 0.337 . . . . 0.93999999999999995 111.233 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.642 ' HG3' ' HB2' ' A' ' 255' ' ' LEU . 5.7 tpt180 50.39 44.51 26.75 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.81 0.814 . . . . 1.49 111.817 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 6.3 p -47.81 -51.87 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 114.692 -1.14 . . . . 0.59999999999999998 112.978 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.483 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -50.46 -52.96 26.55 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 116.087 -0.506 . . . . 0.41999999999999998 113.485 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.642 ' HB2' ' HG3' ' A' ' 252' ' ' ARG . 1.1 mt -65.45 -41.24 93.67 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.538 -0.389 . . . . 0.92000000000000004 110.415 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -60.52 -52.38 52.94 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.694 -0.765 . . . . 0.39000000000000001 112.689 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.82 -41.58 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.96 0.38 . . . . 0.53000000000000003 111.831 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 20.5 p -64.68 -38.75 92.07 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.648 -0.421 . . . . 0.57999999999999996 110.688 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 87.4 m -65.32 -49.23 70.25 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.016 -0.364 . . . . 0.64000000000000001 110.016 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 256' ' ' GLY . 78.4 t -59.6 -45.57 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.60999999999999999 110.578 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -58.72 -45.41 89.65 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.046 0.45 . . . . 1.3500000000000001 110.132 178.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 91.7 m -60.83 -49.96 75.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.927 -0.579 . . . . 0.60999999999999999 110.67 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.32 -46.91 88.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.769 -0.651 . . . . 1.0900000000000001 111.864 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.8 t -68.86 -40.24 79.42 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.842 0.682 . . . . 0.71999999999999997 112.842 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 14.9 t -68.1 -36.23 79.43 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.784 -0.367 . . . . 0.67000000000000004 111.649 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLN . . . . . 0.598 ' HG2' ' HA3' ' A' ' 269' ' ' GLY . 14.3 tt0 -81.25 -35.8 30.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.519 0.199 . . . . 0.82999999999999996 111.026 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 70.5 m 61.66 -126.08 0.81 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.356 -0.384 . . . . 0.78000000000000003 111.127 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.3 p -77.24 43.66 0.38 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.998 0.427 . . . . 1.02 112.078 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.598 ' HA3' ' HG2' ' A' ' 266' ' ' GLN . . . -76.62 56.43 3.39 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.439 -0.41 . . . . 0.77000000000000002 113.581 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.4 t -56.91 136.42 55.89 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.196 0.443 . . . . 1.02 112.196 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 58.6 48.82 11.24 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.091 -0.504 . . . . 1.01 112.15 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 60.85 49.42 6.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.04 0.448 . . . . 1.29 111.315 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.625 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 25.3 m 64.02 50.88 2.39 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.514 -0.766 . . . . 0.87 111.97 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.651 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 27.0 tp -126.85 49.3 3.9 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.252 -0.885 . . . . 1.04 109.714 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 62.7 Cg_exo -60.18 60.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.451 2.767 . . . . 0.90000000000000002 115.499 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.257 1.458 0 CA-C-O 118.262 -0.875 . . . . 1.76 111.363 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.369 0.128 . . . . 2.7400000000000002 110.783 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.403 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 2.7 Cg_endo -76.57 58.58 5.92 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.823 2.349 . . . . 2.23 112.787 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.48 82.76 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.017 0.377 . . . . 2.0 112.017 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -41.36 98.57 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.88 0.371 . . . . 2.6499999999999999 110.306 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 56.1 t -64.32 -49.26 81.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 2.0600000000000001 110.3 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.98 -47.19 91.94 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.965 -0.562 . . . . 1.45 111.806 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 255' ' ' LEU . 8.4 mt -60.36 -46.13 91.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.105 0.479 . . . . 1.5600000000000001 110.885 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.01 -51.97 53.3 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.59 -0.732 . . . . 1.0900000000000001 113.193 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.72 -38.48 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 117.452 0.626 . . . . 1.5 111.031 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 88.7 m -64.42 -42.18 96.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.778 0.323 . . . . 0.95999999999999996 110.223 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 57.1 m -63.52 -47.4 81.82 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.216 -0.447 . . . . 0.70999999999999996 110.177 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 256' ' ' GLY . 87.3 t -61.4 -48.61 88.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.094 -0.503 . . . . 1.25 110.864 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -58.68 -42.67 89.05 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.133 0.492 . . . . 1.54 110.36 179.066 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.6 m -63.29 -49.2 74.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.792 -0.64 . . . . 0.81999999999999995 111.008 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.3 tpt -63.4 -53.14 57.12 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.964 -0.562 . . . . 1.54 111.51 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.9 t -132.21 134.21 45.08 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.366 0.603 . . . . 1.21 111.877 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.3 t -73.72 -32.19 63.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 1.29 111.53 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -162.57 127.36 3.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.494 . . . . 1.2 110.64 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 74.9 m -163.68 -52.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.059 -0.519 . . . . 1.0700000000000001 110.588 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.6 p -68.6 135.56 51.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.378 . . . . 1.9099999999999999 111.0 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -148.94 152.44 24.47 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.639 -0.791 . . . . 2.0299999999999998 113.441 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.2 t -63.3 133.64 54.5 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.241 0.46 . . . . 3.0699999999999998 112.241 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? 69.28 -53.44 0.59 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.507 0.723 . . . . 3.9700000000000002 112.152 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -139.82 123.69 17.55 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.725 -0.472 . . . . 2.3700000000000001 109.725 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.5 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 54.7 m -90.75 -179.01 5.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.214 0.53 . . . . 1.74 111.805 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.697 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 19.6 tp 58.93 36.68 0.28 Allowed Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.869 -1.06 . . . . 1.6299999999999999 111.524 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.697 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 53.1 Cg_exo -59.85 -39.53 71.25 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.056 1.837 . . . . 1.55 112.473 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? . . . . . 0 C--O 1.253 1.251 0 CA-C-O 117.766 -1.111 . . . . 1.74 109.441 179.818 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.426 0.155 . . . . 1.95 111.077 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.761 ' HD2' ' HA3' ' A' ' 254' ' ' GLY . 30.1 Cg_exo -66.06 60.84 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.02 3.147 . . . . 1.1000000000000001 113.938 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 56.47 -142.61 0.75 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.507 0.929 . . . . 0.93000000000000005 113.507 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -50.86 71.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.815 -0.63 . . . . 1.7 112.306 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 254' ' ' GLY . 13.2 p -59.19 -47.63 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.085 0.469 . . . . 0.96999999999999997 110.914 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.761 ' HA3' ' HD2' ' A' ' 250' ' ' PRO . . . -59.59 -46.21 94.36 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.537 -0.756 . . . . 0.56000000000000005 112.202 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 255' ' ' LEU . 7.0 mt -62.14 -45.7 92.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.101 0.477 . . . . 1.0 110.929 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -59.98 -50.63 65.62 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.948 -0.644 . . . . 0.52000000000000002 112.953 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.55 -37.93 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.26 0.53 . . . . 0.62 111.159 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.4 m -62.36 -46.52 88.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.768 0.318 . . . . 0.57999999999999996 110.941 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.527 ' CG2' ' HB3' ' A' ' 275' ' ' PRO . 41.1 p -65.51 -46.94 77.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.264 -0.425 . . . . 0.67000000000000004 110.773 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 256' ' ' GLY . 76.4 t -60.18 -50.45 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.562 -0.29 . . . . 0.66000000000000003 110.639 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.466 ' HA ' HG22 ' A' ' 264' ' ' THR . 25.3 tp -57.45 -47.12 82.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.638 -0.256 . . . . 0.68000000000000005 110.865 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.9 m -57.58 -48.02 80.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.171 0.51 . . . . 0.54000000000000004 110.946 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 28.3 ttt -66.43 -46.11 77.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.685 -0.689 . . . . 1.1399999999999999 112.431 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 261' ' ' LEU . 13.0 t -67.81 -35.27 78.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.313 0.857 . . . . 0.68999999999999995 113.313 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 261' ' ' LEU . 12.7 t -76.62 -1.65 28.69 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.195 -0.316 . . . . 0.77000000000000002 111.691 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 62.23 47.38 5.52 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.225 0.536 . . . . 1.1200000000000001 110.831 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 44.5 t -69.4 151.99 45.46 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.448 -0.796 . . . . 0.69999999999999996 110.979 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.0 m -69.78 56.48 0.13 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.473 0.546 . . . . 1.1399999999999999 112.473 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 179.8 -140.82 4.41 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 112.149 -0.38 . . . . 1.1499999999999999 112.149 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 274' ' ' LEU . 13.8 t 58.25 -142.23 0.69 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.822 0.311 . . . . 1.3300000000000001 111.66 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 270' ' ' SER . 57.6 mtp85 72.12 121.08 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.391 0.676 . . . . 1.8999999999999999 111.995 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 57.27 -140.2 0.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.08 -0.509 . . . . 1.9299999999999999 111.217 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.625 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 58.1 p -86.41 49.46 1.8 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.335 0.588 . . . . 1.8799999999999999 111.996 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.639 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 2.7 mm? -126.79 51.22 6.0 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.393 -0.821 . . . . 1.2 110.217 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 85.3 Cg_exo -56.31 50.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 124.292 3.328 . . . . 2.2400000000000002 115.945 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 276' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.897 -0.573 . . . . 3.6899999999999999 110.377 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.257 0.075 . . . . 2.96 110.924 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.683 ' HG2' ' HA3' ' A' ' 254' ' ' GLY . 97.2 Cg_endo -73.23 -137.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.212 2.608 . . . . 1.3200000000000001 113.768 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' A' ' 250' ' ' PRO . . . -76.39 -148.41 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.033 0.753 . . . . 0.84999999999999998 113.033 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.06 -41.88 88.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.699 -0.682 . . . . 1.26 111.864 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 254' ' ' GLY . 6.4 p -56.08 -53.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.093 0.473 . . . . 0.58999999999999997 111.346 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.683 ' HA3' ' HG2' ' A' ' 250' ' ' PRO . . . -60.77 -45.6 96.13 Favored Glycine 0 C--N 1.323 -0.171 0 CA-C-N 115.498 -0.774 . . . . 0.34999999999999998 112.259 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 255' ' ' LEU . 11.0 mt -59.17 -46.66 87.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.116 0.484 . . . . 0.72999999999999998 111.069 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -63.68 -51.35 54.66 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.736 -0.665 . . . . 0.29999999999999999 113.313 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.2 pp -62.58 -41.32 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 117.429 0.614 . . . . 0.54000000000000004 111.644 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.3 p -66.28 -40.88 90.37 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 122.23 -0.294 . . . . 0.56999999999999995 110.988 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 85.6 m -64.16 -48.73 74.86 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.094 -0.336 . . . . 0.56999999999999995 110.094 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 256' ' ' GLY . 75.3 t -60.54 -48.54 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.163 -0.471 . . . . 0.5 110.884 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.2 OUTLIER -56.52 -43.69 80.06 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.011 0.434 . . . . 1.1499999999999999 110.357 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 92.6 m -60.73 -49.2 78.47 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.688 -0.687 . . . . 0.71999999999999997 110.745 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' MET . . . . . 0.696 ' HA ' ' HG2' ' A' ' 275' ' ' PRO . 88.8 mtp -63.83 -54.58 32.81 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.041 -0.527 . . . . 0.78000000000000003 112.412 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.6 t -126.2 134.96 51.1 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.206 0.527 . . . . 0.58999999999999997 111.937 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.8 t -64.56 119.1 9.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.165 0.507 . . . . 0.93000000000000005 112.031 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 67.5 -61.99 0.34 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.315 -0.857 . . . . 1.3200000000000001 112.322 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 32.4 t -172.33 -141.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.418 . . . . 0.97999999999999998 110.274 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 32.7 t 61.06 -140.81 0.52 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.758 0.423 . . . . 0.77000000000000002 111.317 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -146.58 79.08 0.23 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.902 -0.666 . . . . 0.65000000000000002 112.927 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 50.1 m -60.43 135.94 57.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.913 0.387 . . . . 0.58999999999999997 111.556 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -62.08 -39.01 90.97 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.277 -0.419 . . . . 2.2799999999999998 111.683 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -81.23 33.81 0.35 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.126 0.788 . . . . 1.3799999999999999 113.126 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.578 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 54.0 m -80.18 56.79 2.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.362 0.601 . . . . 0.59999999999999998 111.435 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.705 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 21.2 tp -127.82 42.67 0.9 Allowed Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.582 -0.736 . . . . 1.0800000000000001 110.536 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.705 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 45.5 Cg_exo -64.52 100.38 0.33 Allowed 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 122.53 2.153 . . . . 2.2000000000000002 113.186 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.428 ' HE3' ' HG ' ' A' ' 274' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.448 0 CA-C-O 117.919 -1.039 . . . . 1.8799999999999999 110.561 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.461 0.172 . . . . 1.3100000000000001 111.052 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.524 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 20.1 Cg_exo -70.13 49.5 0.8 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.921 3.081 . . . . 1.1899999999999999 114.107 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 47.34 -123.62 1.49 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.315 0.857 . . . . 1.1899999999999999 113.315 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -40.74 77.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.951 -0.568 . . . . 2.0699999999999998 111.618 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 46.9 t -62.66 -45.18 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.02 0.438 . . . . 1.26 110.311 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.475 ' HA3' ' HD2' ' A' ' 250' ' ' PRO . . . -61.61 -46.44 94.26 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.709 -0.678 . . . . 0.59999999999999998 112.066 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 255' ' ' LEU . 15.2 tp -62.59 -41.24 98.84 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.105 0.479 . . . . 1.05 110.314 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.25 -53.36 42.83 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.879 -0.601 . . . . 0.60999999999999999 112.639 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.46 -35.8 75.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.292 0.546 . . . . 0.81000000000000005 111.396 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.4 m -64.69 -47.8 77.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.835 0.35 . . . . 0.85999999999999999 110.8 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.3 p -64.75 -45.88 84.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.421 -0.354 . . . . 0.96999999999999997 110.989 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 256' ' ' GLY . 73.5 t -59.29 -48.26 87.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.758 -0.201 . . . . 0.71999999999999997 110.85 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 20.3 tp -62.48 -38.32 89.4 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.997 0.427 . . . . 1.0900000000000001 110.773 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 99.4 m -64.31 -49.19 72.72 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.012 -0.54 . . . . 1.3899999999999999 110.91 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 70.2 mtm -67.03 -50.2 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.171 -0.468 . . . . 1.3200000000000001 112.063 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.1 t -127.97 134.87 49.32 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.32 0.581 . . . . 0.96999999999999997 112.289 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.8 t -77.15 61.28 2.04 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.524 0.678 . . . . 1.3100000000000001 111.729 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -64.98 92.04 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.634 -0.712 . . . . 1.29 111.381 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 270' ' ' SER . 88.3 p -78.88 46.89 0.71 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.863 0.32 . . . . 1.26 111.863 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 47.4 t 67.11 -54.71 0.46 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.579 0.752 . . . . 1.96 112.455 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.41 32.26 6.19 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.957 -0.639 . . . . 1.8100000000000001 113.005 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.435 ' HB3' ' OG ' ' A' ' 267' ' ' SER . 88.8 p -95.63 -43.24 8.02 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.896 0.332 . . . . 1.27 111.896 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.6 mtm-85 68.07 -74.93 0.07 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.237 0.615 . . . . 2.3100000000000001 111.644 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -77.58 -38.73 47.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.43 -0.35 . . . . 1.4099999999999999 111.096 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.577 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 19.2 m 65.68 57.89 0.83 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.779 -0.646 . . . . 1.4299999999999999 112.057 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.655 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 2.4 mm? -122.7 44.84 0.95 Allowed Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.875 -0.602 . . . . 2.4900000000000002 112.099 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.655 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 77.7 Cg_exo -56.87 -43.15 57.06 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.655 2.237 . . . . 2.2599999999999998 112.763 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm . . . . . 0 C--O 1.254 1.291 0 CA-C-O 117.943 -1.027 . . . . 3.3399999999999999 109.831 179.481 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.439 0.161 . . . . 2.1699999999999999 110.794 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 17.4 Cg_exo -71.0 56.38 1.92 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.914 3.076 . . . . 2.4700000000000002 113.605 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.71 85.42 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.77 0.319 . . . . 1.05 111.363 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.457 ' O ' ' HD2' ' A' ' 252' ' ' ARG . 20.8 tpt180 -64.83 -44.97 88.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.498 -0.319 . . . . 3.3500000000000001 110.728 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 29.4 t -60.24 -47.75 90.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.612 -0.267 . . . . 2.3300000000000001 110.905 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -61.34 -49.22 79.88 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.967 -0.635 . . . . 1.0 111.854 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.26 -39.56 90.84 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.223 0.535 . . . . 2.3399999999999999 110.425 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.13 -54.35 33.49 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.798 -0.637 . . . . 1.1299999999999999 112.824 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.29 -35.63 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 117.471 0.636 . . . . 2.0299999999999998 111.064 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 90.8 m -64.29 -47.72 78.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.796 0.331 . . . . 1.79 111.128 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.9 p -66.0 -46.13 79.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.37 -0.377 . . . . 1.9399999999999999 110.869 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.82 -47.63 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.449 -0.341 . . . . 1.8500000000000001 110.641 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.445 ' O ' HG22 ' A' ' 265' ' ' THR . 26.8 tp -59.8 -45.51 92.12 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.779 0.323 . . . . 2.23 110.283 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.8 m -60.39 -46.15 91.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.303 0.573 . . . . 2.1699999999999999 111.32 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 52.7 ttp -67.51 -42.83 82.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.747 -0.66 . . . . 2.7200000000000002 112.26 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 261' ' ' LEU . 13.2 t -70.29 -28.03 64.87 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.917 0.71 . . . . 1.6399999999999999 112.917 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 261' ' ' LEU . 10.8 t -82.56 -142.48 0.06 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 120.761 -0.376 . . . . 1.8899999999999999 111.005 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 62.52 32.27 16.63 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.316 0.579 . . . . 2.7599999999999998 110.812 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 48.2 t -111.82 134.76 53.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.861 -0.609 . . . . 2.2000000000000002 111.228 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.4 t -61.98 -40.08 94.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.853 -0.612 . . . . 1.8600000000000001 111.89 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 78.33 -53.17 3.85 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.962 -0.637 . . . . 2.5099999999999998 113.878 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.642 ' O ' ' HG ' ' A' ' 274' ' ' LEU . 46.1 m -58.43 120.32 8.56 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.927 0.363 . . . . 2.9500000000000002 110.795 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.664 ' HD2' HD12 ' A' ' 274' ' ' LEU . 36.7 tpt85 -54.43 -43.22 71.38 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.759 0.651 . . . . 2.3700000000000001 112.759 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.93 -42.92 99.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.174 0.511 . . . . 2.7200000000000002 110.823 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.594 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 5.9 m -96.33 51.96 1.23 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.536 . . . . 2.8199999999999998 111.136 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.664 HD12 ' HD2' ' A' ' 271' ' ' ARG . 12.1 mt -114.12 38.74 0.21 Allowed Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 112.716 0.636 . . . . 2.2200000000000002 112.716 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.594 ' HD3' ' C ' ' A' ' 273' ' ' SER . 68.9 Cg_exo -58.36 -35.34 98.8 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.523 1.482 . . . . 3.8399999999999999 112.309 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' A' ' 276' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.421 0 CA-C-N 115.591 -0.731 . . . . 5.46 111.852 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.431 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.373 0.13 . . . . 3.2200000000000002 111.166 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 22.4 Cg_exo -68.9 68.67 1.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.761 2.974 . . . . 1.75 113.128 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.26 -73.26 0.14 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.661 0.615 . . . . 1.1100000000000001 112.661 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.01 -51.63 56.57 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.643 0.259 . . . . 1.74 111.594 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 254' ' ' GLY . 6.3 p -58.13 -50.57 77.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.77000000000000002 111.144 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.436 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -57.38 -48.51 80.04 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.352 -0.84 . . . . 0.56000000000000005 112.435 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 255' ' ' LEU . 7.5 mt -60.02 -44.39 94.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.327 0.584 . . . . 1.0 111.013 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.26 -52.29 48.27 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.687 -0.768 . . . . 0.44 112.989 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.27 -39.96 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 117.482 0.641 . . . . 0.68000000000000005 111.973 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 22.2 p -65.73 -45.74 81.54 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.62 0.23 . . . . 0.64000000000000001 111.62 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.6 p -65.2 -45.82 83.23 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 121.009 -0.276 . . . . 0.65000000000000002 110.597 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.2 t -60.57 -46.86 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.594 -0.275 . . . . 0.75 110.591 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.55 -45.94 90.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.125 0.488 . . . . 1.3899999999999999 109.753 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 90.7 m -60.24 -49.95 75.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.714 -0.675 . . . . 0.58999999999999997 110.936 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.6 ttt -62.89 -47.35 83.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.863 -0.608 . . . . 1.45 111.963 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.0 t -65.75 -36.51 83.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.866 0.691 . . . . 0.97999999999999998 112.866 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.1 t -73.14 -37.98 66.44 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.425 -0.51 . . . . 0.82999999999999996 111.363 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -74.99 -39.95 60.95 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.564 0.221 . . . . 1.0600000000000001 111.127 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 30.6 t 62.94 -141.55 0.38 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.156 -0.474 . . . . 0.93000000000000005 110.753 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 64.7 p -74.75 -45.66 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.94999999999999996 111.384 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 165.12 -142.72 7.93 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.714 -0.755 . . . . 0.92000000000000004 112.824 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.2 t 55.97 -130.66 1.84 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.604 0.362 . . . . 1.4399999999999999 111.08 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -84.05 9.01 13.56 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 111.792 0.293 . . . . 1.0 111.792 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 52.28 -140.07 0.94 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.568 0.347 . . . . 0.79000000000000004 111.568 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.686 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 34.1 p -102.08 31.68 3.83 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.61 0.596 . . . . 1.04 112.61 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.672 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 0.3 OUTLIER -123.22 45.8 1.21 Allowed Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 116.03 -0.532 . . . . 1.05 110.456 175.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.686 ' HD3' ' C ' ' A' ' 273' ' ' SER . 47.0 Cg_exo -64.55 61.35 0.27 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.943 2.429 . . . . 2.0299999999999998 114.235 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.455 -0.783 . . . . 2.7599999999999998 111.835 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.8 0.333 . . . . 1.3400000000000001 110.918 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.575 ' HG2' ' HA3' ' A' ' 254' ' ' GLY . 68.8 Cg_endo -71.06 73.24 2.01 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.293 2.662 . . . . 0.85999999999999999 113.587 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 61.15 -150.55 0.4 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.536 0.939 . . . . 0.81000000000000005 113.536 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.458 ' O ' ' HD3' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -64.37 -46.52 83.01 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.972 -0.558 . . . . 1.9199999999999999 112.197 -178.224 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 254' ' ' GLY . 10.7 p -55.59 -47.54 78.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.271 0.558 . . . . 0.81999999999999995 110.354 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.575 ' HA3' ' HG2' ' A' ' 250' ' ' PRO . . . -61.27 -49.35 78.72 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.027 -0.988 . . . . 0.42999999999999999 112.109 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.2 mt -59.24 -43.6 92.38 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.013 0.435 . . . . 0.87 111.152 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.98 -53.54 42.08 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.816 -0.629 . . . . 0.35999999999999999 112.941 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 254' ' ' GLY . 2.4 pp -62.34 -38.43 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 117.36 0.58 . . . . 0.64000000000000001 110.93 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 41.9 m -62.62 -43.35 99.04 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.987 0.422 . . . . 0.54000000000000004 109.984 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 46.5 m -63.2 -46.55 86.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.48999999999999999 110.096 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.556 ' O ' HG22 ' A' ' 264' ' ' THR . 99.1 t -61.41 -49.88 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.128 -0.487 . . . . 0.55000000000000004 110.841 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.52 -43.55 79.92 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.029 0.442 . . . . 1.24 110.485 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 68.0 m -62.55 -50.99 69.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.54000000000000004 110.618 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 54.2 ttp -60.47 -46.53 89.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.798 -0.637 . . . . 0.82999999999999996 111.934 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.602 HG23 ' HG2' ' A' ' 266' ' ' GLN . 11.6 t -75.23 -10.14 59.19 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.576 0.584 . . . . 0.59999999999999998 112.576 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.4 t 33.47 58.18 0.52 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.557 1.143 . . . . 0.5 113.546 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' GLN . . . . . 0.602 ' HG2' HG23 ' A' ' 264' ' ' THR . 13.0 mm-40 -70.19 -26.08 63.72 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.487 -0.779 . . . . 0.95999999999999996 112.521 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 37.4 m 64.04 48.43 3.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.908 0.385 . . . . 0.94999999999999996 111.614 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 42.2 t 62.42 34.65 15.38 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.89 -0.595 . . . . 0.98999999999999999 112.204 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -176.88 -89.05 0.07 OUTLIER Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.994 -0.622 . . . . 0.85999999999999999 112.881 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 60.2 p -173.88 137.32 0.58 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 110.321 -0.252 . . . . 1.03 110.321 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.539 ' HD3' ' O ' ' A' ' 274' ' ' LEU . 17.0 ttm180 -131.92 132.2 43.36 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.585 -0.446 . . . . 0.80000000000000004 111.743 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -87.31 -137.1 0.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.257 -0.429 . . . . 1.24 110.839 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.444 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 58.0 p -76.46 59.93 1.52 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.495 0.664 . . . . 1.05 112.056 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.571 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 25.6 tp -129.1 47.38 2.81 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.04 -0.982 . . . . 1.02 110.174 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 91.9 Cg_exo -50.49 139.28 38.02 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.531 2.154 . . . . 0.82999999999999996 113.688 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.712 -0.661 . . . . 2.0800000000000001 111.776 -179.811 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.592 0.234 . . . . 1.9099999999999999 111.119 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 32.6 Cg_exo -64.72 132.87 34.27 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.224 2.616 . . . . 1.3100000000000001 112.954 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.66 76.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.112 -0.495 . . . . 0.68000000000000005 112.289 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -59.42 -48.44 81.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.649 0.262 . . . . 1.0900000000000001 111.567 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.57 -45.73 98.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.409 -0.359 . . . . 0.69999999999999996 110.893 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.501 ' O ' HG13 ' A' ' 257' ' ' ILE . . . -61.19 -48.39 85.97 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.665 -0.779 . . . . 0.40000000000000002 111.46 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.4 mt -60.64 -49.48 77.33 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 122.832 -0.217 . . . . 0.81000000000000005 110.948 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.91 -50.74 61.71 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 116.101 -0.499 . . . . 0.34999999999999998 113.117 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 254' ' ' GLY . 2.5 pp -63.07 -33.65 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 117.21 0.505 . . . . 0.53000000000000003 110.016 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 91.4 m -63.82 -47.6 80.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.708 -0.224 . . . . 0.54000000000000004 110.546 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -43.43 96.23 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.682 0.277 . . . . 1.1299999999999999 110.745 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.615 HG13 ' HB ' ' A' ' 264' ' ' THR . 75.6 t -61.1 -48.32 89.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.327 -0.397 . . . . 0.55000000000000004 110.77 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -41.69 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.502 . . . . 1.3600000000000001 110.481 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 86.2 m -63.45 -51.73 64.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.571 -0.741 . . . . 0.60999999999999999 112.118 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 20.5 ptp -159.67 56.7 0.38 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.896 1.073 . . . . 0.94999999999999996 113.896 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.615 ' HB ' HG13 ' A' ' 260' ' ' VAL . 8.8 t -55.23 -34.36 63.92 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.958 -0.464 . . . . 0.68000000000000005 112.133 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 9.3 t -71.31 -5.41 32.16 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.216 0.821 . . . . 0.79000000000000004 113.216 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -63.57 124.54 21.63 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.843 0.354 . . . . 1.4199999999999999 111.096 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 75.5 p -82.2 141.81 32.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.194 0.521 . . . . 1.0600000000000001 111.8 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.4 m -160.91 142.37 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.986 -0.552 . . . . 1.3500000000000001 110.469 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 70.78 -132.16 21.87 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.686 -0.768 . . . . 0.72999999999999998 112.098 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 58.1 m -163.51 131.82 3.73 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 122.774 -0.25 . . . . 0.93000000000000005 110.82 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 69.78 -46.4 0.59 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.583 0.586 . . . . 1.4099999999999999 112.583 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -145.55 -135.66 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.839 -0.164 . . . . 1.1200000000000001 111.296 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.483 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 65.5 p 54.19 59.15 4.39 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.797 0.666 . . . . 1.01 112.797 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.571 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 92.5 mt -121.88 43.02 0.64 Allowed Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 115.611 -0.722 . . . . 1.1599999999999999 111.697 177.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 80.8 Cg_exo -54.25 -49.49 16.82 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 122.113 1.875 . . . . 1.3400000000000001 113.113 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 96.1 mttt . . . . . 0 C--O 1.253 1.278 0 CA-C-N 115.612 -0.722 . . . . 1.3500000000000001 112.816 178.87 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.635 0.255 . . . . 3.7400000000000002 111.147 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 17.4 Cg_exo -70.51 58.18 1.89 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.93 3.087 . . . . 3.3900000000000001 113.429 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -59.17 -47.69 84.39 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 111.887 0.328 . . . . 2.5899999999999999 111.887 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.01 -42.27 99.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.997 0.427 . . . . 2.1400000000000001 110.225 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 49.8 t -64.11 -49.02 83.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.031 -0.531 . . . . 2.54 110.531 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.84 -47.67 89.29 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.991 -0.55 . . . . 2.0299999999999998 111.968 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 255' ' ' LEU . 8.9 mt -60.87 -44.31 97.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.378 0.609 . . . . 1.74 110.892 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.76 -52.1 50.92 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.544 -0.753 . . . . 1.25 113.031 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.71 -37.88 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 117.622 0.711 . . . . 2.1499999999999999 111.225 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 91.1 m -64.31 -47.56 78.98 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.83 0.347 . . . . 1.5900000000000001 111.16 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.2 p -64.71 -45.0 88.41 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.485 -0.325 . . . . 0.81999999999999995 110.731 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 264' ' ' THR . 57.8 t -61.81 -49.46 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.521 -0.309 . . . . 1.77 110.416 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.65 -42.58 83.76 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.912 0.386 . . . . 2.1800000000000002 110.626 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 93.1 m -62.17 -48.98 77.64 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.942 -0.572 . . . . 1.1100000000000001 110.3 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 57.0 ttp -60.02 -47.75 84.55 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.51 -0.768 . . . . 1.6699999999999999 111.616 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 260' ' ' VAL . 8.8 t -79.25 46.33 0.71 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.252 0.464 . . . . 2.2200000000000002 112.252 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.7 t -58.61 -39.43 80.42 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.892 0.377 . . . . 1.52 111.201 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -89.89 129.88 36.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.235 -0.438 . . . . 2.1200000000000001 110.201 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.8 t -165.59 159.1 16.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.775 0.322 . . . . 1.3300000000000001 111.0 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 30.8 t -61.83 -36.66 81.84 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.358 -0.383 . . . . 1.3700000000000001 111.878 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 75.54 -60.28 2.86 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.627 -0.589 . . . . 1.6899999999999999 111.627 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.4 t -104.86 -152.43 0.46 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 110.053 -0.351 . . . . 2.2599999999999998 110.053 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? 69.93 -50.92 0.64 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.511 0.724 . . . . 2.4300000000000002 112.414 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 59.04 42.12 19.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.036 0.446 . . . . 2.6800000000000002 110.887 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.53 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 14.1 m -74.18 59.39 0.75 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.345 0.593 . . . . 2.3500000000000001 112.283 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.654 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 0.8 OUTLIER -123.36 40.95 0.51 Allowed Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.608 -0.724 . . . . 3.9700000000000002 111.641 177.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.654 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 63.4 Cg_exo -57.58 -40.41 80.57 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.101 1.867 . . . . 4.5599999999999996 112.681 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 276' ' ' LYS . 1.6 ttpm? . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.978 -1.011 . . . . 5.6900000000000004 112.675 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.432 0.158 . . . . 1.72 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -64.59 124.7 13.65 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.06 2.506 . . . . 1.21 112.849 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.74 85.69 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.168 -0.469 . . . . 0.83999999999999997 112.264 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -56.9 -47.83 79.61 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.135 0.493 . . . . 1.0600000000000001 111.694 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 32.8 t -68.53 -45.0 82.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.94999999999999996 110.867 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.3 -48.68 84.81 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.906 -0.664 . . . . 0.67000000000000004 111.622 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 255' ' ' LEU . 8.0 mt -61.14 -43.7 98.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.158 0.504 . . . . 0.89000000000000001 110.824 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.09 -53.01 45.93 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.37 -0.919 . . . . 0.44 112.983 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.85 -40.13 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 117.471 0.636 . . . . 0.80000000000000004 111.948 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 19.3 p -64.65 -45.72 85.55 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.718 0.266 . . . . 0.77000000000000002 111.718 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.3 p -65.95 -46.12 79.28 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.187 -0.205 . . . . 0.62 110.923 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.42 -48.43 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.824 -0.171 . . . . 0.68999999999999995 110.662 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 42.3 mt -61.33 -40.51 94.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.791 0.329 . . . . 0.79000000000000004 111.182 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.2 m -67.12 -46.7 73.36 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.203 0.525 . . . . 0.82999999999999996 111.32 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.5 tpt -64.53 -43.61 93.47 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.657 -0.701 . . . . 1.49 112.313 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.6 t -70.99 136.06 48.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.372 0.606 . . . . 0.68000000000000005 111.624 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.2 t -73.89 141.05 46.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.921 -0.582 . . . . 0.69999999999999996 111.824 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 69.76 -51.77 0.62 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.22 0.822 . . . . 1.1799999999999999 113.22 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 85.9 p 55.35 60.11 3.56 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.131 0.573 . . . . 0.73999999999999999 111.503 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 72.8 m 73.56 52.46 0.12 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.574 -0.739 . . . . 1.1899999999999999 111.459 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 81.87 -52.39 4.59 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 116.028 -0.533 . . . . 1.1499999999999999 113.873 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 90.6 p -159.36 152.26 21.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.303 . . . . 1.1699999999999999 110.871 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.687 ' CZ ' ' HA ' ' A' ' 271' ' ' ARG . 2.7 tpm_? -79.18 49.32 0.95 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.334 0.588 . . . . 1.1499999999999999 112.195 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -96.68 99.23 10.85 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.118 -0.364 . . . . 1.24 110.973 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.584 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 69.1 m 58.5 -151.53 0.42 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.268 0.556 . . . . 1.8500000000000001 112.004 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.576 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 91.9 mt 60.42 31.06 0.11 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 114.048 1.129 . . . . 2.2200000000000002 114.048 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.584 ' HD3' ' C ' ' A' ' 273' ' ' SER . 89.1 Cg_exo -53.82 -33.56 71.55 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.818 1.679 . . . . 1.8200000000000001 112.966 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.112 -0.947 . . . . 2.6200000000000001 110.591 179.072 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.426 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.318 0.104 . . . . 2.02 111.07 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.462 ' HG2' ' N ' ' A' ' 254' ' ' GLY . 71.9 Cg_endo -72.64 47.85 1.23 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.221 2.614 . . . . 1.4299999999999999 114.141 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 48.88 -115.84 0.79 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.403 0.89 . . . . 0.91000000000000003 113.403 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -49.88 -48.72 51.2 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.437 0.695 . . . . 2.5800000000000001 112.45 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.41 -44.1 97.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.336 -0.393 . . . . 1.3 111.113 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.462 ' N ' ' HG2' ' A' ' 250' ' ' PRO . . . -61.43 -48.21 86.33 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 121.023 -0.608 . . . . 0.66000000000000003 112.006 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 255' ' ' LEU . 15.7 tp -61.71 -42.65 99.23 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.953 0.406 . . . . 1.3300000000000001 110.448 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.07 -54.22 38.5 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.076 -0.583 . . . . 0.68000000000000005 112.804 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.46 -35.85 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 117.345 0.573 . . . . 1.1799999999999999 111.352 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.2 m -65.16 -47.0 78.55 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.758 0.313 . . . . 0.96999999999999997 111.028 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 27.6 p -66.56 -46.66 75.32 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.521 -0.309 . . . . 1.0900000000000001 110.734 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 73.0 t -58.88 -46.82 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.674 -0.239 . . . . 1.29 110.517 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 265' ' ' THR . 26.5 tp -61.3 -44.6 96.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.869 0.366 . . . . 1.26 110.329 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 96.7 m -60.41 -48.12 83.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.149 0.499 . . . . 1.0700000000000001 111.213 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 95.9 mmm -65.15 -42.49 93.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.531 0.567 . . . . 2.1899999999999999 112.531 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.6 t -68.25 -32.87 73.36 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.91 0.708 . . . . 1.4199999999999999 112.91 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 261' ' ' LEU . 10.4 t -84.91 32.47 0.53 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.18 0.514 . . . . 0.90000000000000002 111.884 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -79.14 56.64 2.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.176 0.512 . . . . 1.3999999999999999 111.196 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 50.8 m -74.6 56.59 0.7 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.232 -0.44 . . . . 0.83999999999999997 111.874 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 92.5 p -160.6 141.29 11.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.593 -0.276 . . . . 0.80000000000000004 111.133 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -72.44 72.2 1.0 Allowed Glycine 0 CA--C 1.524 0.614 0 CA-C-N 116.146 -0.479 . . . . 0.96999999999999997 113.37 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 77.8 p -65.73 -54.38 28.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.863 0.364 . . . . 1.0800000000000001 111.972 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.47 ' NH1' ' H ' ' A' ' 276' ' ' LYS . 49.9 ttp180 -76.79 70.78 3.3 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.964 0.412 . . . . 1.5900000000000001 111.677 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.57 -29.91 68.27 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.608 0.596 . . . . 1.3600000000000001 112.608 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.473 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 55.4 m -144.1 -174.76 4.37 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.973 0.416 . . . . 1.6499999999999999 111.676 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.643 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 98.3 mt 59.03 38.14 0.36 Allowed Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 115.205 -0.907 . . . . 1.9099999999999999 111.759 -176.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 91.8 Cg_exo -51.36 133.83 43.57 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.808 2.339 . . . . 1.3 114.45 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.47 ' H ' ' NH1' ' A' ' 271' ' ' ARG . 55.2 mttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.455 -0.783 . . . . 2.2599999999999998 110.686 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.625 0.25 . . . . 2.0299999999999998 111.066 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 15.9 Cg_exo -71.91 50.91 1.52 Allowed 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 124.08 3.187 . . . . 1.99 113.458 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 63.42 -66.59 0.1 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.52 0.728 . . . . 1.1200000000000001 112.778 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.643 ' HB3' ' HB2' ' A' ' 255' ' ' LEU . 25.5 mmt180 -88.74 60.8 5.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.132 0.491 . . . . 1.3899999999999999 111.849 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 254' ' ' GLY . 2.5 p -52.96 -56.45 7.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.79000000000000004 111.865 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.556 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -56.52 -46.31 88.28 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.666 -0.697 . . . . 0.63 112.822 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.643 ' HB2' ' HB3' ' A' ' 252' ' ' ARG . 6.7 mt -62.45 -45.4 93.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.981 0.42 . . . . 0.89000000000000001 111.048 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.447 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.8 -51.39 56.06 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.841 -0.618 . . . . 0.29999999999999999 112.756 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.78 -37.68 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 117.175 0.487 . . . . 0.81999999999999995 111.063 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.6 m -64.84 -41.96 95.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.933 0.397 . . . . 0.69999999999999996 110.017 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 54.1 m -63.17 -46.44 87.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.121 -0.49 . . . . 0.52000000000000002 110.051 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.457 ' O ' HG22 ' A' ' 264' ' ' THR . 93.6 t -59.75 -48.18 88.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 116.212 -0.449 . . . . 0.67000000000000004 110.201 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.469 ' HA ' HG22 ' A' ' 264' ' ' THR . 0.9 OUTLIER -59.34 -44.66 92.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.919 0.39 . . . . 1.2 110.512 178.406 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 265' ' ' THR . 92.7 m -58.51 -49.39 77.54 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.803 -0.635 . . . . 0.55000000000000004 111.482 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 21.4 ptp -72.69 -34.42 67.16 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.785 0.661 . . . . 0.85999999999999999 112.785 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 261' ' ' LEU . 14.3 t -80.64 -16.57 53.72 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.024 1.12 . . . . 0.67000000000000004 114.024 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 262' ' ' THR . 9.2 t -75.17 49.84 0.47 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.075 0.941 . . . . 0.73999999999999999 111.741 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -75.35 68.53 2.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.142 -0.935 . . . . 0.72999999999999998 110.862 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 52.3 m 63.29 42.52 6.88 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.098 -0.501 . . . . 1.05 110.8 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.841 ' HA ' ' HB2' ' A' ' 273' ' ' SER . 47.3 m -60.87 -40.99 95.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.737 -0.665 . . . . 0.69999999999999996 111.722 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -73.82 59.72 2.14 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.215 -0.448 . . . . 1.45 113.221 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 78.1 p -147.3 -49.33 0.18 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.83 0.347 . . . . 1.1200000000000001 110.71 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -159.41 46.67 0.28 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.218 -0.446 . . . . 1.6000000000000001 110.382 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 61.17 47.15 7.38 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.709 -0.678 . . . . 0.94999999999999996 112.365 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.841 ' HB2' ' HA ' ' A' ' 268' ' ' SER . 10.0 m -78.33 65.21 3.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.329 0.585 . . . . 0.55000000000000004 111.717 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.611 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 17.7 tp -126.9 43.64 1.07 Allowed Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 115.689 -0.687 . . . . 1.1399999999999999 110.93 177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 85.8 Cg_exo -53.05 141.95 55.71 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.517 2.145 . . . . 0.87 113.715 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.093 -0.956 . . . . 1.4299999999999999 110.898 179.791 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.665 0.269 . . . . 2.2799999999999998 111.342 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -70.16 66.36 2.01 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.703 2.935 . . . . 1.77 113.208 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -55.42 -46.28 76.67 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.826 0.306 . . . . 1.1200000000000001 111.826 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -59.48 -45.86 90.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.046 0.45 . . . . 2.1600000000000001 110.842 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.0 t -65.06 -48.34 84.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.885 -0.598 . . . . 1.48 110.99 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.32 -49.4 72.99 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.006 -0.616 . . . . 0.52000000000000002 111.888 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 255' ' ' LEU . 8.8 mt -60.0 -45.81 91.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.277 0.561 . . . . 1.29 111.025 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.92 -52.64 48.91 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.798 -0.715 . . . . 0.59999999999999998 113.354 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.32 -40.33 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 117.628 0.714 . . . . 0.72999999999999998 111.687 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.1 p -65.3 -45.33 84.82 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.947 -0.301 . . . . 0.78000000000000003 111.697 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.3 p -64.72 -44.45 90.15 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 121.046 -0.262 . . . . 1.04 110.703 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 264' ' ' THR . 59.5 t -61.49 -51.58 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.753 -0.203 . . . . 0.95999999999999996 110.615 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.2 mt -57.66 -38.49 75.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.655 0.264 . . . . 0.85999999999999999 111.068 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 96.1 m -65.66 -49.05 70.06 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.204 0.526 . . . . 1.03 110.575 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 27.6 ttt -61.49 -50.9 70.86 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.858 -0.61 . . . . 1.4199999999999999 111.552 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 260' ' ' VAL . 9.4 t -94.24 41.39 1.09 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.226 0.536 . . . . 0.92000000000000004 111.689 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.5 t -61.36 -31.17 71.05 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.534 0.568 . . . . 0.72999999999999998 112.534 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -79.99 56.85 2.47 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.139 0.422 . . . . 0.94999999999999996 112.139 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.7 t 62.61 -125.16 0.67 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.608 -0.269 . . . . 0.81000000000000005 111.363 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.7 m -159.12 149.78 19.68 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.86 0.362 . . . . 1.21 111.47 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -170.97 -135.01 1.85 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.87 -0.681 . . . . 0.96999999999999997 112.935 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 40.3 t -71.39 -11.62 60.99 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.688 0.625 . . . . 1.4199999999999999 112.688 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.541 ' HB3' ' H ' ' A' ' 272' ' ' ALA . 0.6 OUTLIER 64.23 -143.71 0.28 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.588 0.355 . . . . 1.1899999999999999 111.242 -178.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.541 ' H ' ' HB3' ' A' ' 271' ' ' ARG . . . 54.12 38.83 29.9 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.602 0.594 . . . . 1.8 112.602 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.461 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 42.0 m -167.05 -166.79 0.84 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.982 0.42 . . . . 1.45 111.082 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.612 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 87.6 mt 62.57 35.36 0.21 Allowed Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 115.01 -0.996 . . . . 1.23 112.487 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 81.1 Cg_exo -52.32 129.56 32.05 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.968 1.779 . . . . 1.1699999999999999 113.123 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 276' ' ' LYS . 13.5 tptp . . . . . 0 C--O 1.257 1.477 0 CA-C-O 118.127 -0.94 . . . . 2.1600000000000001 111.351 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.563 0.221 . . . . 3.1600000000000001 111.028 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -65.27 131.79 29.49 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.077 2.518 . . . . 2.25 112.695 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.23 -48.98 75.41 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.197 0.522 . . . . 1.4199999999999999 111.039 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.553 ' HB3' ' HB2' ' A' ' 255' ' ' LEU . 21.8 mmt180 -93.96 55.21 2.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.157 0.503 . . . . 1.3799999999999999 111.376 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.586 HG13 ' H ' ' A' ' 254' ' ' GLY . 2.5 p -49.76 -57.23 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.22 -0.9 . . . . 1.3799999999999999 112.391 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.586 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -55.26 -48.28 69.88 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.869 -0.605 . . . . 0.94999999999999996 112.671 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 252' ' ' ARG . 8.0 mt -60.18 -45.88 91.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.199 0.523 . . . . 1.21 111.156 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.68 -50.85 58.58 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.7 -0.762 . . . . 0.40000000000000002 113.238 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.2 pp -63.24 -40.23 88.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 117.394 0.597 . . . . 1.3100000000000001 111.955 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 26.7 p -68.04 -43.92 77.59 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 121.028 -0.269 . . . . 1.3999999999999999 111.723 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 p -64.81 -45.26 86.99 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.065 -0.254 . . . . 1.1000000000000001 110.568 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.668 ' O ' HG22 ' A' ' 264' ' ' THR . 56.6 t -62.16 -49.71 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.56 -0.291 . . . . 0.71999999999999997 110.626 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.4 OUTLIER -56.31 -45.1 80.43 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.959 0.409 . . . . 1.3500000000000001 110.674 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 97.8 m -60.96 -47.22 87.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.745 -0.661 . . . . 1.6499999999999999 110.629 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.1 ttt -62.55 -54.37 40.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.832 -0.622 . . . . 1.6000000000000001 111.507 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.668 HG22 ' O ' ' A' ' 260' ' ' VAL . 8.8 t -86.72 38.53 0.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.212 0.53 . . . . 1.1499999999999999 111.59 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 7.2 t -64.39 -28.22 69.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.147 -0.479 . . . . 1.1299999999999999 111.556 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 55.27 -108.21 0.42 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.085 -0.507 . . . . 1.6100000000000001 112.319 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 58.2 m -162.04 137.36 7.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.749 0.309 . . . . 0.93999999999999995 111.178 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.4 p -76.89 46.37 0.46 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.353 0.501 . . . . 1.49 112.353 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 159.94 -150.96 21.54 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.343 -0.932 . . . . 1.26 113.239 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 45.2 t -91.88 -23.05 19.76 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.734 0.272 . . . . 1.54 111.734 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.415 ' HB3' HD22 ' A' ' 274' ' ' LEU . 51.8 ttm-85 -66.02 131.09 45.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.994 0.426 . . . . 1.8600000000000001 111.968 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -69.43 135.24 49.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.45 110.95 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.532 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 27.3 m 64.58 52.46 1.75 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.461 0.648 . . . . 1.6200000000000001 111.418 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.516 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 32.4 tp -122.74 49.86 2.52 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.252 -0.885 . . . . 1.28 110.04 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.532 ' HD3' ' C ' ' A' ' 273' ' ' SER . 76.0 Cg_exo -48.64 -44.31 31.22 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 122.494 2.13 . . . . 1.27 113.369 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.447 -0.787 . . . . 2.1600000000000001 111.064 179.16 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.418 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.539 0.209 . . . . 1.7 111.01 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.577 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 94.5 Cg_endo -73.25 58.13 3.55 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.47 2.78 . . . . 1.22 113.442 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -55.94 -45.58 78.77 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.946 0.35 . . . . 1.4199999999999999 111.946 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -42.24 99.2 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.993 0.425 . . . . 2.79 110.225 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 50.0 t -65.09 -49.01 81.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.071 -0.513 . . . . 1.1000000000000001 110.57 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.03 -47.51 90.4 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.949 -0.569 . . . . 0.62 112.148 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 255' ' ' LEU . 17.2 tp -61.75 -42.99 99.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.998 0.428 . . . . 1.9099999999999999 110.198 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.03 -53.24 44.33 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.9 -0.667 . . . . 0.96999999999999997 112.907 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.63 -40.13 87.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 117.286 0.543 . . . . 0.96999999999999997 111.646 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 21.0 p -65.69 -39.17 90.99 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.95 -0.3 . . . . 0.98999999999999999 110.982 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 90.2 m -65.32 -47.75 75.46 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.947 -0.39 . . . . 1.49 109.947 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 256' ' ' GLY . 78.0 t -59.66 -48.05 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.031 -0.531 . . . . 1.25 110.422 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 261' ' ' LEU . 50.6 mt -59.62 -47.41 85.71 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.532 -0.304 . . . . 1.03 110.859 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.8 m -58.44 -44.16 89.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.338 0.59 . . . . 1.23 111.172 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.2 tpt -68.0 -46.99 69.73 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.549 -0.75 . . . . 2.1200000000000001 111.904 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 260' ' ' VAL . 10.7 t -69.62 -39.3 77.26 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.279 0.474 . . . . 1.24 112.279 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.5 t -139.84 138.65 35.93 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.351 0.596 . . . . 0.93000000000000005 111.35 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -163.43 -48.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.35 -0.386 . . . . 1.3600000000000001 111.209 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 78.4 p 52.11 50.55 18.24 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.102 -0.499 . . . . 1.3799999999999999 111.84 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 68.5 m -159.22 -154.78 0.43 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.372 -0.376 . . . . 1.5800000000000001 110.983 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 171.49 -134.11 2.96 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.589 -0.815 . . . . 1.4299999999999999 112.821 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 50.4 m 67.59 -58.05 0.44 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.489 0.716 . . . . 2.54 112.4 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -94.26 -50.16 5.39 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.768 -0.196 . . . . 2.0899999999999999 111.247 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 68.31 -51.19 0.55 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.364 0.876 . . . . 2.3999999999999999 113.364 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 68.7 p -74.96 109.14 8.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.385 0.612 . . . . 2.04 111.926 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.731 ' H ' HD23 ' A' ' 274' ' ' LEU . 2.1 pt? -84.52 -16.12 0.22 Allowed Pre-proline 0 CA--C 1.557 1.232 0 N-CA-C 114.315 1.228 . . . . 3.04 114.315 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 274' ' ' LEU . 54.5 Cg_exo -58.97 -41.2 64.07 Favored 'Trans proline' 0 C--N 1.374 1.92 0 CA-C-N 121.905 1.716 . . . . 2.48 114.137 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.642 -0.694 . . . . 3.7599999999999998 111.338 -179.685 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.41 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.492 0.187 . . . . 2.7400000000000002 111.012 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.41 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 83.3 Cg_endo -75.35 50.66 2.69 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.315 2.677 . . . . 1.8500000000000001 113.324 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 56.68 -101.17 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.053 -0.522 . . . . 1.7 111.924 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.624 HH11 HD12 ' A' ' 255' ' ' LEU . 15.2 mmt85 -81.17 61.52 4.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.555 0.576 . . . . 1.3999999999999999 112.555 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 254' ' ' GLY . 3.0 p -51.09 -54.36 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.934 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.503 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -55.67 -49.29 66.35 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.609 -0.723 . . . . 0.56999999999999995 112.768 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.624 HD12 HH11 ' A' ' 252' ' ' ARG . 3.2 mt -63.61 -41.9 98.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.848 0.356 . . . . 1.01 110.764 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.39 -52.49 51.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.804 -0.712 . . . . 0.5 112.601 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.43 -37.83 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 117.086 0.443 . . . . 0.75 111.172 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.7 m -64.98 -41.25 95.6 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.745 0.307 . . . . 0.70999999999999996 110.328 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 58.8 m -64.8 -48.71 73.46 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 110.002 -0.37 . . . . 0.63 110.002 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 256' ' ' GLY . 97.4 t -60.51 -46.57 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.121 -0.49 . . . . 0.63 110.626 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.648 ' HG ' ' HB2' ' A' ' 267' ' ' SER . 21.7 tp -60.45 -42.8 96.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.861 0.363 . . . . 0.98999999999999999 110.842 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 97.2 m -63.82 -46.87 83.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.223 0.535 . . . . 0.81000000000000005 110.839 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 49.0 tpp -63.06 -45.0 94.23 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.603 -0.726 . . . . 1.05 112.037 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 9.0 t -68.4 145.05 54.48 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.301 0.572 . . . . 0.77000000000000002 111.698 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.643 ' HA ' ' HA3' ' A' ' 269' ' ' GLY . 9.0 t -64.19 -14.43 55.24 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.65 0.611 . . . . 1.04 112.65 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -57.38 -44.55 84.54 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.996 0.369 . . . . 1.4099999999999999 111.996 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' SER . . . . . 0.648 ' HB2' ' HG ' ' A' ' 261' ' ' LEU . 38.2 t -83.75 48.68 1.47 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.77 0.319 . . . . 1.04 110.884 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.4 m 60.3 41.06 16.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.998 -0.546 . . . . 1.3100000000000001 111.255 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 265' ' ' THR . . . -67.78 -44.12 81.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.067 -0.587 . . . . 1.02 112.811 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 47.2 m -79.0 48.75 0.87 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.745 0.307 . . . . 1.2 111.466 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 69.83 132.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.979 0.912 . . . . 1.3700000000000001 111.642 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -75.44 51.06 0.55 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.617 0.599 . . . . 1.78 112.617 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.578 ' HB2' ' HD2' ' A' ' 275' ' ' PRO . 69.6 p -170.91 114.65 0.43 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.762 0.791 . . . . 0.98999999999999999 111.922 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.488 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 51.0 tp -68.03 -28.58 1.91 Allowed Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 114.07 -1.423 . . . . 3.4700000000000002 113.154 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 273' ' ' SER . 52.9 Cg_exo -61.54 -168.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 121.672 1.581 . . . . 2.29 113.569 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 7.9 ttpp . . . . . 0 C--O 1.256 1.429 0 CA-C-O 118.406 -0.807 . . . . 3.5600000000000001 111.8 179.714 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 N--CA 1.461 0.101 0 CA-C-O 120.635 0.255 . . . . 0.68 110.708 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.84 -48.0 85.01 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.116 -0.564 . . . . 0.43 111.797 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.3 mt -61.45 -45.27 94.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.109 0.481 . . . . 0.84 110.785 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.43 -52.27 52.44 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.643 -0.708 . . . . 0.33 113.116 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.66 -38.59 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 117.415 0.608 . . . . 0.58 110.896 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.5 m -63.25 -42.85 99.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.079 0.466 . . . . 0.66 109.987 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 263' ' ' MET . 57.5 m -62.69 -48.92 77.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.906 -0.588 . . . . 0.59 110.156 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 256' ' ' GLY . 98.9 t -59.2 -49.14 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.122 -0.49 . . . . 0.51 110.452 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 23.5 tp -57.52 -40.19 78.18 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.305 -0.407 . . . . 0.77 110.321 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 93.2 m -64.25 -48.54 75.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.888 -0.596 . . . . 0.69 110.525 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 259' ' ' THR . 96.3 mmm . . . . . 0 CA--C 1.534 0.339 0 CA-C-N 115.837 -0.62 . . . . 0.86 112.38 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.751 0.31 . . . . 1.34 111.505 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.08 -46.21 94.1 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.922 -0.581 . . . . 0.81 112.17 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 255' ' ' LEU . 6.2 mt -62.47 -45.06 94.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.896 0.379 . . . . 1.15 110.779 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.13 -50.85 61.25 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.034 -0.603 . . . . 0.58 112.821 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.5 pp -64.07 -36.53 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 117.31 0.555 . . . . 0.96 110.69 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 88.4 m -66.06 -42.06 89.96 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.718 -0.475 . . . . 1.01 109.718 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.7 m -63.96 -49.19 73.5 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.915 -0.584 . . . . 0.99 110.012 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 256' ' ' GLY . 82.6 t -59.9 -48.97 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.126 -0.488 . . . . 0.81 110.391 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.2 OUTLIER -56.7 -42.82 79.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.039 0.447 . . . . 1.3 109.826 178.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 85.5 m -61.61 -47.46 85.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.761 -0.654 . . . . 1.33 110.666 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 89.4 mtp . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 115.993 -0.548 . . . . 1.51 111.689 179.587 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.673 0.273 . . . . 0.86 110.712 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.99 91.42 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.913 -0.585 . . . . 0.4 111.992 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 255' ' ' LEU . 11.1 mt -60.66 -46.02 91.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.268 0.556 . . . . 0.8 111.297 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.51 -51.73 54.08 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.705 -0.76 . . . . 0.51 113.092 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.45 -40.99 91.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 117.384 0.592 . . . . 0.82 111.928 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 25.7 p -65.88 -43.9 86.93 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.79 0.293 . . . . 0.52 111.79 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.0 p -65.77 -47.09 76.34 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.902 -0.319 . . . . 0.54 110.623 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.65 -45.94 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.487 -0.324 . . . . 0.84 110.438 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.77 -46.71 89.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.893 0.377 . . . . 1.02 110.522 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 91.1 m -59.92 -49.85 76.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.332 0.587 . . . . 0.59 110.66 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.613 -0.721 . . . . 1.21 111.926 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 254' ' ' GLY . 6.3 p . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 112.978 0.733 . . . . 0.6 112.978 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.483 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -50.46 -52.96 26.55 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 116.087 -0.506 . . . . 0.42 113.485 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 255' ' ' LEU . 1.1 mt -65.45 -41.24 93.67 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.538 -0.389 . . . . 0.92 110.415 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -60.52 -52.38 52.94 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.694 -0.765 . . . . 0.39 112.689 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.82 -41.58 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.96 0.38 . . . . 0.53 111.831 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 20.5 p -64.68 -38.75 92.07 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.648 -0.421 . . . . 0.58 110.688 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 87.4 m -65.32 -49.23 70.25 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.016 -0.364 . . . . 0.64 110.016 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 256' ' ' GLY . 78.4 t -59.6 -45.57 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.61 110.578 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -58.72 -45.41 89.65 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.046 0.45 . . . . 1.35 110.132 178.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 91.7 m -60.83 -49.96 75.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.927 -0.579 . . . . 0.61 110.67 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.769 -0.651 . . . . 1.09 111.864 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.685 0.279 . . . . 2.06 110.3 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.98 -47.19 91.94 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.965 -0.562 . . . . 1.45 111.806 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 255' ' ' LEU . 8.4 mt -60.36 -46.13 91.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.105 0.479 . . . . 1.56 110.885 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.01 -51.97 53.3 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.59 -0.732 . . . . 1.09 113.193 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.72 -38.48 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 117.452 0.626 . . . . 1.5 111.031 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 88.7 m -64.42 -42.18 96.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.778 0.323 . . . . 0.96 110.223 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 57.1 m -63.52 -47.4 81.82 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.216 -0.447 . . . . 0.71 110.177 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 256' ' ' GLY . 87.3 t -61.4 -48.61 88.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.094 -0.503 . . . . 1.25 110.864 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -58.68 -42.67 89.05 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.133 0.492 . . . . 1.54 110.36 179.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.6 m -63.29 -49.2 74.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.792 -0.64 . . . . 0.82 111.008 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 CA--C 1.535 0.385 0 CA-C-N 115.964 -0.562 . . . . 1.54 111.51 -179.913 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 254' ' ' GLY . 13.2 p . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.085 0.469 . . . . 0.97 110.914 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.415 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -59.59 -46.21 94.36 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.537 -0.756 . . . . 0.56 112.202 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.0 mt -62.14 -45.7 92.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.101 0.477 . . . . 1.0 110.929 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -59.98 -50.63 65.62 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.948 -0.644 . . . . 0.52 112.953 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.55 -37.93 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.26 0.53 . . . . 0.62 111.159 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.4 m -62.36 -46.52 88.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.768 0.318 . . . . 0.58 110.941 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 41.1 p -65.51 -46.94 77.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.264 -0.425 . . . . 0.67 110.773 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 256' ' ' GLY . 76.4 t -60.18 -50.45 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.562 -0.29 . . . . 0.66 110.639 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 25.3 tp -57.45 -47.12 82.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.638 -0.256 . . . . 0.68 110.865 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.9 m -57.58 -48.02 80.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.171 0.51 . . . . 0.54 110.946 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 CA--C 1.54 0.567 0 CA-C-N 115.685 -0.689 . . . . 1.14 112.431 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 254' ' ' GLY . 6.4 p . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 121.093 0.473 . . . . 0.59 111.346 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.487 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -60.77 -45.6 96.13 Favored Glycine 0 C--N 1.323 -0.171 0 CA-C-N 115.498 -0.774 . . . . 0.35 112.259 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 255' ' ' LEU . 11.0 mt -59.17 -46.66 87.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.116 0.484 . . . . 0.73 111.069 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -63.68 -51.35 54.66 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.736 -0.665 . . . . 0.3 113.313 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.2 pp -62.58 -41.32 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 117.429 0.614 . . . . 0.54 111.644 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.3 p -66.28 -40.88 90.37 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 122.23 -0.294 . . . . 0.57 110.988 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 85.6 m -64.16 -48.73 74.86 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.094 -0.336 . . . . 0.57 110.094 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 256' ' ' GLY . 75.3 t -60.54 -48.54 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.163 -0.471 . . . . 0.5 110.884 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.2 OUTLIER -56.52 -43.69 80.06 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.011 0.434 . . . . 1.15 110.357 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 92.6 m -60.73 -49.2 78.47 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.688 -0.687 . . . . 0.72 110.745 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 CA--C 1.538 0.486 0 CA-C-N 116.041 -0.527 . . . . 0.78 112.412 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 121.02 0.438 . . . . 1.26 110.311 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -61.61 -46.44 94.26 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.709 -0.678 . . . . 0.6 112.066 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 255' ' ' LEU . 15.2 tp -62.59 -41.24 98.84 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.105 0.479 . . . . 1.05 110.314 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.25 -53.36 42.83 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.879 -0.601 . . . . 0.61 112.639 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.46 -35.8 75.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.292 0.546 . . . . 0.81 111.396 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.4 m -64.69 -47.8 77.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.835 0.35 . . . . 0.86 110.8 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.3 p -64.75 -45.88 84.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.421 -0.354 . . . . 0.97 110.989 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 256' ' ' GLY . 73.5 t -59.29 -48.26 87.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.758 -0.201 . . . . 0.72 110.85 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 20.3 tp -62.48 -38.32 89.4 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.997 0.427 . . . . 1.09 110.773 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 99.4 m -64.31 -49.19 72.72 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.012 -0.54 . . . . 1.39 110.91 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 CA--C 1.537 0.449 0 CA-C-N 116.171 -0.468 . . . . 1.32 112.063 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 CA--C 1.53 0.2 0 CA-C-O 120.636 0.255 . . . . 2.33 110.905 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -61.34 -49.22 79.88 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.967 -0.635 . . . . 1.0 111.854 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.26 -39.56 90.84 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.223 0.535 . . . . 2.34 110.425 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.13 -54.35 33.49 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.798 -0.637 . . . . 1.13 112.824 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.29 -35.63 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 117.471 0.636 . . . . 2.03 111.064 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 90.8 m -64.29 -47.72 78.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.796 0.331 . . . . 1.79 111.128 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.9 p -66.0 -46.13 79.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.37 -0.377 . . . . 1.94 110.869 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.82 -47.63 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.449 -0.341 . . . . 1.85 110.641 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.8 -45.51 92.12 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.779 0.323 . . . . 2.23 110.283 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.8 m -60.39 -46.15 91.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.303 0.573 . . . . 2.17 111.32 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.747 -0.66 . . . . 2.72 112.26 -179.859 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 254' ' ' GLY . 6.3 p . . . . . 0 N--CA 1.464 0.243 0 CA-C-O 120.966 0.412 . . . . 0.77 111.144 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.436 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -57.38 -48.51 80.04 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.352 -0.84 . . . . 0.56 112.435 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.5 mt -60.02 -44.39 94.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.327 0.584 . . . . 1.0 111.013 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.26 -52.29 48.27 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.687 -0.768 . . . . 0.44 112.989 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.27 -39.96 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 117.482 0.641 . . . . 0.68 111.973 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 22.2 p -65.73 -45.74 81.54 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.62 0.23 . . . . 0.64 111.62 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.6 p -65.2 -45.82 83.23 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 121.009 -0.276 . . . . 0.65 110.597 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.2 t -60.57 -46.86 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.594 -0.275 . . . . 0.75 110.591 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.55 -45.94 90.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.125 0.488 . . . . 1.39 109.753 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 90.7 m -60.24 -49.95 75.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.714 -0.675 . . . . 0.59 110.936 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 CA--C 1.537 0.467 0 CA-C-N 115.863 -0.608 . . . . 1.45 111.963 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 254' ' ' GLY . 10.7 p . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.271 0.558 . . . . 0.82 110.354 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.425 ' O ' HG13 ' A' ' 257' ' ' ILE . . . -61.27 -49.35 78.72 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.027 -0.988 . . . . 0.43 112.109 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.2 mt -59.24 -43.6 92.38 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.013 0.435 . . . . 0.87 111.152 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.98 -53.54 42.08 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.816 -0.629 . . . . 0.36 112.941 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 254' ' ' GLY . 2.4 pp -62.34 -38.43 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 117.36 0.58 . . . . 0.64 110.93 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 41.9 m -62.62 -43.35 99.04 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.987 0.422 . . . . 0.54 109.984 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 46.5 m -63.2 -46.55 86.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.49 110.096 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 256' ' ' GLY . 99.1 t -61.41 -49.88 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.128 -0.487 . . . . 0.55 110.841 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.52 -43.55 79.92 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.029 0.442 . . . . 1.24 110.485 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 68.0 m -62.55 -50.99 69.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.54 110.618 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 54.2 ttp . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 115.798 -0.637 . . . . 0.83 111.934 179.649 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.376 0.131 . . . . 0.7 110.893 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.501 ' O ' HG13 ' A' ' 257' ' ' ILE . . . -61.19 -48.39 85.97 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.665 -0.779 . . . . 0.4 111.46 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.4 mt -60.64 -49.48 77.33 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 122.832 -0.217 . . . . 0.81 110.948 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.91 -50.74 61.71 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 116.101 -0.499 . . . . 0.35 113.117 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 254' ' ' GLY . 2.5 pp -63.07 -33.65 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 117.21 0.505 . . . . 0.53 110.016 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 91.4 m -63.82 -47.6 80.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.708 -0.224 . . . . 0.54 110.546 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -43.43 96.23 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.682 0.277 . . . . 1.13 110.745 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.1 -48.32 89.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.327 -0.397 . . . . 0.55 110.77 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -41.69 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.502 . . . . 1.36 110.481 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 86.2 m -63.45 -51.73 64.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.571 -0.741 . . . . 0.61 112.118 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 20.5 ptp . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 113.896 1.073 . . . . 0.95 113.896 -178.599 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.746 0.307 . . . . 2.54 110.531 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.84 -47.67 89.29 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.991 -0.55 . . . . 2.03 111.968 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 255' ' ' LEU . 8.9 mt -60.87 -44.31 97.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.378 0.609 . . . . 1.74 110.892 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.76 -52.1 50.92 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.544 -0.753 . . . . 1.25 113.031 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.71 -37.88 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 117.622 0.711 . . . . 2.15 111.225 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 91.1 m -64.31 -47.56 78.98 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.83 0.347 . . . . 1.59 111.16 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.2 p -64.71 -45.0 88.41 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.485 -0.325 . . . . 0.82 110.731 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.81 -49.46 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.521 -0.309 . . . . 1.77 110.416 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.65 -42.58 83.76 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.912 0.386 . . . . 2.18 110.626 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 93.1 m -62.17 -48.98 77.64 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.942 -0.572 . . . . 1.11 110.3 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 115.51 -0.768 . . . . 1.67 111.616 179.351 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.499 0.19 . . . . 0.95 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.3 -48.68 84.81 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.906 -0.664 . . . . 0.67 111.622 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 255' ' ' LEU . 8.0 mt -61.14 -43.7 98.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.158 0.504 . . . . 0.89 110.824 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.09 -53.01 45.93 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.37 -0.919 . . . . 0.44 112.983 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.85 -40.13 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 117.471 0.636 . . . . 0.8 111.948 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 19.3 p -64.65 -45.72 85.55 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.718 0.266 . . . . 0.77 111.718 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.3 p -65.95 -46.12 79.28 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.187 -0.205 . . . . 0.62 110.923 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.42 -48.43 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.824 -0.171 . . . . 0.69 110.662 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 42.3 mt -61.33 -40.51 94.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.791 0.329 . . . . 0.79 111.182 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.2 m -67.12 -46.7 73.36 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.203 0.525 . . . . 0.83 111.32 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 CA--C 1.536 0.421 0 CA-C-N 115.657 -0.701 . . . . 1.49 112.313 -179.195 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.675 0.274 . . . . 1.3 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -61.43 -48.21 86.33 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 121.023 -0.608 . . . . 0.66 112.006 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 255' ' ' LEU . 15.7 tp -61.71 -42.65 99.23 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.953 0.406 . . . . 1.33 110.448 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.07 -54.22 38.5 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.076 -0.583 . . . . 0.68 112.804 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.46 -35.85 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 117.345 0.573 . . . . 1.18 111.352 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.2 m -65.16 -47.0 78.55 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.758 0.313 . . . . 0.97 111.028 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 27.6 p -66.56 -46.66 75.32 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.521 -0.309 . . . . 1.09 110.734 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 73.0 t -58.88 -46.82 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.674 -0.239 . . . . 1.29 110.517 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 26.5 tp -61.3 -44.6 96.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.869 0.366 . . . . 1.26 110.329 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 96.7 m -60.41 -48.12 83.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.149 0.499 . . . . 1.07 111.213 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 112.531 0.567 . . . . 2.19 112.531 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 254' ' ' GLY . 2.5 p . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 120.872 0.368 . . . . 0.79 111.865 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.556 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -56.52 -46.31 88.28 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.666 -0.697 . . . . 0.63 112.822 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 255' ' ' LEU . 6.7 mt -62.45 -45.4 93.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.981 0.42 . . . . 0.89 111.048 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.447 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.8 -51.39 56.06 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.841 -0.618 . . . . 0.3 112.756 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.78 -37.68 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 117.175 0.487 . . . . 0.82 111.063 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.6 m -64.84 -41.96 95.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.933 0.397 . . . . 0.7 110.017 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 54.1 m -63.17 -46.44 87.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.121 -0.49 . . . . 0.52 110.051 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 256' ' ' GLY . 93.6 t -59.75 -48.18 88.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 116.212 -0.449 . . . . 0.67 110.201 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.34 -44.66 92.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.919 0.39 . . . . 1.2 110.512 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 92.7 m -58.51 -49.39 77.54 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.803 -0.635 . . . . 0.55 111.482 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 21.4 ptp . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.785 0.661 . . . . 0.86 112.785 -179.748 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.0 t . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.351 0.119 . . . . 1.48 110.99 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.32 -49.4 72.99 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.006 -0.616 . . . . 0.52 111.888 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 255' ' ' LEU . 8.8 mt -60.0 -45.81 91.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.277 0.561 . . . . 1.29 111.025 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.92 -52.64 48.91 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.798 -0.715 . . . . 0.6 113.354 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.32 -40.33 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 117.628 0.714 . . . . 0.73 111.687 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.1 p -65.3 -45.33 84.82 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.947 -0.301 . . . . 0.78 111.697 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.3 p -64.72 -44.45 90.15 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 121.046 -0.262 . . . . 1.04 110.703 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.5 t -61.49 -51.58 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.753 -0.203 . . . . 0.96 110.615 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.2 mt -57.66 -38.49 75.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.655 0.264 . . . . 0.86 111.068 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 96.1 m -65.66 -49.05 70.06 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.204 0.526 . . . . 1.03 110.575 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 CA--C 1.537 0.471 0 CA-C-N 115.858 -0.61 . . . . 1.42 111.552 179.622 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.586 HG13 ' H ' ' A' ' 254' ' ' GLY . 2.5 p . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 112.391 0.515 . . . . 1.38 112.391 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.586 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -55.26 -48.28 69.88 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.869 -0.605 . . . . 0.95 112.671 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 255' ' ' LEU . 8.0 mt -60.18 -45.88 91.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.199 0.523 . . . . 1.21 111.156 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.68 -50.85 58.58 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.7 -0.762 . . . . 0.4 113.238 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.2 pp -63.24 -40.23 88.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 117.394 0.597 . . . . 1.31 111.955 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 26.7 p -68.04 -43.92 77.59 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 121.028 -0.269 . . . . 1.4 111.723 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 p -64.81 -45.26 86.99 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.065 -0.254 . . . . 1.1 110.568 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 56.6 t -62.16 -49.71 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.56 -0.291 . . . . 0.72 110.626 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.4 OUTLIER -56.31 -45.1 80.43 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.959 0.409 . . . . 1.35 110.674 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 97.8 m -60.96 -47.22 87.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.745 -0.661 . . . . 1.65 110.629 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.535 0.397 0 CA-C-N 115.832 -0.622 . . . . 1.6 111.507 179.633 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 50.0 t . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.77 0.319 . . . . 1.1 110.57 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.03 -47.51 90.4 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.949 -0.569 . . . . 0.62 112.148 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 255' ' ' LEU . 17.2 tp -61.75 -42.99 99.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.998 0.428 . . . . 1.91 110.198 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.03 -53.24 44.33 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.9 -0.667 . . . . 0.97 112.907 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.63 -40.13 87.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 117.286 0.543 . . . . 0.97 111.646 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 21.0 p -65.69 -39.17 90.99 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.95 -0.3 . . . . 0.99 110.982 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 90.2 m -65.32 -47.75 75.46 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.947 -0.39 . . . . 1.49 109.947 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 256' ' ' GLY . 78.0 t -59.66 -48.05 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.031 -0.531 . . . . 1.25 110.422 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 261' ' ' LEU . 50.6 mt -59.62 -47.41 85.71 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.532 -0.304 . . . . 1.03 110.859 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.8 m -58.44 -44.16 89.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.338 0.59 . . . . 1.23 111.172 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 CA--C 1.538 0.482 0 CA-C-N 115.549 -0.75 . . . . 2.12 111.904 -179.745 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 254' ' ' GLY . 3.0 p . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 120.884 0.374 . . . . 1.0 111.934 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.503 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -55.67 -49.29 66.35 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.609 -0.723 . . . . 0.57 112.768 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.2 mt -63.61 -41.9 98.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.848 0.356 . . . . 1.01 110.764 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.39 -52.49 51.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.804 -0.712 . . . . 0.5 112.601 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.43 -37.83 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 117.086 0.443 . . . . 0.75 111.172 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.7 m -64.98 -41.25 95.6 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.745 0.307 . . . . 0.71 110.328 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 58.8 m -64.8 -48.71 73.46 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 110.002 -0.37 . . . . 0.63 110.002 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 256' ' ' GLY . 97.4 t -60.51 -46.57 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.121 -0.49 . . . . 0.63 110.626 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 21.7 tp -60.45 -42.8 96.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.861 0.363 . . . . 0.99 110.842 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 97.2 m -63.82 -46.87 83.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.223 0.535 . . . . 0.81 110.839 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 49.0 tpp . . . . . 0 CA--C 1.537 0.478 0 CA-C-N 115.603 -0.726 . . . . 1.05 112.037 -179.755 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.776 0.322 . . . . 3.15 111.311 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.53 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 22.5 Cg_exo -68.12 106.51 1.37 Allowed 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.158 2.572 . . . . 1.35 112.496 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.41 98.51 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.197 -0.456 . . . . 0.89 111.743 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -44.77 95.95 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.267 -0.424 . . . . 1.81 110.749 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 93.9 t -64.93 -47.98 86.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 0.68 110.708 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.84 -48.0 85.01 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.116 -0.564 . . . . 0.43 111.797 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.3 mt -61.45 -45.27 94.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.109 0.481 . . . . 0.84 110.785 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.43 -52.27 52.44 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.643 -0.708 . . . . 0.33 113.116 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.66 -38.59 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 117.415 0.608 . . . . 0.58 110.896 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.5 m -63.25 -42.85 99.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.079 0.466 . . . . 0.66 109.987 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 263' ' ' MET . 57.5 m -62.69 -48.92 77.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.906 -0.588 . . . . 0.59 110.156 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.607 ' O ' HG22 ' A' ' 264' ' ' THR . 98.9 t -59.2 -49.14 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.122 -0.49 . . . . 0.51 110.452 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 23.5 tp -57.52 -40.19 78.18 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.305 -0.407 . . . . 0.77 110.321 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 93.2 m -64.25 -48.54 75.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.888 -0.596 . . . . 0.69 110.525 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 259' ' ' THR . 96.3 mmm -62.2 -46.09 90.44 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.837 -0.62 . . . . 0.86 112.38 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 260' ' ' VAL . 9.8 t -78.16 53.56 1.23 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.372 0.508 . . . . 0.53 112.372 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.914 ' HA ' ' HA ' ' A' ' 272' ' ' ALA . 1.2 t -60.3 -46.96 88.05 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.279 0.474 . . . . 0.48 112.279 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 68.67 -47.37 0.56 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.271 0.628 . . . . 1.33 112.249 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 45.3 t -69.91 -22.19 63.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.521 -0.308 . . . . 0.75 111.591 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.5 t 65.66 47.5 2.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.256 0.551 . . . . 1.15 111.828 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -147.58 49.55 0.61 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.825 -0.702 . . . . 0.7 112.731 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 60.4 m 69.65 -52.89 0.61 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.651 0.78 . . . . 0.91 112.32 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -86.2 152.39 22.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.438 -0.346 . . . . 0.8 110.76 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.914 ' HA ' ' HA ' ' A' ' 265' ' ' THR . . . -75.45 -122.41 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.466 -0.334 . . . . 0.61 110.17 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.59 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 20.8 p -80.49 51.85 1.53 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.642 0.734 . . . . 0.72 111.291 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.663 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 27.2 tp -129.11 48.32 3.57 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.991 -1.004 . . . . 0.84 109.827 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.663 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 51.1 Cg_exo -61.29 56.82 0.1 Allowed 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 123.194 2.596 . . . . 0.6 114.758 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.393 0 CA-C-O 118.32 -0.848 . . . . 1.07 110.973 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 111.291 0.108 . . . . 3.93 111.291 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.421 ' HB2' ' H ' ' A' ' 251' ' ' ALA . 61.5 Cg_endo -76.33 -147.02 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.265 2.644 . . . . 3.13 113.362 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.421 ' H ' ' HB2' ' A' ' 250' ' ' PRO . . . -150.92 -70.33 0.18 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.126 0.489 . . . . 2.06 111.452 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.801 ' HB3' ' HB2' ' A' ' 255' ' ' LEU . 14.3 mmt180 -94.73 67.77 3.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.437 0.637 . . . . 1.74 111.916 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.3 t -55.39 -50.86 62.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.739 -1.119 . . . . 1.34 111.505 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.08 -46.21 94.1 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.922 -0.581 . . . . 0.81 112.17 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.801 ' HB2' ' HB3' ' A' ' 252' ' ' ARG . 6.2 mt -62.47 -45.06 94.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.896 0.379 . . . . 1.15 110.779 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.13 -50.85 61.25 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.034 -0.603 . . . . 0.58 112.821 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.5 pp -64.07 -36.53 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 117.31 0.555 . . . . 0.96 110.69 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 88.4 m -66.06 -42.06 89.96 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.718 -0.475 . . . . 1.01 109.718 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.7 m -63.96 -49.19 73.5 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.915 -0.584 . . . . 0.99 110.012 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.621 ' O ' HG22 ' A' ' 264' ' ' THR . 82.6 t -59.9 -48.97 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.126 -0.488 . . . . 0.81 110.391 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.2 OUTLIER -56.7 -42.82 79.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.039 0.447 . . . . 1.3 109.826 178.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 85.5 m -61.61 -47.46 85.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.761 -0.654 . . . . 1.33 110.666 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 89.4 mtp -62.57 -54.4 40.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.993 -0.548 . . . . 1.51 111.689 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 260' ' ' VAL . 10.0 t -86.49 46.05 1.31 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.493 0.663 . . . . 1.15 111.248 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.763 HG21 ' HG2' ' A' ' 275' ' ' PRO . 8.9 t -74.09 43.76 0.17 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.879 -0.601 . . . . 1.55 112.582 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -96.91 64.43 2.02 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.158 -0.338 . . . . 1.24 111.23 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 34.5 t -158.03 130.6 7.22 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.065 0.46 . . . . 1.93 111.716 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 73.6 m -91.94 120.49 32.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.114 -0.494 . . . . 2.31 110.6 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 176.9 -133.69 2.34 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.698 -0.763 . . . . 2.23 112.865 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.8 m -61.9 -40.61 96.03 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.793 0.296 . . . . 2.93 111.409 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -78.15 127.67 32.64 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.836 0.35 . . . . 1.81 110.736 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -73.17 85.98 1.39 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.358 -0.383 . . . . 1.09 111.309 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.57 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 70.3 m -73.89 60.84 0.75 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.169 0.509 . . . . 1.41 112.131 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.675 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 22.2 tp -124.51 41.91 0.66 Allowed Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 115.648 -0.705 . . . . 2.31 110.998 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.763 ' HG2' HG21 ' A' ' 265' ' ' THR . 51.1 Cg_exo -60.74 -31.05 91.48 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.448 2.099 . . . . 2.89 112.63 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.909 ' HA ' ' HE2' ' A' ' 276' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.325 -0.845 . . . . 4.42 111.145 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.678 0.275 . . . . 1.98 110.977 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.512 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 85.6 Cg_endo -74.97 59.88 5.28 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.47 2.78 . . . . 1.24 113.327 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.82 91.3 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.915 0.339 . . . . 0.73 111.915 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -44.38 95.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.189 0.518 . . . . 1.84 110.075 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 61.7 t -62.43 -49.0 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.618 -0.719 . . . . 0.86 110.712 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.99 91.42 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.913 -0.585 . . . . 0.4 111.992 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 255' ' ' LEU . 11.1 mt -60.66 -46.02 91.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.268 0.556 . . . . 0.8 111.297 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.51 -51.73 54.08 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.705 -0.76 . . . . 0.51 113.092 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.45 -40.99 91.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 117.384 0.592 . . . . 0.82 111.928 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 25.7 p -65.88 -43.9 86.93 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.79 0.293 . . . . 0.52 111.79 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.0 p -65.77 -47.09 76.34 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.902 -0.319 . . . . 0.54 110.623 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.65 -45.94 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.487 -0.324 . . . . 0.84 110.438 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.406 ' HA ' HG22 ' A' ' 264' ' ' THR . 25.1 tp -60.77 -46.71 89.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.893 0.377 . . . . 1.02 110.522 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 91.1 m -59.92 -49.85 76.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.332 0.587 . . . . 0.59 110.66 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 47.4 ttm -60.62 -47.62 85.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.613 -0.721 . . . . 1.21 111.926 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 261' ' ' LEU . 13.2 t -65.89 -38.2 88.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.748 0.648 . . . . 0.88 112.748 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 12.0 t -73.06 -33.44 65.66 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.514 -0.474 . . . . 0.85 110.959 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -68.81 -42.15 77.69 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.218 0.532 . . . . 1.0 109.909 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 35.3 t -91.09 -152.73 0.29 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.18 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 54.3 p -73.88 124.96 27.13 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.203 -0.311 . . . . 0.72 110.56 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -71.66 62.45 1.2 Allowed Glycine 0 CA--C 1.522 0.531 0 C-N-CA 121.277 -0.487 . . . . 0.81 112.823 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.9 t -166.12 143.61 5.39 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 122.419 0.287 . . . . 0.86 110.862 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 71.43 43.86 0.58 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.004 -0.544 . . . . 1.09 111.804 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -89.81 130.8 36.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 1.32 111.178 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.466 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 77.4 p -88.39 -175.87 5.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.52 0.676 . . . . 1.06 112.134 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.627 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 22.7 tp 56.16 40.42 0.65 Allowed Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 114.588 -1.187 . . . . 1.23 111.959 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 81.8 Cg_exo -52.95 132.56 47.88 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.342 2.028 . . . . 1.02 114.063 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.187 -0.911 . . . . 2.43 111.091 179.277 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.454 0.168 . . . . 2.29 110.611 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.493 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 17.8 Cg_exo -70.1 76.72 1.25 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.357 2.705 . . . . 1.4 112.859 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.12 118.42 4.67 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.808 0.337 . . . . 0.94 111.233 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.642 ' HG3' ' HB2' ' A' ' 255' ' ' LEU . 5.7 tpt180 50.39 44.51 26.75 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.81 0.814 . . . . 1.49 111.817 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 6.3 p -47.81 -51.87 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 114.692 -1.14 . . . . 0.6 112.978 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.483 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -50.46 -52.96 26.55 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 116.087 -0.506 . . . . 0.42 113.485 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.642 ' HB2' ' HG3' ' A' ' 252' ' ' ARG . 1.1 mt -65.45 -41.24 93.67 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.538 -0.389 . . . . 0.92 110.415 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -60.52 -52.38 52.94 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.694 -0.765 . . . . 0.39 112.689 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.82 -41.58 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.96 0.38 . . . . 0.53 111.831 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 20.5 p -64.68 -38.75 92.07 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.648 -0.421 . . . . 0.58 110.688 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 87.4 m -65.32 -49.23 70.25 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.016 -0.364 . . . . 0.64 110.016 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 256' ' ' GLY . 78.4 t -59.6 -45.57 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.61 110.578 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -58.72 -45.41 89.65 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.046 0.45 . . . . 1.35 110.132 178.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 91.7 m -60.83 -49.96 75.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.927 -0.579 . . . . 0.61 110.67 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.32 -46.91 88.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.769 -0.651 . . . . 1.09 111.864 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.8 t -68.86 -40.24 79.42 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.842 0.682 . . . . 0.72 112.842 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 14.9 t -68.1 -36.23 79.43 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.784 -0.367 . . . . 0.67 111.649 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . 0.598 ' HG2' ' HA3' ' A' ' 269' ' ' GLY . 54.7 tt0 -81.25 -35.8 30.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.519 0.199 . . . . 0.83 111.026 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 70.5 m 61.66 -126.08 0.81 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.356 -0.384 . . . . 0.78 111.127 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.3 p -77.24 43.66 0.38 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.998 0.427 . . . . 1.02 112.078 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.598 ' HA3' ' HG2' ' A' ' 266' ' ' GLN . . . -76.62 56.43 3.39 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.439 -0.41 . . . . 0.77 113.581 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.4 t -56.91 136.42 55.89 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.196 0.443 . . . . 1.02 112.196 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 58.6 48.82 11.24 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.091 -0.504 . . . . 1.01 112.15 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 60.85 49.42 6.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.04 0.448 . . . . 1.29 111.315 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.625 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 25.3 m 64.02 50.88 2.39 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.514 -0.766 . . . . 0.87 111.97 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.651 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 27.0 tp -126.85 49.3 3.9 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.252 -0.885 . . . . 1.04 109.714 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 62.7 Cg_exo -60.18 60.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.451 2.767 . . . . 0.9 115.499 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.257 1.458 0 CA-C-O 118.262 -0.875 . . . . 1.76 111.363 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.369 0.128 . . . . 2.74 110.783 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.403 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 2.7 Cg_endo -76.57 58.58 5.92 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.823 2.349 . . . . 2.23 112.787 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.48 82.76 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.017 0.377 . . . . 2.0 112.017 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -41.36 98.57 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.88 0.371 . . . . 2.65 110.306 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 56.1 t -64.32 -49.26 81.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 2.06 110.3 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.98 -47.19 91.94 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.965 -0.562 . . . . 1.45 111.806 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 255' ' ' LEU . 8.4 mt -60.36 -46.13 91.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.105 0.479 . . . . 1.56 110.885 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.01 -51.97 53.3 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.59 -0.732 . . . . 1.09 113.193 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.72 -38.48 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 117.452 0.626 . . . . 1.5 111.031 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 88.7 m -64.42 -42.18 96.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.778 0.323 . . . . 0.96 110.223 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 57.1 m -63.52 -47.4 81.82 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.216 -0.447 . . . . 0.71 110.177 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 256' ' ' GLY . 87.3 t -61.4 -48.61 88.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.094 -0.503 . . . . 1.25 110.864 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -58.68 -42.67 89.05 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.133 0.492 . . . . 1.54 110.36 179.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.6 m -63.29 -49.2 74.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.792 -0.64 . . . . 0.82 111.008 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.3 tpt -63.4 -53.14 57.12 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.964 -0.562 . . . . 1.54 111.51 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.9 t -132.21 134.21 45.08 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.366 0.603 . . . . 1.21 111.877 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.3 t -73.72 -32.19 63.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 1.29 111.53 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -162.57 127.36 3.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.494 . . . . 1.2 110.64 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 74.9 m -163.68 -52.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.059 -0.519 . . . . 1.07 110.588 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.6 p -68.6 135.56 51.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.378 . . . . 1.91 111.0 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -148.94 152.44 24.47 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.639 -0.791 . . . . 2.03 113.441 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.2 t -63.3 133.64 54.5 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.241 0.46 . . . . 3.07 112.241 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? 69.28 -53.44 0.59 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.507 0.723 . . . . 3.97 112.152 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -139.82 123.69 17.55 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.725 -0.472 . . . . 2.37 109.725 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.5 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 54.7 m -90.75 -179.01 5.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.214 0.53 . . . . 1.74 111.805 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.697 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 19.6 tp 58.93 36.68 0.28 Allowed Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.869 -1.06 . . . . 1.63 111.524 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.697 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 53.1 Cg_exo -59.85 -39.53 71.25 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.056 1.837 . . . . 1.55 112.473 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? . . . . . 0 C--O 1.253 1.251 0 CA-C-O 117.766 -1.111 . . . . 1.74 109.441 179.818 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.426 0.155 . . . . 1.95 111.077 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.761 ' HD2' ' HA3' ' A' ' 254' ' ' GLY . 30.1 Cg_exo -66.06 60.84 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.02 3.147 . . . . 1.1 113.938 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 56.47 -142.61 0.75 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.507 0.929 . . . . 0.93 113.507 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -50.86 71.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.815 -0.63 . . . . 1.7 112.306 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 254' ' ' GLY . 13.2 p -59.19 -47.63 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.085 0.469 . . . . 0.97 110.914 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.761 ' HA3' ' HD2' ' A' ' 250' ' ' PRO . . . -59.59 -46.21 94.36 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.537 -0.756 . . . . 0.56 112.202 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.0 mt -62.14 -45.7 92.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.101 0.477 . . . . 1.0 110.929 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -59.98 -50.63 65.62 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.948 -0.644 . . . . 0.52 112.953 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.55 -37.93 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.26 0.53 . . . . 0.62 111.159 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.4 m -62.36 -46.52 88.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.768 0.318 . . . . 0.58 110.941 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.527 ' CG2' ' HB3' ' A' ' 275' ' ' PRO . 41.1 p -65.51 -46.94 77.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.264 -0.425 . . . . 0.67 110.773 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 256' ' ' GLY . 76.4 t -60.18 -50.45 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.562 -0.29 . . . . 0.66 110.639 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.466 ' HA ' HG22 ' A' ' 264' ' ' THR . 25.3 tp -57.45 -47.12 82.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.638 -0.256 . . . . 0.68 110.865 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.9 m -57.58 -48.02 80.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.171 0.51 . . . . 0.54 110.946 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 28.3 ttt -66.43 -46.11 77.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.685 -0.689 . . . . 1.14 112.431 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 261' ' ' LEU . 13.0 t -67.81 -35.27 78.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.313 0.857 . . . . 0.69 113.313 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 261' ' ' LEU . 12.7 t -76.62 -1.65 28.69 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.195 -0.316 . . . . 0.77 111.691 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 62.23 47.38 5.52 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.225 0.536 . . . . 1.12 110.831 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 44.5 t -69.4 151.99 45.46 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.448 -0.796 . . . . 0.7 110.979 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.0 m -69.78 56.48 0.13 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.473 0.546 . . . . 1.14 112.473 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 179.8 -140.82 4.41 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 112.149 -0.38 . . . . 1.15 112.149 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 274' ' ' LEU . 13.8 t 58.25 -142.23 0.69 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.822 0.311 . . . . 1.33 111.66 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 270' ' ' SER . 57.6 mtp85 72.12 121.08 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.391 0.676 . . . . 1.9 111.995 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 57.27 -140.2 0.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.08 -0.509 . . . . 1.93 111.217 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.625 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 58.1 p -86.41 49.46 1.8 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.335 0.588 . . . . 1.88 111.996 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.639 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 2.7 mm? -126.79 51.22 6.0 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.393 -0.821 . . . . 1.2 110.217 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 85.3 Cg_exo -56.31 50.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 124.292 3.328 . . . . 2.24 115.945 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 276' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.897 -0.573 . . . . 3.69 110.377 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.257 0.075 . . . . 2.96 110.924 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.683 ' HG2' ' HA3' ' A' ' 254' ' ' GLY . 97.2 Cg_endo -73.23 -137.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.212 2.608 . . . . 1.32 113.768 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' A' ' 250' ' ' PRO . . . -76.39 -148.41 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.033 0.753 . . . . 0.85 113.033 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.06 -41.88 88.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.699 -0.682 . . . . 1.26 111.864 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 254' ' ' GLY . 6.4 p -56.08 -53.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.093 0.473 . . . . 0.59 111.346 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.683 ' HA3' ' HG2' ' A' ' 250' ' ' PRO . . . -60.77 -45.6 96.13 Favored Glycine 0 C--N 1.323 -0.171 0 CA-C-N 115.498 -0.774 . . . . 0.35 112.259 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 255' ' ' LEU . 11.0 mt -59.17 -46.66 87.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.116 0.484 . . . . 0.73 111.069 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -63.68 -51.35 54.66 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.736 -0.665 . . . . 0.3 113.313 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.2 pp -62.58 -41.32 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 117.429 0.614 . . . . 0.54 111.644 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.3 p -66.28 -40.88 90.37 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 122.23 -0.294 . . . . 0.57 110.988 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 85.6 m -64.16 -48.73 74.86 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.094 -0.336 . . . . 0.57 110.094 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 256' ' ' GLY . 75.3 t -60.54 -48.54 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.163 -0.471 . . . . 0.5 110.884 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.2 OUTLIER -56.52 -43.69 80.06 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.011 0.434 . . . . 1.15 110.357 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 92.6 m -60.73 -49.2 78.47 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.688 -0.687 . . . . 0.72 110.745 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . 0.696 ' HA ' ' HG2' ' A' ' 275' ' ' PRO . 88.8 mtp -63.83 -54.58 32.81 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.041 -0.527 . . . . 0.78 112.412 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.6 t -126.2 134.96 51.1 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.206 0.527 . . . . 0.59 111.937 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.8 t -64.56 119.1 9.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.165 0.507 . . . . 0.93 112.031 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 67.5 -61.99 0.34 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.315 -0.857 . . . . 1.32 112.322 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 32.4 t -172.33 -141.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.418 . . . . 0.98 110.274 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 32.7 t 61.06 -140.81 0.52 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.758 0.423 . . . . 0.77 111.317 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -146.58 79.08 0.23 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.902 -0.666 . . . . 0.65 112.927 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 50.1 m -60.43 135.94 57.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.913 0.387 . . . . 0.59 111.556 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -62.08 -39.01 90.97 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.277 -0.419 . . . . 2.28 111.683 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -81.23 33.81 0.35 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.126 0.788 . . . . 1.38 113.126 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.578 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 54.0 m -80.18 56.79 2.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.362 0.601 . . . . 0.6 111.435 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.705 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 21.2 tp -127.82 42.67 0.9 Allowed Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.582 -0.736 . . . . 1.08 110.536 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.705 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 45.5 Cg_exo -64.52 100.38 0.33 Allowed 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 122.53 2.153 . . . . 2.2 113.186 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.428 ' HE3' ' HG ' ' A' ' 274' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.448 0 CA-C-O 117.919 -1.039 . . . . 1.88 110.561 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.461 0.172 . . . . 1.31 111.052 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.524 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 20.1 Cg_exo -70.13 49.5 0.8 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.921 3.081 . . . . 1.19 114.107 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 47.34 -123.62 1.49 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.315 0.857 . . . . 1.19 113.315 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -40.74 77.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.951 -0.568 . . . . 2.07 111.618 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 46.9 t -62.66 -45.18 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.02 0.438 . . . . 1.26 110.311 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.475 ' HA3' ' HD2' ' A' ' 250' ' ' PRO . . . -61.61 -46.44 94.26 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.709 -0.678 . . . . 0.6 112.066 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 255' ' ' LEU . 15.2 tp -62.59 -41.24 98.84 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.105 0.479 . . . . 1.05 110.314 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.25 -53.36 42.83 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.879 -0.601 . . . . 0.61 112.639 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.46 -35.8 75.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.292 0.546 . . . . 0.81 111.396 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.4 m -64.69 -47.8 77.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.835 0.35 . . . . 0.86 110.8 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.3 p -64.75 -45.88 84.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.421 -0.354 . . . . 0.97 110.989 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 256' ' ' GLY . 73.5 t -59.29 -48.26 87.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.758 -0.201 . . . . 0.72 110.85 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 20.3 tp -62.48 -38.32 89.4 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.997 0.427 . . . . 1.09 110.773 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 99.4 m -64.31 -49.19 72.72 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.012 -0.54 . . . . 1.39 110.91 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 70.2 mtm -67.03 -50.2 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.171 -0.468 . . . . 1.32 112.063 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.1 t -127.97 134.87 49.32 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.32 0.581 . . . . 0.97 112.289 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.8 t -77.15 61.28 2.04 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.524 0.678 . . . . 1.31 111.729 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -64.98 92.04 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.634 -0.712 . . . . 1.29 111.381 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 270' ' ' SER . 88.3 p -78.88 46.89 0.71 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.863 0.32 . . . . 1.26 111.863 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 47.4 t 67.11 -54.71 0.46 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.579 0.752 . . . . 1.96 112.455 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.41 32.26 6.19 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.957 -0.639 . . . . 1.81 113.005 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.435 ' HB3' ' OG ' ' A' ' 267' ' ' SER . 88.8 p -95.63 -43.24 8.02 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.896 0.332 . . . . 1.27 111.896 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.6 mtm-85 68.07 -74.93 0.07 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.237 0.615 . . . . 2.31 111.644 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -77.58 -38.73 47.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.43 -0.35 . . . . 1.41 111.096 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.577 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 19.2 m 65.68 57.89 0.83 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.779 -0.646 . . . . 1.43 112.057 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.655 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 2.4 mm? -122.7 44.84 0.95 Allowed Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.875 -0.602 . . . . 2.49 112.099 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.655 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 77.7 Cg_exo -56.87 -43.15 57.06 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.655 2.237 . . . . 2.26 112.763 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm . . . . . 0 C--O 1.254 1.291 0 CA-C-O 117.943 -1.027 . . . . 3.34 109.831 179.481 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.439 0.161 . . . . 2.17 110.794 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 17.4 Cg_exo -71.0 56.38 1.92 Allowed 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.914 3.076 . . . . 2.47 113.605 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.71 85.42 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.77 0.319 . . . . 1.05 111.363 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.457 ' O ' ' HD2' ' A' ' 252' ' ' ARG . 20.8 tpt180 -64.83 -44.97 88.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.498 -0.319 . . . . 3.35 110.728 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 29.4 t -60.24 -47.75 90.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.612 -0.267 . . . . 2.33 110.905 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -61.34 -49.22 79.88 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.967 -0.635 . . . . 1.0 111.854 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.26 -39.56 90.84 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.223 0.535 . . . . 2.34 110.425 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.13 -54.35 33.49 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.798 -0.637 . . . . 1.13 112.824 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.29 -35.63 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 117.471 0.636 . . . . 2.03 111.064 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 90.8 m -64.29 -47.72 78.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.796 0.331 . . . . 1.79 111.128 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.9 p -66.0 -46.13 79.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.37 -0.377 . . . . 1.94 110.869 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.82 -47.63 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.449 -0.341 . . . . 1.85 110.641 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.445 ' O ' HG22 ' A' ' 265' ' ' THR . 26.8 tp -59.8 -45.51 92.12 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.779 0.323 . . . . 2.23 110.283 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.8 m -60.39 -46.15 91.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.303 0.573 . . . . 2.17 111.32 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 52.7 ttp -67.51 -42.83 82.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.747 -0.66 . . . . 2.72 112.26 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 261' ' ' LEU . 13.2 t -70.29 -28.03 64.87 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.917 0.71 . . . . 1.64 112.917 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 261' ' ' LEU . 10.8 t -82.56 -142.48 0.06 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 120.761 -0.376 . . . . 1.89 111.005 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 62.52 32.27 16.63 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.316 0.579 . . . . 2.76 110.812 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 48.2 t -111.82 134.76 53.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.861 -0.609 . . . . 2.2 111.228 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.4 t -61.98 -40.08 94.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.853 -0.612 . . . . 1.86 111.89 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 78.33 -53.17 3.85 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.962 -0.637 . . . . 2.51 113.878 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.642 ' O ' ' HG ' ' A' ' 274' ' ' LEU . 46.1 m -58.43 120.32 8.56 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.927 0.363 . . . . 2.95 110.795 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.664 ' HD2' HD12 ' A' ' 274' ' ' LEU . 36.7 tpt85 -54.43 -43.22 71.38 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.759 0.651 . . . . 2.37 112.759 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.93 -42.92 99.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.174 0.511 . . . . 2.72 110.823 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.594 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 5.9 m -96.33 51.96 1.23 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.536 . . . . 2.82 111.136 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.664 HD12 ' HD2' ' A' ' 271' ' ' ARG . 12.1 mt -114.12 38.74 0.21 Allowed Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 112.716 0.636 . . . . 2.22 112.716 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.594 ' HD3' ' C ' ' A' ' 273' ' ' SER . 68.9 Cg_exo -58.36 -35.34 98.8 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.523 1.482 . . . . 3.84 112.309 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' A' ' 276' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.421 0 CA-C-N 115.591 -0.731 . . . . 5.46 111.852 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.431 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.373 0.13 . . . . 3.22 111.166 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 22.4 Cg_exo -68.9 68.67 1.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.761 2.974 . . . . 1.75 113.128 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.26 -73.26 0.14 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.661 0.615 . . . . 1.11 112.661 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.01 -51.63 56.57 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.643 0.259 . . . . 1.74 111.594 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 254' ' ' GLY . 6.3 p -58.13 -50.57 77.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.77 111.144 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.436 ' N ' HG13 ' A' ' 253' ' ' VAL . . . -57.38 -48.51 80.04 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.352 -0.84 . . . . 0.56 112.435 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.5 mt -60.02 -44.39 94.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.327 0.584 . . . . 1.0 111.013 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.26 -52.29 48.27 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.687 -0.768 . . . . 0.44 112.989 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.27 -39.96 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 117.482 0.641 . . . . 0.68 111.973 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 22.2 p -65.73 -45.74 81.54 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.62 0.23 . . . . 0.64 111.62 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.6 p -65.2 -45.82 83.23 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 121.009 -0.276 . . . . 0.65 110.597 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.2 t -60.57 -46.86 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.594 -0.275 . . . . 0.75 110.591 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.55 -45.94 90.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.125 0.488 . . . . 1.39 109.753 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 90.7 m -60.24 -49.95 75.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.714 -0.675 . . . . 0.59 110.936 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.6 ttt -62.89 -47.35 83.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.863 -0.608 . . . . 1.45 111.963 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.0 t -65.75 -36.51 83.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.866 0.691 . . . . 0.98 112.866 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.1 t -73.14 -37.98 66.44 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.425 -0.51 . . . . 0.83 111.363 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -74.99 -39.95 60.95 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.564 0.221 . . . . 1.06 111.127 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 30.6 t 62.94 -141.55 0.38 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.156 -0.474 . . . . 0.93 110.753 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 64.7 p -74.75 -45.66 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.95 111.384 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 165.12 -142.72 7.93 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.714 -0.755 . . . . 0.92 112.824 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.2 t 55.97 -130.66 1.84 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.604 0.362 . . . . 1.44 111.08 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -84.05 9.01 13.56 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 111.792 0.293 . . . . 1.0 111.792 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 52.28 -140.07 0.94 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.568 0.347 . . . . 0.79 111.568 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.686 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 34.1 p -102.08 31.68 3.83 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.61 0.596 . . . . 1.04 112.61 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.672 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 0.3 OUTLIER -123.22 45.8 1.21 Allowed Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 116.03 -0.532 . . . . 1.05 110.456 175.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.686 ' HD3' ' C ' ' A' ' 273' ' ' SER . 47.0 Cg_exo -64.55 61.35 0.27 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.943 2.429 . . . . 2.03 114.235 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.455 -0.783 . . . . 2.76 111.835 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.8 0.333 . . . . 1.34 110.918 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.575 ' HG2' ' HA3' ' A' ' 254' ' ' GLY . 68.8 Cg_endo -71.06 73.24 2.01 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.293 2.662 . . . . 0.86 113.587 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 61.15 -150.55 0.4 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.536 0.939 . . . . 0.81 113.536 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.458 ' O ' ' HD3' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -64.37 -46.52 83.01 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.972 -0.558 . . . . 1.92 112.197 -178.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 254' ' ' GLY . 10.7 p -55.59 -47.54 78.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.271 0.558 . . . . 0.82 110.354 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.575 ' HA3' ' HG2' ' A' ' 250' ' ' PRO . . . -61.27 -49.35 78.72 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.027 -0.988 . . . . 0.43 112.109 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.2 mt -59.24 -43.6 92.38 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.013 0.435 . . . . 0.87 111.152 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.98 -53.54 42.08 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.816 -0.629 . . . . 0.36 112.941 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 254' ' ' GLY . 2.4 pp -62.34 -38.43 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 117.36 0.58 . . . . 0.64 110.93 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 41.9 m -62.62 -43.35 99.04 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.987 0.422 . . . . 0.54 109.984 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 46.5 m -63.2 -46.55 86.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.49 110.096 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.556 ' O ' HG22 ' A' ' 264' ' ' THR . 99.1 t -61.41 -49.88 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.128 -0.487 . . . . 0.55 110.841 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.52 -43.55 79.92 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.029 0.442 . . . . 1.24 110.485 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 68.0 m -62.55 -50.99 69.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.54 110.618 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 54.2 ttp -60.47 -46.53 89.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.798 -0.637 . . . . 0.83 111.934 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.602 HG23 ' HG2' ' A' ' 266' ' ' GLN . 11.6 t -75.23 -10.14 59.19 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.576 0.584 . . . . 0.6 112.576 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.4 t 33.47 58.18 0.52 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.557 1.143 . . . . 0.5 113.546 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . 0.602 ' HG2' HG23 ' A' ' 264' ' ' THR . 13.0 mm-40 -70.19 -26.08 63.72 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.487 -0.779 . . . . 0.96 112.521 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 37.4 m 64.04 48.43 3.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.908 0.385 . . . . 0.95 111.614 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 42.2 t 62.42 34.65 15.38 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.89 -0.595 . . . . 0.99 112.204 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -176.88 -89.05 0.07 OUTLIER Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.994 -0.622 . . . . 0.86 112.881 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 60.2 p -173.88 137.32 0.58 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 110.321 -0.252 . . . . 1.03 110.321 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.539 ' HD3' ' O ' ' A' ' 274' ' ' LEU . 17.0 ttm180 -131.92 132.2 43.36 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.585 -0.446 . . . . 0.8 111.743 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -87.31 -137.1 0.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.257 -0.429 . . . . 1.24 110.839 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.444 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 58.0 p -76.46 59.93 1.52 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.495 0.664 . . . . 1.05 112.056 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.571 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 25.6 tp -129.1 47.38 2.81 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.04 -0.982 . . . . 1.02 110.174 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 91.9 Cg_exo -50.49 139.28 38.02 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.531 2.154 . . . . 0.83 113.688 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.712 -0.661 . . . . 2.08 111.776 -179.811 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.592 0.234 . . . . 1.91 111.119 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 32.6 Cg_exo -64.72 132.87 34.27 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.224 2.616 . . . . 1.31 112.954 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.66 76.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.112 -0.495 . . . . 0.68 112.289 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -59.42 -48.44 81.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.649 0.262 . . . . 1.09 111.567 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.57 -45.73 98.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.409 -0.359 . . . . 0.7 110.893 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.501 ' O ' HG13 ' A' ' 257' ' ' ILE . . . -61.19 -48.39 85.97 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.665 -0.779 . . . . 0.4 111.46 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 255' ' ' LEU . 7.4 mt -60.64 -49.48 77.33 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 122.832 -0.217 . . . . 0.81 110.948 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.91 -50.74 61.71 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 116.101 -0.499 . . . . 0.35 113.117 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 254' ' ' GLY . 2.5 pp -63.07 -33.65 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 117.21 0.505 . . . . 0.53 110.016 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 91.4 m -63.82 -47.6 80.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.708 -0.224 . . . . 0.54 110.546 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -43.43 96.23 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.682 0.277 . . . . 1.13 110.745 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.615 HG13 ' HB ' ' A' ' 264' ' ' THR . 75.6 t -61.1 -48.32 89.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.327 -0.397 . . . . 0.55 110.77 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -41.69 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.502 . . . . 1.36 110.481 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 86.2 m -63.45 -51.73 64.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.571 -0.741 . . . . 0.61 112.118 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 20.5 ptp -159.67 56.7 0.38 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.896 1.073 . . . . 0.95 113.896 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.615 ' HB ' HG13 ' A' ' 260' ' ' VAL . 8.8 t -55.23 -34.36 63.92 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.958 -0.464 . . . . 0.68 112.133 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 9.3 t -71.31 -5.41 32.16 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.216 0.821 . . . . 0.79 113.216 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -63.57 124.54 21.63 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.843 0.354 . . . . 1.42 111.096 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 75.5 p -82.2 141.81 32.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.194 0.521 . . . . 1.06 111.8 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.4 m -160.91 142.37 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.986 -0.552 . . . . 1.35 110.469 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 70.78 -132.16 21.87 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.686 -0.768 . . . . 0.73 112.098 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 58.1 m -163.51 131.82 3.73 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 122.774 -0.25 . . . . 0.93 110.82 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 69.78 -46.4 0.59 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.583 0.586 . . . . 1.41 112.583 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -145.55 -135.66 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.839 -0.164 . . . . 1.12 111.296 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.483 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 65.5 p 54.19 59.15 4.39 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.797 0.666 . . . . 1.01 112.797 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.571 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 92.5 mt -121.88 43.02 0.64 Allowed Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 115.611 -0.722 . . . . 1.16 111.697 177.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 80.8 Cg_exo -54.25 -49.49 16.82 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 122.113 1.875 . . . . 1.34 113.113 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 96.1 mttt . . . . . 0 C--O 1.253 1.278 0 CA-C-N 115.612 -0.722 . . . . 1.35 112.816 178.87 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.635 0.255 . . . . 3.74 111.147 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 17.4 Cg_exo -70.51 58.18 1.89 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.93 3.087 . . . . 3.39 113.429 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -59.17 -47.69 84.39 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 111.887 0.328 . . . . 2.59 111.887 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.01 -42.27 99.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.997 0.427 . . . . 2.14 110.225 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 49.8 t -64.11 -49.02 83.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.031 -0.531 . . . . 2.54 110.531 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -58.84 -47.67 89.29 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.991 -0.55 . . . . 2.03 111.968 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 255' ' ' LEU . 8.9 mt -60.87 -44.31 97.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.378 0.609 . . . . 1.74 110.892 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.76 -52.1 50.92 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.544 -0.753 . . . . 1.25 113.031 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.71 -37.88 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 117.622 0.711 . . . . 2.15 111.225 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 91.1 m -64.31 -47.56 78.98 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.83 0.347 . . . . 1.59 111.16 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.2 p -64.71 -45.0 88.41 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.485 -0.325 . . . . 0.82 110.731 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 264' ' ' THR . 57.8 t -61.81 -49.46 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.521 -0.309 . . . . 1.77 110.416 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.65 -42.58 83.76 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.912 0.386 . . . . 2.18 110.626 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 93.1 m -62.17 -48.98 77.64 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.942 -0.572 . . . . 1.11 110.3 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 57.0 ttp -60.02 -47.75 84.55 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.51 -0.768 . . . . 1.67 111.616 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 260' ' ' VAL . 8.8 t -79.25 46.33 0.71 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.252 0.464 . . . . 2.22 112.252 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.7 t -58.61 -39.43 80.42 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.892 0.377 . . . . 1.52 111.201 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -89.89 129.88 36.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.235 -0.438 . . . . 2.12 110.201 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.8 t -165.59 159.1 16.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.775 0.322 . . . . 1.33 111.0 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 30.8 t -61.83 -36.66 81.84 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.358 -0.383 . . . . 1.37 111.878 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 75.54 -60.28 2.86 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.627 -0.589 . . . . 1.69 111.627 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.4 t -104.86 -152.43 0.46 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 110.053 -0.351 . . . . 2.26 110.053 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? 69.93 -50.92 0.64 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.511 0.724 . . . . 2.43 112.414 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 59.04 42.12 19.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.036 0.446 . . . . 2.68 110.887 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.53 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 14.1 m -74.18 59.39 0.75 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.345 0.593 . . . . 2.35 112.283 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.654 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 0.8 OUTLIER -123.36 40.95 0.51 Allowed Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.608 -0.724 . . . . 3.97 111.641 177.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.654 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 63.4 Cg_exo -57.58 -40.41 80.57 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.101 1.867 . . . . 4.56 112.681 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 276' ' ' LYS . 1.6 ttpm? . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.978 -1.011 . . . . 5.69 112.675 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.432 0.158 . . . . 1.72 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -64.59 124.7 13.65 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.06 2.506 . . . . 1.21 112.849 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.74 85.69 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.168 -0.469 . . . . 0.84 112.264 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -56.9 -47.83 79.61 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.135 0.493 . . . . 1.06 111.694 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 32.8 t -68.53 -45.0 82.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.95 110.867 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.3 -48.68 84.81 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.906 -0.664 . . . . 0.67 111.622 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 255' ' ' LEU . 8.0 mt -61.14 -43.7 98.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.158 0.504 . . . . 0.89 110.824 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -62.09 -53.01 45.93 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.37 -0.919 . . . . 0.44 112.983 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.85 -40.13 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 117.471 0.636 . . . . 0.8 111.948 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 19.3 p -64.65 -45.72 85.55 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.718 0.266 . . . . 0.77 111.718 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 24.3 p -65.95 -46.12 79.28 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.187 -0.205 . . . . 0.62 110.923 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.42 -48.43 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.824 -0.171 . . . . 0.69 110.662 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 42.3 mt -61.33 -40.51 94.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.791 0.329 . . . . 0.79 111.182 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.2 m -67.12 -46.7 73.36 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.203 0.525 . . . . 0.83 111.32 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.5 tpt -64.53 -43.61 93.47 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.657 -0.701 . . . . 1.49 112.313 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.6 t -70.99 136.06 48.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.372 0.606 . . . . 0.68 111.624 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.2 t -73.89 141.05 46.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.921 -0.582 . . . . 0.7 111.824 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 69.76 -51.77 0.62 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.22 0.822 . . . . 1.18 113.22 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 85.9 p 55.35 60.11 3.56 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.131 0.573 . . . . 0.74 111.503 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 72.8 m 73.56 52.46 0.12 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.574 -0.739 . . . . 1.19 111.459 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 81.87 -52.39 4.59 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 116.028 -0.533 . . . . 1.15 113.873 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 90.6 p -159.36 152.26 21.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.303 . . . . 1.17 110.871 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.687 ' CZ ' ' HA ' ' A' ' 271' ' ' ARG . 2.7 tpm_? -79.18 49.32 0.95 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.334 0.588 . . . . 1.15 112.195 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -96.68 99.23 10.85 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.118 -0.364 . . . . 1.24 110.973 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.584 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 69.1 m 58.5 -151.53 0.42 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.268 0.556 . . . . 1.85 112.004 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.576 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 91.9 mt 60.42 31.06 0.11 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 114.048 1.129 . . . . 2.22 114.048 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.584 ' HD3' ' C ' ' A' ' 273' ' ' SER . 89.1 Cg_exo -53.82 -33.56 71.55 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.818 1.679 . . . . 1.82 112.966 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.112 -0.947 . . . . 2.62 110.591 179.072 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.426 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.318 0.104 . . . . 2.02 111.07 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.462 ' HG2' ' N ' ' A' ' 254' ' ' GLY . 71.9 Cg_endo -72.64 47.85 1.23 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.221 2.614 . . . . 1.43 114.141 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 48.88 -115.84 0.79 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.403 0.89 . . . . 0.91 113.403 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -49.88 -48.72 51.2 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.437 0.695 . . . . 2.58 112.45 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.41 -44.1 97.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.336 -0.393 . . . . 1.3 111.113 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.462 ' N ' ' HG2' ' A' ' 250' ' ' PRO . . . -61.43 -48.21 86.33 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 121.023 -0.608 . . . . 0.66 112.006 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 255' ' ' LEU . 15.7 tp -61.71 -42.65 99.23 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.953 0.406 . . . . 1.33 110.448 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.07 -54.22 38.5 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.076 -0.583 . . . . 0.68 112.804 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.46 -35.85 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 117.345 0.573 . . . . 1.18 111.352 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 85.2 m -65.16 -47.0 78.55 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.758 0.313 . . . . 0.97 111.028 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 27.6 p -66.56 -46.66 75.32 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.521 -0.309 . . . . 1.09 110.734 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 73.0 t -58.88 -46.82 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.674 -0.239 . . . . 1.29 110.517 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 265' ' ' THR . 26.5 tp -61.3 -44.6 96.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.869 0.366 . . . . 1.26 110.329 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 96.7 m -60.41 -48.12 83.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.149 0.499 . . . . 1.07 111.213 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 95.9 mmm -65.15 -42.49 93.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.531 0.567 . . . . 2.19 112.531 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.6 t -68.25 -32.87 73.36 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.91 0.708 . . . . 1.42 112.91 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 261' ' ' LEU . 10.4 t -84.91 32.47 0.53 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.18 0.514 . . . . 0.9 111.884 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -79.14 56.64 2.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.176 0.512 . . . . 1.4 111.196 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 50.8 m -74.6 56.59 0.7 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.232 -0.44 . . . . 0.84 111.874 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 92.5 p -160.6 141.29 11.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.593 -0.276 . . . . 0.8 111.133 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -72.44 72.2 1.0 Allowed Glycine 0 CA--C 1.524 0.614 0 CA-C-N 116.146 -0.479 . . . . 0.97 113.37 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 77.8 p -65.73 -54.38 28.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.863 0.364 . . . . 1.08 111.972 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.47 ' NH1' ' H ' ' A' ' 276' ' ' LYS . 49.9 ttp180 -76.79 70.78 3.3 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.964 0.412 . . . . 1.59 111.677 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.57 -29.91 68.27 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.608 0.596 . . . . 1.36 112.608 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.473 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 55.4 m -144.1 -174.76 4.37 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.973 0.416 . . . . 1.65 111.676 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.643 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 98.3 mt 59.03 38.14 0.36 Allowed Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 115.205 -0.907 . . . . 1.91 111.759 -176.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 91.8 Cg_exo -51.36 133.83 43.57 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.808 2.339 . . . . 1.3 114.45 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.47 ' H ' ' NH1' ' A' ' 271' ' ' ARG . 55.2 mttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.455 -0.783 . . . . 2.26 110.686 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.625 0.25 . . . . 2.03 111.066 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 249' ' ' ALA . 15.9 Cg_exo -71.91 50.91 1.52 Allowed 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 124.08 3.187 . . . . 1.99 113.458 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 63.42 -66.59 0.1 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.52 0.728 . . . . 1.12 112.778 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.643 ' HB3' ' HB2' ' A' ' 255' ' ' LEU . 25.5 mmt180 -88.74 60.8 5.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.132 0.491 . . . . 1.39 111.849 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 254' ' ' GLY . 2.5 p -52.96 -56.45 7.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.79 111.865 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.556 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -56.52 -46.31 88.28 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.666 -0.697 . . . . 0.63 112.822 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.643 ' HB2' ' HB3' ' A' ' 252' ' ' ARG . 6.7 mt -62.45 -45.4 93.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.981 0.42 . . . . 0.89 111.048 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.447 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.8 -51.39 56.06 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.841 -0.618 . . . . 0.3 112.756 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.78 -37.68 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 117.175 0.487 . . . . 0.82 111.063 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.6 m -64.84 -41.96 95.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.933 0.397 . . . . 0.7 110.017 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 54.1 m -63.17 -46.44 87.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.121 -0.49 . . . . 0.52 110.051 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.457 ' O ' HG22 ' A' ' 264' ' ' THR . 93.6 t -59.75 -48.18 88.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 116.212 -0.449 . . . . 0.67 110.201 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.469 ' HA ' HG22 ' A' ' 264' ' ' THR . 0.9 OUTLIER -59.34 -44.66 92.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.919 0.39 . . . . 1.2 110.512 178.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 265' ' ' THR . 92.7 m -58.51 -49.39 77.54 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.803 -0.635 . . . . 0.55 111.482 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 21.4 ptp -72.69 -34.42 67.16 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.785 0.661 . . . . 0.86 112.785 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 261' ' ' LEU . 14.3 t -80.64 -16.57 53.72 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.024 1.12 . . . . 0.67 114.024 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 262' ' ' THR . 9.2 t -75.17 49.84 0.47 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.075 0.941 . . . . 0.74 111.741 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -75.35 68.53 2.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.142 -0.935 . . . . 0.73 110.862 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 52.3 m 63.29 42.52 6.88 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.098 -0.501 . . . . 1.05 110.8 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.841 ' HA ' ' HB2' ' A' ' 273' ' ' SER . 47.3 m -60.87 -40.99 95.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.737 -0.665 . . . . 0.7 111.722 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -73.82 59.72 2.14 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.215 -0.448 . . . . 1.45 113.221 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 78.1 p -147.3 -49.33 0.18 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.83 0.347 . . . . 1.12 110.71 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -159.41 46.67 0.28 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.218 -0.446 . . . . 1.6 110.382 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 61.17 47.15 7.38 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.709 -0.678 . . . . 0.95 112.365 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.841 ' HB2' ' HA ' ' A' ' 268' ' ' SER . 10.0 m -78.33 65.21 3.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.329 0.585 . . . . 0.55 111.717 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.611 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 17.7 tp -126.9 43.64 1.07 Allowed Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 115.689 -0.687 . . . . 1.14 110.93 177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 85.8 Cg_exo -53.05 141.95 55.71 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.517 2.145 . . . . 0.87 113.715 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.093 -0.956 . . . . 1.43 110.898 179.791 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.665 0.269 . . . . 2.28 111.342 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -70.16 66.36 2.01 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.703 2.935 . . . . 1.77 113.208 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -55.42 -46.28 76.67 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.826 0.306 . . . . 1.12 111.826 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -59.48 -45.86 90.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.046 0.45 . . . . 2.16 110.842 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.0 t -65.06 -48.34 84.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.885 -0.598 . . . . 1.48 110.99 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -57.32 -49.4 72.99 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.006 -0.616 . . . . 0.52 111.888 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 255' ' ' LEU . 8.8 mt -60.0 -45.81 91.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.277 0.561 . . . . 1.29 111.025 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.92 -52.64 48.91 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.798 -0.715 . . . . 0.6 113.354 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.32 -40.33 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 117.628 0.714 . . . . 0.73 111.687 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.1 p -65.3 -45.33 84.82 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.947 -0.301 . . . . 0.78 111.697 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.3 p -64.72 -44.45 90.15 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 121.046 -0.262 . . . . 1.04 110.703 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 264' ' ' THR . 59.5 t -61.49 -51.58 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.753 -0.203 . . . . 0.96 110.615 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.2 mt -57.66 -38.49 75.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.655 0.264 . . . . 0.86 111.068 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 96.1 m -65.66 -49.05 70.06 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.204 0.526 . . . . 1.03 110.575 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 27.6 ttt -61.49 -50.9 70.86 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.858 -0.61 . . . . 1.42 111.552 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 260' ' ' VAL . 9.4 t -94.24 41.39 1.09 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.226 0.536 . . . . 0.92 111.689 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.5 t -61.36 -31.17 71.05 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.534 0.568 . . . . 0.73 112.534 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -79.99 56.85 2.47 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.139 0.422 . . . . 0.95 112.139 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.7 t 62.61 -125.16 0.67 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.608 -0.269 . . . . 0.81 111.363 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.7 m -159.12 149.78 19.68 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.86 0.362 . . . . 1.21 111.47 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -170.97 -135.01 1.85 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.87 -0.681 . . . . 0.97 112.935 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 40.3 t -71.39 -11.62 60.99 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.688 0.625 . . . . 1.42 112.688 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.541 ' HB3' ' H ' ' A' ' 272' ' ' ALA . 0.6 OUTLIER 64.23 -143.71 0.28 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.588 0.355 . . . . 1.19 111.242 -178.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.541 ' H ' ' HB3' ' A' ' 271' ' ' ARG . . . 54.12 38.83 29.9 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.602 0.594 . . . . 1.8 112.602 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.461 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 42.0 m -167.05 -166.79 0.84 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.982 0.42 . . . . 1.45 111.082 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.612 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 87.6 mt 62.57 35.36 0.21 Allowed Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 115.01 -0.996 . . . . 1.23 112.487 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 274' ' ' LEU . 81.1 Cg_exo -52.32 129.56 32.05 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.968 1.779 . . . . 1.17 113.123 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 276' ' ' LYS . 13.5 tptp . . . . . 0 C--O 1.257 1.477 0 CA-C-O 118.127 -0.94 . . . . 2.16 111.351 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.563 0.221 . . . . 3.16 111.028 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -65.27 131.79 29.49 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.077 2.518 . . . . 2.25 112.695 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.23 -48.98 75.41 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.197 0.522 . . . . 1.42 111.039 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.553 ' HB3' ' HB2' ' A' ' 255' ' ' LEU . 21.8 mmt180 -93.96 55.21 2.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.157 0.503 . . . . 1.38 111.376 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.586 HG13 ' H ' ' A' ' 254' ' ' GLY . 2.5 p -49.76 -57.23 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.22 -0.9 . . . . 1.38 112.391 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.586 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -55.26 -48.28 69.88 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.869 -0.605 . . . . 0.95 112.671 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 252' ' ' ARG . 8.0 mt -60.18 -45.88 91.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.199 0.523 . . . . 1.21 111.156 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.68 -50.85 58.58 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.7 -0.762 . . . . 0.4 113.238 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 261' ' ' LEU . 2.2 pp -63.24 -40.23 88.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 117.394 0.597 . . . . 1.31 111.955 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 26.7 p -68.04 -43.92 77.59 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 121.028 -0.269 . . . . 1.4 111.723 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 p -64.81 -45.26 86.99 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.065 -0.254 . . . . 1.1 110.568 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.668 ' O ' HG22 ' A' ' 264' ' ' THR . 56.6 t -62.16 -49.71 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.56 -0.291 . . . . 0.72 110.626 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 257' ' ' ILE . 0.4 OUTLIER -56.31 -45.1 80.43 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.959 0.409 . . . . 1.35 110.674 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 97.8 m -60.96 -47.22 87.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.745 -0.661 . . . . 1.65 110.629 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 26.1 ttt -62.55 -54.37 40.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.832 -0.622 . . . . 1.6 111.507 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.668 HG22 ' O ' ' A' ' 260' ' ' VAL . 8.8 t -86.72 38.53 0.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.212 0.53 . . . . 1.15 111.59 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 7.2 t -64.39 -28.22 69.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.147 -0.479 . . . . 1.13 111.556 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 55.27 -108.21 0.42 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.085 -0.507 . . . . 1.61 112.319 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 58.2 m -162.04 137.36 7.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.749 0.309 . . . . 0.94 111.178 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.4 p -76.89 46.37 0.46 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.353 0.501 . . . . 1.49 112.353 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 159.94 -150.96 21.54 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.343 -0.932 . . . . 1.26 113.239 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 45.2 t -91.88 -23.05 19.76 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.734 0.272 . . . . 1.54 111.734 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.415 ' HB3' HD22 ' A' ' 274' ' ' LEU . 51.8 ttm-85 -66.02 131.09 45.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.994 0.426 . . . . 1.86 111.968 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -69.43 135.24 49.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.45 110.95 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.532 ' C ' ' HD3' ' A' ' 275' ' ' PRO . 27.3 m 64.58 52.46 1.75 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.461 0.648 . . . . 1.62 111.418 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.516 ' N ' ' HD3' ' A' ' 275' ' ' PRO . 32.4 tp -122.74 49.86 2.52 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.252 -0.885 . . . . 1.28 110.04 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.532 ' HD3' ' C ' ' A' ' 273' ' ' SER . 76.0 Cg_exo -48.64 -44.31 31.22 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 122.494 2.13 . . . . 1.27 113.369 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.447 -0.787 . . . . 2.16 111.064 179.16 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.418 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.539 0.209 . . . . 1.7 111.01 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.577 ' HB2' ' HB ' ' A' ' 253' ' ' VAL . 94.5 Cg_endo -73.25 58.13 3.55 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.47 2.78 . . . . 1.22 113.442 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -55.94 -45.58 78.77 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.946 0.35 . . . . 1.42 111.946 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -42.24 99.2 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.993 0.425 . . . . 2.79 110.225 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 250' ' ' PRO . 50.0 t -65.09 -49.01 81.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.071 -0.513 . . . . 1.1 110.57 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -59.03 -47.51 90.4 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.949 -0.569 . . . . 0.62 112.148 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 255' ' ' LEU . 17.2 tp -61.75 -42.99 99.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.998 0.428 . . . . 1.91 110.198 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -62.03 -53.24 44.33 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.9 -0.667 . . . . 0.97 112.907 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.63 -40.13 87.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 117.286 0.543 . . . . 0.97 111.646 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 21.0 p -65.69 -39.17 90.99 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.95 -0.3 . . . . 0.99 110.982 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 90.2 m -65.32 -47.75 75.46 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.947 -0.39 . . . . 1.49 109.947 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 256' ' ' GLY . 78.0 t -59.66 -48.05 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.031 -0.531 . . . . 1.25 110.422 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 261' ' ' LEU . 50.6 mt -59.62 -47.41 85.71 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.532 -0.304 . . . . 1.03 110.859 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 98.8 m -58.44 -44.16 89.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.338 0.59 . . . . 1.23 111.172 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 15.2 tpt -68.0 -46.99 69.73 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.549 -0.75 . . . . 2.12 111.904 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 260' ' ' VAL . 10.7 t -69.62 -39.3 77.26 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.279 0.474 . . . . 1.24 112.279 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.5 t -139.84 138.65 35.93 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.351 0.596 . . . . 0.93 111.35 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -163.43 -48.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.35 -0.386 . . . . 1.36 111.209 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 78.4 p 52.11 50.55 18.24 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.102 -0.499 . . . . 1.38 111.84 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 68.5 m -159.22 -154.78 0.43 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.372 -0.376 . . . . 1.58 110.983 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . 171.49 -134.11 2.96 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.589 -0.815 . . . . 1.43 112.821 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 50.4 m 67.59 -58.05 0.44 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.489 0.716 . . . . 2.54 112.4 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -94.26 -50.16 5.39 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.768 -0.196 . . . . 2.09 111.247 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . 68.31 -51.19 0.55 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.364 0.876 . . . . 2.4 113.364 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 68.7 p -74.96 109.14 8.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.385 0.612 . . . . 2.04 111.926 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.731 HD23 ' H ' ' A' ' 274' ' ' LEU . 2.1 pt? -84.52 -16.12 0.22 Allowed Pre-proline 0 CA--C 1.557 1.232 0 N-CA-C 114.315 1.228 . . . . 3.04 114.315 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 274' ' ' LEU . 54.5 Cg_exo -58.97 -41.2 64.07 Favored 'Trans proline' 0 C--N 1.374 1.92 0 CA-C-N 121.905 1.716 . . . . 2.48 114.137 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.642 -0.694 . . . . 3.76 111.338 -179.685 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.41 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.492 0.187 . . . . 2.74 111.012 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.41 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 83.3 Cg_endo -75.35 50.66 2.69 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.315 2.677 . . . . 1.85 113.324 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 56.68 -101.17 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.053 -0.522 . . . . 1.7 111.924 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.624 HH11 HD12 ' A' ' 255' ' ' LEU . 15.2 mmt85 -81.17 61.52 4.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.555 0.576 . . . . 1.4 112.555 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 254' ' ' GLY . 3.0 p -51.09 -54.36 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.934 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.503 ' H ' HG13 ' A' ' 253' ' ' VAL . . . -55.67 -49.29 66.35 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.609 -0.723 . . . . 0.57 112.768 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.624 HD12 HH11 ' A' ' 252' ' ' ARG . 3.2 mt -63.61 -41.9 98.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.848 0.356 . . . . 1.01 110.764 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 260' ' ' VAL . . . -61.39 -52.49 51.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.804 -0.712 . . . . 0.5 112.601 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.43 -37.83 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 117.086 0.443 . . . . 0.75 111.172 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.7 m -64.98 -41.25 95.6 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.745 0.307 . . . . 0.71 110.328 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 58.8 m -64.8 -48.71 73.46 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 110.002 -0.37 . . . . 0.63 110.002 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 256' ' ' GLY . 97.4 t -60.51 -46.57 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.121 -0.49 . . . . 0.63 110.626 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.648 ' HG ' ' HB2' ' A' ' 267' ' ' SER . 21.7 tp -60.45 -42.8 96.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.861 0.363 . . . . 0.99 110.842 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 97.2 m -63.82 -46.87 83.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.223 0.535 . . . . 0.81 110.839 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 49.0 tpp -63.06 -45.0 94.23 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.603 -0.726 . . . . 1.05 112.037 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 9.0 t -68.4 145.05 54.48 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.301 0.572 . . . . 0.77 111.698 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.643 ' HA ' ' HA3' ' A' ' 269' ' ' GLY . 9.0 t -64.19 -14.43 55.24 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.65 0.611 . . . . 1.04 112.65 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -57.38 -44.55 84.54 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.996 0.369 . . . . 1.41 111.996 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . 0.648 ' HB2' ' HG ' ' A' ' 261' ' ' LEU . 38.2 t -83.75 48.68 1.47 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.77 0.319 . . . . 1.04 110.884 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.4 m 60.3 41.06 16.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.998 -0.546 . . . . 1.31 111.255 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 265' ' ' THR . . . -67.78 -44.12 81.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.067 -0.587 . . . . 1.02 112.811 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 47.2 m -79.0 48.75 0.87 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.745 0.307 . . . . 1.2 111.466 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 69.83 132.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.979 0.912 . . . . 1.37 111.642 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -75.44 51.06 0.55 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.617 0.599 . . . . 1.78 112.617 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.578 ' HB2' ' HD2' ' A' ' 275' ' ' PRO . 69.6 p -170.91 114.65 0.43 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.762 0.791 . . . . 0.99 111.922 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.488 ' N ' ' CD ' ' A' ' 275' ' ' PRO . 51.0 tp -68.03 -28.58 1.91 Allowed Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 114.07 -1.423 . . . . 3.47 113.154 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 273' ' ' SER . 52.9 Cg_exo -61.54 -168.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 121.672 1.581 . . . . 2.29 113.569 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 7.9 ttpp . . . . . 0 C--O 1.256 1.429 0 CA-C-O 118.406 -0.807 . . . . 3.56 111.8 179.714 . . . . . . . . 0 0 . 1 stop_ save_